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ABSTRACT   
Attention-deficit hyperactivity disorder (ADHD) is a chronic disorder characterised by 
hyperactivity, difficulty in concentration and impulsivity. Other problems, such as academic 
difficulties and impeded social behaviours, tend to accompany this disorder, thus increasing the 
likelihood of a reduced adaptive functionality in adulthood. Conventional medications, although 
effective for most sufferers, have been documented to present with adverse effects and an 
increased risk of dependency, therefore compliance from patients may be poor. As a result, 
individuals struggling with ADHD often seek out other forms of treatment. Neurofeedback 
(electroencephalography biofeedback) is a type of therapy that aims to correct brain-wave 
dysregulation and enhance proper brain functionality, and is commonly used in conditions such as 
depression, anxiety and ADHD. Despite the abundance of evidence that affirms its value in the 
treatment of ADHD, there have been limited studies done to date regarding neurotherapists’ 
experiences of neurofeedback in the treatment of this condition.   
  
The purpose of this study was to discover and describe the experiences of neurotherapists in the 
province of Gauteng, South Africa who are treating ADHD patients with neurofeedback therapy, 
by means of face-to-face interviews. This exploratory and phenomenological qualitative research 
study thus used interviews to examine the experiences of neurotherapists using neurofeedback 
therapy in treating their ADHD patients in private practices located within the province of 
Gauteng, South Africa. Neurotherapists registered with the Biofeedback Association of South 
Africa (BFSA) were recruited through purposive sampling. Recruitment communication was done 
via email and telephonic means and all relevant information sheets regarding the study were 
emailed before the commencement of the interviews. Those who volunteered to take part gave 
permission for both their participation and the audio recording of the interviews. All six 
participants involved met all inclusion criteria of the study. Every interview was driven by the 
central question, “Tell me about your experiences using neurofeedback as a treatment for patients 
with ADHD in your practice?”  
  
Three themes were identified from the data collected by interviewing six neurotherapists who 
make use of neurofeedback in the treatment of ADHD in their practice. Data was coded line-by-
line and organised for analysis. Theme one was the experiences of the neurotherapists and the 
challenges they encountered while using the therapy. Theme two was the value of neurofeedback 
in private practice, while theme three was the reputation neurofeedback has amongst the public. 
Participants reported positive experiences with neurofeedback. They described neurofeedback as 
their preferred method of treating ADHD, as well as other neurological conditions such as 
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Tourette’s syndrome and tics. Emotional irregularities like depression and anxiety were also 
discussed as benefiting from the therapy. Participants mentioned that although they face 
challenges when treating patients with ADHD, they have learnt to adapt their sessions to ensure 
that the patient receives the most benefit. All neurotherapists expressed their frustrations in the 
limitations they have found with their treatment, which include how patient compliance and 
chaotic life situations have a direct impact on the patient’s improvement. Neurotherapists also 
expressed their concern about the public misconception of neurofeedback, which is largely owing 
to unlicensed individuals treating patients and advertising it as a “cure all” modality.   
  
In terms of recommendations, neurotherapists should publish case studies and articles in accredited 
online journals. With regards to the unmonitored online training in neurofeedback, perhaps laws 
can be drafted that prohibit sites from offering neurofeedback-related courses unless they are 
approved by the BFSA. Owing to the lack of knowledge and limited research done regarding the 
therapy, it is imperative that more studies like this one are carried out in the future.  
  
From this qualitative study, a crucial understanding of the value that neurofeedback therapy has 
for neurotherapists treating patients with ADHD was discovered, paving the way for further 
studies in this field.   
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CHAPTER 1: OVERVIEW OF THE STUDY   
  
1.1 INTRODUCTION   
This first chapter provides an outline of the study, illustrating the background of the research, the 
methodology and the research problem.   
  
1.2 Attention-deficit hyperactivity disorder (ADHD)   
1.2.1 Introduction to ADHD   
ADHD is a developmental disorder presenting with consistent symptoms of inattention or the 
inability to focus, together with impulsivity and hyperactivity. This disorder negatively impacts on 
the individual’s social, behavioural, cognitive and occupational development. As much as 50% of 
ADHD children will live with the disorder into their adult lives (Bangma et al., 2019). In recent 
decades, ADHD has become one of the most prevalent childhood neuropsychiatric disorders 
worldwide, and around 70% of symptoms continue into adulthood. Owing to the lack of training 
in primary healthcare facilities which leads to incorrect ADHD diagnoses, limited access to 
information resources, the lack of necessary referrals to specialised doctors, an insufficient supply 
of treatment and an absence of recorded South African patient data, there is a lack of accurate 
prevalence statistics. It is however noted that in South Africa, ADHD affects between 2% and 16% 
of school children. When extracting statistics from the South African Journal of Psychiatry, it has 
been calculated that there are around 1 million people between the ages of 20 years and 50 years 
who are affected by ADHD (Schoeman et al., 2017). In a database analysis done in South Africa, 
it was estimated that the prevalence of ADHD in adults is between 2.5% and 4.3%, of which 9.09% 
have co-morbidity with at least one other psychiatric condition, and 10.95% have two or more 
concomitant psychiatric conditions (Danielson et al., 2018).  
  
1.2.2 Diagnosis of ADHD   
There is no single genetic, physical or medical test that can be used to diagnose ADHD. However, 
a qualified physician may use several evaluations in order to assess patients for this condition 
(NIMH, 2016). The American Psychiatric Association’s Diagnostics and Statistical Manual of 
Mental Disorders, fifth edition (DSM-5) classifies ADHD under the Neurodevelopmental 
Disorder category and arranges it into three types: hyperactive/impulsive, predominantly 
inattentive and combined (refer to Appendix A for the DSM-5 classification) (DSM-5, 2013).  
  
It is important to only consider diagnosing ADHD if the individual meets the ADHD criteria and, 
upon completing a symptom checklist, acknowledges that six or more of the 
hyperactivity/impulsivity or inattention symptoms are evident in most days for a period of at least 
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six months, and that these symptoms are linked to impaired social, behavioural and developmental 
functionality (CDC, 2017; DSM-5, 2013). A comprehensive history of past and current academic 
and behavioural performances, a medical history of both the individual and the family, a social 
and developmental history and an evaluation from a psychiatrist if present, are also helpful in 
reaching a diagnosis (Flisher & Hawkridge, 2013).   
  
In South Africa, the Diagnostic Interview Schedule for Children (DISC-IV) is routinely used to 
discern and diagnose ADHD in children. Rating scales, which involve input from the parents and 
teachers, are used to collect a wide range of data. Examples of such scales include the Conner’s 
Parent Rating Scale – Revised (CPRS-R) and the Conner’s Teacher Rating Scale – Revised 
(CTRS-R). Both scales are useful in discerning the severity of the condition. Other commonly used 
rating scales include the MOXO ADHD test and the Conner’s Comprehensive Behaviour Rating 
Scale (CBRS) (CDC, 2017).  
  
1.2.3 Pathophysiology of ADHD  
ADHD is a multi-faceted condition and several pathophysiological processes that are involved in 
its development have been identified.   
  
1.2.3.1 Specific genes  
   
In previous years, genetic-wide association studies (GWAS) and familial candidate gene studies 
have narrowed down the genetic factors responsible for ADHD (Hawi et al., 2015). These genes 
are divided into four types of pathways: noradrenergic (NET1/SLC6A2, ADRA2A and ADRA2C), 
dopaminergic (DAT1 and DRD4), nicotinergic (CHRNA4) and serotonergic (5HTT/SLC6A4, 
HTR1B and SLC6A3) (Hong et al., 2018). It appears that in order to create the ADHD genetic 
substrate seen in most ADHD sufferers, certain genes need to be influenced by negative 
environmental factors interacting with each other within the body (Hayman & Fernandez, 2018). 
Another polymorphic allele, 5-HTTLPR (serotonin-transporter-linked polymorphic region) is a 
mutated repeat of the gene SLC6A4, which codes for the transportation of serotonin, and is often 
found in ADHD sufferers who show a significantly reduced gene expression of serotonin 
transportation (Thakur et al., 2010).   
  
1.2.3.2 Brain abnormalities   
Functional magnetic resonance imaging (fMRI) studies conducted over a thirty-three year follow-
up period have shown occipital cortical thinning in ADHD patients, which results in the individual 
being easily distracted while performing tasks, owing to the close interaction the occipital lobe has 
with the system that maintains attention, i.e. the dorsal network. Cortical thinning of the temporal, 
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posterior frontal and parietal areas of the brain have also been observed, correlating to the dorsal 
attentional network and limbic areas, which control emotion and behaviour (Proal et al., 2011).   
  
1.2.3.3 Development  
A vital component of child development is the state of the environment in which the child is 
nurtured. Both impoverished as well as overly polished environments may play a negative role in 
the maturation and refinement of synaptic circuits of the pre-frontal cortex, suggesting that later in 
life there may be social, intellectual and emotional issues. A highly stressful environment, or one 
which lacks emotional nurturing, not only hinders the maturation of neuronal pathways, but also 
leads to irreversible modifications of prefrontal cortex connections (Gould et al., 2018).  
  
1.2.3.4 Nutrient deficiencies  
Magnesium plays a vital role in all enzymatic systems within the body, including communication 
of neurotransmitters such as serotonin, dopamine and norepinephrine (Huang et al., 2018). 
Magnesium stimulates tyrosine hydroxylase, an enzyme necessary for the production of dopamine, 
thus a deficiency of magnesium may therefore cause an inadequate amount of dopamine to be 
synthesised (Villagomez & Ramtekkar, 2014). A recent meta-analysis conducted on twenty-seven 
studies relating to mineral deficiencies deduced that people diagnosed with ADHD did in fact have 
lower magnesium levels, evidenced in both blood and hair samples (Mahmoud et al., 2011).    
  
Deficiencies in nutrients such as iron, zinc and vitamin D are often associated with conditions that 
mimic ADHD symptomology. Furthermore, a lack of dietary iron may lead to restless legs 
syndrome, a form of hyperactivity often seen in ADHD children. Inadequate amounts of vitamin 
D in the diet during development has detrimental effects on the ability of maturing brain cells to 
differentiate and on the dopaminergic system, and is associated with an enzyme responsible for 
dopamine synthesis: tyrosine hydroxylase (Villagomez & Ramtekkar, 2014).   
  
1.2.3.5 Neurotransmitters  
Dopamine is a vital neurotransmitter for learning, cognition, motor control, memory and 
neuroendocrine signalling, and low levels are found to be associated with ADHD (Tovo-Rodrigues 
et al., 2013). For many years, ADHD has been described as a hypodopaminergic disorder because 
of an inadequate amount of dopamine found in the synaptic clefts. Research studies have shown 
that abnormalities in this neurotransmitter, result from mutated dopaminergic genes such as DRD2, 
DRD4, DRD5, DAT1 and DBH, of which DRD4 is the most researched. The hypodopaminergic 
theory has been clinically validated by the benefits observed when ADHD patients use 
pharmacological agents that increase the concentration of dopamine in the synaptic clefts (Dunn 
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et al., 2019). Serotonin is also known to be a significant modulator in behaviour and reduced levels 
have been observed in ADHD individuals (Dayan & Huys, 2009; Wang et al., 2018a). Minerals 
such as magnesium, iron, zinc and vitamin D play a role in the synthesis of neurotransmitters, 
which explains why mineral deficiency may lead to ADHD-like symptoms (Villagomez & 
Ramtekkar, 2014).   
  
1.2.3.6 Pre-natal exposure to alcohol and tobacco  
A recent case-control research study done on children in China found a prominent link between 
exposure to tobacco in the womb and ADHD, owing to gene mutations of SLC6A4 rs6354, DRD2 
rs1124491 and ADRA2A rs553668. Furthermore, there was an additive effect of the gene 
ADRA2A rs553668 already present with environmental risks, such as post-natal tobacco or 
alcohol exposure (Wang et al., 2019). A recent journal article argued that foetal alcohol spectrum 
disorders (FASD) appear to have a surprising influence on the development of ADHD, and a 
diagnosis of FASD increases the risk for this condition by 19% (Pagnin et al., 2018; Burd, 2016).   
  
1.2.3.7 Brain waves and their effect on ADHD  
Correct brainwave frequencies are vital for optimal cognitive functionality of the brain. Theta 
brainwaves occur when daydreaming and are crucial for creativity. Larger frequencies of theta 
waves are often present when an individual engages in cognitive tasks and problem solving as well 
as during deep meditative states. An excessive concentration of theta waves occurring during a 
normal wakeful state is commonly found in learning disorders characterised by inattention, such 
as ADHD (Roy, 2014b). Alpha waves occur in relaxed and calm states and ADHD individuals 
tend to have a low concentration of alpha wave activity in the frontal cortex (Roy, 2014b). Beta 
waves are prevalent when there are intellectual and cognitive tasks being performed, such as 
problem solving and information processing. Excessive beta wave activity is often found in cases 
of obsessive-compulsive disorder, anxiety, insomnia and ADHD (Li et al., 2017). Gamma waves 
are present when information is being processed and neuronal connections are transferring 
information to various parts of the brain. Higher intelligence is often associated with high levels 
of gamma waves, while low concentrations of gamma are often associated with impeded mental 
functionality, cognitive decline and learning difficulties (Tombor et al., 2018).   
  
1.2.4 Pharmacological treatment of ADHD  
ADHD medications aim to increase an individual’s attention and concentration as well as control 
activity levels and impulsivity. They are divided into two categories, based on both chemical 
composition and duration of the effects (Brown et al., 2018).  
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• Stimulants e.g. Concerta and Ritalin (Methylphenidate hydrochloride): These medications 
work by enhancing the concentration of dopamine and norepinephrine in the brain by 
promoting their delivery in the prefrontal cortex. The active ingredient connects to the 
dopamine transporter and interferes with the reuptake of dopamine in the synaptic cleft 
(Shier et al., 2013). Adverse effects may include impeded growth, depression, anxiety, 
anorexia, raised blood pressure, headaches, insomnia and gastric upsets (Bolea-Almanac 
et al., 2014).   
• Non-stimulants e.g. Vyvanse (Lisdexamfetamine): These medications specifically target 
norepinephrine, which is vital in executive function and can therefore aid control over 
emotions and task completion. They may be associated with weariness, drowsiness and 
dizziness because of reduced blood pressure, heart palpitations, anorexia, gastric upsets, 
headaches, anxiety, irritability and depressive episodes (Shier et al., 2013; AACAP, 2013).   
  
Other treatment for ADHD may include selective-serotonin reuptake inhibitors (SSRIs), tricyclic 
antidepressants (TCAs) and serotonin norepinephrine reuptake inhibitors (SNRIs), because of the 
impact they have on serotonin levels in the brain, which is now acknowledged as being a significant 
modulator in behaviour (Park et al., 2014). These medications may result in sexual dysfunction, 
insomnia and weight gain (Allen, 2011; Santarsieri & Swartz, 2015).  
  
The benefits of pharmacological treatment are evident when the individual is on the medication 
daily; however taking medication every day causes the gap between independence and abuse to 
narrow (Bolea-Alamanac et al., 2014). According to a 2014 press release by the Attention Deficit 
and Hyperactivity Support Group (ADHASA), South Africa has one of the highest prescription 
rates for ADHD medications, as well as a large misdiagnosed population (ADHASA, 2014). In a 
study done on 818 university students in the Free State, it was revealed that 17.2% of participants 
had previously used methylphenidate, although only 2.9% had been diagnosed with ADHD (Jain 
et al., 2017). Almost a third of users illegally consumed methylphenidate products, with the 
majority using it during times of stress. There was also a connection found between the use of 
methylphenidate and substance abuse (Stein et al., 2015).   
  
1.2.5 The socio-economic impact of ADHD   
ADHD is known to be a debilitating chronic disorder that interferes with several aspects of the 
individual’s life. It has an impact on social interaction and educational performances, and creates 
a strained child-parent relationship (Hillard et al., 2013; Babinski et al., 2014). Several studies 
done on both ADHD patients and their families have shown that parents are often dissatisfied with 
their child’s behaviour, as there is an increased demand for supervision, resulting in frustration and 
   6  
strained relationships with their child. It is also common for parents to become depressed, owing 
to feelings of guilt (Flouri et al., 2017).   
  
The ADHD primary school child will start showing differences in maturity and skills. These 
differences impede learning. Many ADHD primary school children display early academic 
failures, develop low self-esteem and experience peer rejection (Merrill et al., 2019).   
  
Later, in adolescence, a distorted development of self-esteem and an impaired image of self may 
lead to anti-social, aggressive and possibly criminal behaviours (Flouri et al., 2017; Watts, 2018). 
Adolescents with ADHD may develop a condition called oppositional defiant disorder (ODD), 
which is characterised by displays of aggressive behaviours towards authoritative figures, violating 
another’s rights and being defiant and disobedient with others. There may be an increased 
incidence of academic failures, leading to dropping out of high school or university, criminal acts, 
teenage pregnancy and traffic accidents, as ADHD individuals often display impulsive behaviours 
(Hillard et al., 2013).   
  
Finally, adults suffering from the effects of ADHD often experience difficulty in obtaining and 
maintaining employment and in preserving healthy relationships, both collegial and personal, 
increasing the risk for substance abuse and depression (Babinski et al., 2014).   
  
1.3  NEUROFEEDBACK THERAPY  
1.3.1 Introduction to neurofeedback therapy  
Neurofeedback is a type of neuro-stimulatory behavioural therapy, implemented by means of 
cerebral-computer-integration, in which one incorporates real-time measuring of brain-wave 
activities and operant conditioning to allow for optimal self-regulation of cognitive activities 
(Pigott et al., 2012). It is a pain-free procedure in which one retrains the mechanisms and neuronal 
connections in the brain. This alternative therapy falls under biofeedback, a category belonging to 
the biomedical field. This approach has the potential to produce long-term results from short term 
exposure to therapy (Mohagheghi et al., 2017). Neurofeedback works in three stages: firstly, it 
normalises cortical activity of inappropriate brain-wave frequencies by inhibiting high 
concentrations of slow-wave activity (theta waves) and favouring fast-wave activity (alpha and 
beta waves) (Mohagheghi et al., 2017); secondly, it increases sensorimotor rhythm (SMR) also 
known as brainwaves and reduces hyper-motoric symptoms such as physical restlessness; and 
thirdly, it increases the threshold of the otherwise slow cortical potential (namely theta waves) 
seen in ADHD (Gonzalez-Castro et al., 2015). This training paradigm directs stimulant features of 
cortical arousal. Neurofeedback uses positive feedback that leads to the induction of morphological 
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neural changes and alteration of dendrite activity, which results in improved neuroplasticity in the 
brain. After therapy, the number of new action potentials increase, allowing for additional 
connections to be made. As a form of neurorehabilitation, neurofeedback also helps the individual 
improve their social functioning (Markiewicz, 2017).  
  
1.3.2 Types of neurofeedback therapy  
1.3.2.1 Sensorimotor (SMR) neurofeedback/power training   
Sensorimotor is the traditional type of neurofeedback, also known as power training or 
electroencephalography (EEG) biofeedback (Bratt, 2012a). The amplitude of the patient’s 
brainwaves that govern cognitive functioning are observed and the frequency bands are modulated 
as required (BFSA, 2018b).  
  
1.3.2.2 Exact low-resolution brain electromagnetic tomography   
Exact low-resolution brain electromagnetic tomography (eLoRETA) is used to reveal in a three-
dimensional aspect, which brain areas are active and functional while the individual is performing 
a mental activity and localises the electrical functionality of the brain using scalp potentials of 
several channel EEG recordings (Roy, 2011).   
  
1.3.2.3 Alpha/theta neurofeedback  
This deep-state type of neurofeedback is performed with closed eyes and is of huge benefit to those 
with “high beta dominance” and addicts (BFSA, 2018b). It is used to facilitate deep-change 
psychotherapy when treating addictions, anxiety, insomnia and pain and to enhance peak 
performance (Bratt, 2012b).   
  
1.3.2.4 Neuro-gen HPN ultra low power neurofeedback  
This training is used for concussion syndromes, post-traumatic stress disorder (PTSD), depression, 
anxiety, traumatic brain injuries and ADHD. It tracks and determines the electrical functionality 
of brainwaves, then delivers a subtle signal back to the brain based on the brain frequency 
observed. Even though the frequency is subtle and weak, the brain responds by altering its 
cognitive functioning relative to those weak receiving signals to a more optimal threshold (Bratt, 
2012c).  
  
1.3.2.5 Hemoencephalography (HEG)  
This training uses the blood flow to the brain as a means of feedback instead of brainwave 
frequencies. The patient is therefore trained to increase their cerebral blood flow to a targeted brain 
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location, which causes an improvement in cognitive activity and performance in the brain (Bratt, 
2012d).  
  
1.3.2.6 Beta reset neurofeedback  
This type of neurofeedback corrects non-neuronal and neuronal dysfunction and is beneficial in 
treating chronic neurodegenerative conditions such as Parkinson’s, neuromuscular diseases and 
possibly Alzheimer’s (Bratt, 2012e).  
  
1.3.2.7 Infra-low (ILF) neurofeedback  
This type of neurofeedback, also known as “slow cortical potential neurofeedback”, involves 
training with the slowest frequencies, less than 0.5 hertz. It regulates the brainwaves through subtle 
stimulation and enables the brain to match a slow, steady rhythm (Roy, 2015).  
  
1.3.2.8 Coherence training  
Unlike the traditional type of neurofeedback, which focuses predominantly on amplitude training, 
coherence training targets the communication between the various areas of the brain. If the areas 
are hypo-coherent, there is under connectivity of the brain, while hyper-coherence shows over-
connective brain areas. Both types are considered to cause cognitive miscommunication (Bratt, 
2012f). Coherence training aims to improve communication between these neurological areas, 
which consequently improves neuronal connectivity and network plasticity (BFSA, 2018b).   
  
1.3.2.9 Live Z-score training   
This training incorporates coherence and power training (Loewenthal, 2019) to stabilise 
incompetent electrical networks by improving neuronal connections (BFSA, 2018b).   
  
1.3.3 The quantitative EEG session (qEEG)  
A qEEG test is done before the initial neurofeedback session to provide the therapist with an 
analysis and reference that can be used to track progress during the sessions; it enables the therapist 
to understand which brainwaves need to be reduced and which need to be enhanced for optimal 
cognitive functioning. It is a procedure that organises the processed EEG activity using a 
multielectrode scalp cap directed by a computer software algorithm. The digital data obtained from 
the qEEG software is then compared to “normative” database values for reference. The EEG data 
is displayed to the neurotherapist as a map of colours over the brain regions. The session is divided 
into two separate parts of recording brain wave activity: in the first part, the patient sits still for 
five to eight minutes with his/her eyes open, and in the second, the patient closes his/her eyes for 
five to eight minutes (Roy, 2011).   
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1.3.4 The neurofeedback session   
The patient will start by sitting in a quiet, isolated room in a reclined chair and is made as 
comfortable as possible. EEG sensors (electrodes) are placed on specific areas of the scalp in 
relation to the cerebral lobes to enable the transmission of brain-waves to the machine and the 
computer screen that is placed in front of the patient. Electrodes are also connected to each earlobe 
as a reference and to track muscle movement. The feedback the neurotherapist receives is depicted 
as brainwave amplitudes and frequencies, which are displayed on a computer screen facing the 
neurotherapist, enabling him/her to make necessary changes during the course of the session 
(Markiewicz, 2017). The computer software transmits real-time information regarding brain-wave 
activities back to the patient via speakers and the computer screen in front of the patient in the 
form of a game. The brainwaves then manipulate the video game (Roy, 2012). The feedback to the 
patient consists of visual and auditory “rewards” (ISNR, 2009). These stimulatory games have 
modified control components that guide the patient to a favoured course of change. When the brain 
meets a satisfactory brainwave level for a certain period of time, rewards are delivered by sound. 
The patient’s brain then seeks more of these sounds, so will wish to repeat that experience. 
Neuromodulators (such as dopamine) are released, which promote structural neuroplasticity, 
where new and improved networks are built within the brain. As the patient’s condition improves, 
the neurofeedback therapist continues to increase the level of difficulty to challenge the 
individual’s neuroadaptation and lead the patient to a higher state of self-regulation and cognition 
(ISNR, 2009).   
  
1.3.5 Neurotherapists’ scope of practice in South Africa   
In 2018, there were twenty neurotherapists registered with the Biofeedback Association of South 
Africa (BFSA), eleven of which resided in Gauteng. Neurotherapists are required to have a 
minimum of a four-year degree in the field of either Health Sciences (e.g. homoeopathic 
practitioners), or Allied Health or Behavioural Sciences (e.g. psychologists). The member has to 
be registered with the Health Professions Council of South Africa (HPCSA) or his/her own 
regulatory council. The practitioner needs to attend biofeedback courses with a minimum of 
thirtysix hours of learning prior to registration (BFSA, 2016). After passing the board exam 
designed by the Biofeedback Certification International Alliance, the individual will then intern 
under a mentor, becoming a registered technician once he/she has had a minimum of five years of 
experience and accumulated over a hundred patient hours (Loewenthal, 2018). Each neurotherapist 
can only work within his/her scope of training and may need to refer patients to and work alongside 
other types of practitioners, such as medical practitioners, homoeopaths, psychiatrists and 
nutritionists. Each neurotherapist has to be affiliated with the BFSA, which is the only governing 
body for practitioners using biofeedback and neurofeedback in South Africa (BFSA, 2018a).  
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1.3.6 The role of neurofeedback in the treatment of ADHD  
EEG studies have found that there is an excess of slow-wave activity (theta brainwaves) in patients 
with ADHD (Markiewicz, 2017), which coincides with the lack of fast-wave activity (alpha and 
beta brainwaves) in the frontal cortex (Hillard et al., 2013). The correct concentration of alpha 
waves is related to ideal cognitive processing and memory functionality and persistent activity of 
the brain and memory functionality. A sensorimotor rhythm known as “low beta waves” is often 
found to be lacking. An excess of theta waves may result in the negative symptoms often observed 
with ADHD sufferers, such as inability to focus, impulsivity and hyperactivity (Markiewicz, 
2017). Most therapists implement theta suppression at the central or frontocentral site, while 
simultaneously increasing the sensorimotor rhythm or low beta waves (Hillard et al., 2013). 
Neurofeedback uses positive feedback and the neuroplasticity of the brain to heighten beta and 
alpha wave activity, resulting in a focused and alert but relaxed state (Roy, 2012).   
  
1.3.7 Homoeopathy  
Homoeopathy is a complementary form of medicine that was established over 200 years ago by a 
German chemist, physician and linguist named Dr Samuel Hahnemann, who was born on 10 April 
1755 and died in 1843 (Loudon, 2006). After rejecting the violent and superstitious treatment of 
patients of the time, he sought out to develop a more gentle, holistic form of therapy. 
Homoeopathic medicines are made from a variety of sources, such as plants, metals, minerals, 
animals, diseased secretions, and both healthy and diseased organs (Grollman & Maurer, 2002).   
  
Homoeopathy is founded on several important principles, namely (1) “similia similibus curentar” 
or “let like be cured by like”; (2) the principle of minimum dose; (3) the principle of the single 
dose; and (4) the Laws of Cure, which state the different patterns of healing that can be observed 
by the doctor in his patient (Hahnemann, 2011a; Hahnemann, 2011b; Hahnemann, 2011d; Loudon, 
2006; Harrison, 2011).    
  
1.3.7.1 The homoeopathic consultation  
In Hahnemann’s treatise on homoeopathy, “Organon of Medicine,” he states that, in order for the 
homoeopath to achieve complete cure for every patient he/she treats, treatment must be done in 
the gentlest, most empathetic and individualised way possible (Hahnemann, 2011c; Hahnemann, 
2011e). Homeopaths greatly value sympathy, empathy, understanding, holism and time (Ernst, 
2011). In a homoeopathic consultation, it is common to find a healthy, communicative patient-
practitioner relationship, which is a major contributing factor to the success rate of treatment 
response and patient satisfaction (Brien et al., 2010).  
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1.3.7.2 Neurofeedback and homoeopathy  
Neurofeedback aims to manage and, if possible, permanently alleviate an individual’s neurological 
deficit and help them develop coping skills in the most non-invasive, holistic and scientifically 
valid method possible (Hammond, 2010a). To this degree, it can be integrated with homoeopathy, 
an alternative, natural approach to health that views the patient as an individual and strives to use 
the gentlest and most suitable form of treatment possible to effect permanent cure (European 
Committee for Homoeopathy, 2017). It is important to note that there are similarities in 
homoeopathic and neurofeedback consultations. Neurotherapists typically use one-on-one sessions 
characterised by frequent communication between practitioner and patient, and the time spent in 
every session results in a close and trusting relationship between the two. It is vital that every 
practitioner-patient relationship is based on a professional and empathetic foundation to ensure the 
best outcome for each patient (Krogh et al., 2019).   
  
1.4 RATIONALE   
A systematic review and meta-analysis done in 2018 on the effect of neurofeedback on ADHD 
evaluated 10 clinical trials. The study found evidence of sustained behavioural improvements 
when neurofeedback is administered over a period of up to a year. Patients receiving 
neurofeedback were found to have more durable treatment effects for more than six months 
posttreatment. The authors concluded that neurofeedback can be considered a sustainable form of 
alternative treatment to ADHD when pharmacological interventions are no longer an option (Van 
Doren et al., 2018). No qualitative studies have been conducted on the experiences of 
neurotherapists in the treatment of ADHD.   
  
1.5 PROBLEM STATEMENT  
ADHD often results in academic difficulties and impeded social behaviours, increasing the 
likelihood of reduced adaptive functionality in adulthood (Flouri et al., 2017). Conventional 
medications, although effective for most sufferers, have been documented to present with adverse 
effects and an increased risk of dependency (Johnston et al., 2013; Hogue, 2015). As a result, 
individuals struggling with ADHD often seek out other forms of treatment (Van Doren et al., 
2018). With regards to neurofeedback, although there is an abundance of evidence to confirm its 
value in the treatment of ADHD, there are no studies on neurotherapists’ experiences of the use of 
neurofeedback in the treatment of this condition. Many alternative therapies are not well-known 
to the public, and neurofeedback in particular is misunderstood, owing to the public’s lack of 
knowledge and its poor reputation (Bow, 2019; Van Niekerk, 2019).   
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1.6 AIM OF THE STUDY  
The aim of the study was to use in-depth individual interviews to explore and describe 
neurotherapists’ experiences of the use of neurofeedback in the treatment of ADHD.  
  
1.7 RESEARCH QUESTION  
The central question of this study was carefully developed in order to obtain information-rich data 
for this research. Sub-questions were devised in order to facilitate the interview process and gather 
further information.   
  
1.7.1 Central Question   
Tell me about your experiences using neurofeedback as a treatment for patients with ADHD in 
your practice?  
  
1.7.2 Sub-questions  
1.7.2.1 What are the challenges you face when dealing with ADHD patients in particular?  
1.7.2.2 What challenges do you experience with neurofeedback as a therapy?  
1.7.2.3 In your experience, what is the role of neurofeedback in treating ADHD?  
1.7.2.4 How long on average before an effect is noticed with neurofeedback on your ADHD 
patients?  
1.7.2.5 Do you find neurofeedback to be a valuable tool for ADHD patients in your practice?  
  
1.8 OBJECTIVES OF THE STUDY  
To accomplish the aim of the study, the following objectives had to be met:   
  
1.8.1 To examine and discuss, using a qualitative phenomenological framework, the experiences 
of neurotherapists who use neurofeedback to treat patients with ADHD in their practice.  
1.8.2 To identify the challenges faced by neurotherapists when treating ADHD patients.      
1.8.3 To identify the perceived value and role that neurofeedback plays in the treatment of ADHD  
 
1.9 KEY CONCEPTS   
1.9.1 The Biofeedback Association of South Africa (BFSA)  
The BFSA is the only governing body for practitioners using biofeedback and neurofeedback in 
South Africa. Its aim is to offer the opportunity for education and training and to provide guidance 
and regulations to its practitioners who adhere to the standards and scope of practice regarding the 
use of biofeedback and neurofeedback in a professional and ethical manner (BFSA, 2018a).  
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1.9.2 Experience  
Experience is gained through direct, personal participation and observation in a situation, which 
causes an individual to gain subjective knowledge and perception (Merriam-Webster, 2019a).  
  
1.9.3 Neurofeedback   
Neurofeedback is a type of biofeedback that deals with regulating brain wave activity. It is also 
called EEG biofeedback (BFSA, 2018b).   
  
1.9.4 Neurotherapist   
A therapist or practitioner who has been trained and specialises in the alternative treatment of 
neurotherapy. They are affiliated with the Biofeedback Association of South Africa. In order to 
study neurofeedback, an individual has to obtain a health science degree (BFSA, 2018a).  
 
1.9.5 Neurotherapy 
This form of psychotherapy deals with issues such as depression, insomnia, anxiety and 
neurological deficits. This term includes alternative therapies like neurofeedback and biofeedback 
which approaches neurological conditions in a more holistic manner (Loewenthal, 2018).  
 
1.9.6 Phenomenological  
Phenomenology is the philosophical study of the way humans experience situations, thus giving 
meaning to how things are observed (Merriam-Webster, 2019b). This includes appreciating the 
importance of a person’s perception, memory, emotion, thought, desire, imagination and volition 
(Smith, 2018).   
  
1.9.7 Qualitative research  
This type of research sees value in the quality of something measured, rather than the quantity 
(Oxford Dictionary, 2019).   
  
1.10 REVIEW OF RESEARCH DESIGN AND METHOD  
1.10.1 Research design   
This study uses  a qualitative, phenomenological research design to explore the subjective 
experiences of neurotherapists using neurofeedback as a form of ADHD treatment (Creswell, 
2013). The interview comprised of open-ended questions, and data was elicited from information-
rich participants.   
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1.10.2 Research method  
The study population consisted of six neurotherapists registered with the BFSA, who used 
neurofeedback as their sole form of treatment for ADHD patients. Each neurotherapist was 
recruited by means of purposive sampling, as their contact information was freely accessible on 
the BFSA website (BFSA, 2016). Participants were chosen based on their location in and around 
the Gauteng province. There was no pre-determined sample size; participants were recruited until 
data saturation was reached, which is imperative to this type of study (Fusch & Ness, 2015).   
  
An email providing information (Appendix B) about the study was sent by the researcher to all 
potential participants. Those who were interested in participating were asked to contact the 
researcher, whose contact details were provided in the information letter, and appointments were 
scheduled at the participants’ convenience. Those who wished to participate were requested to sign 
both the consent form (Appendix C) and a form that requested permission to audiotape the session 
(Appendix D). To ensure a private setting, the interview was conducted in each of the participants’ 
consulting rooms and lasted on average thirty minutes. A face-to-face interview with one central 
question – namely, “Tell me about your experiences using neurofeedback as a treatment for 
patients with ADHD in your practice?” – was conducted and the session was audiotaped. 
Additional questions were asked to expand on answers provided and to facilitate the interview 
process. Bracketing was performed by the researcher to ensure objective, unbiased results 
(Creswell, 2013). When each interview was in process, field notes were made by the researcher, 
which were used at a later stage in the data analysis. The audiotapes were erased after the 
transcriptions were done. Refinement of the interview technique occurred with each interview. A 
confidentiality form was also signed by the qualitative analyst (Appendix E) to ensure 
confidentiality. Interviews occurred until data saturation was achieved, i.e. no new information 
was obtained.  
  
1.10.3 Data analysis    
Data was analysed with the help of a qualitative analyst, and the qualitative software ATLAS.ti 8 
was used to manage the data by assigning codes to the statements, categorising them and 
developing themes. After the identification of common patterns and trends, the data was assembled 
and compressed and then displayed using visual, tabulated and textual means (Feely, 2014). The 
report written by the qualitative analyst can be seen in Appendix F.   
  
1.11 RELIABILITY AND VALIDITY   
Policies were strictly followed to ensure trustworthiness of the study. It is imperative for a 
qualitative study to demonstrate trustworthiness so that reliability and validity are achieved. For 
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qualitative studies, credibility, transferability, dependability and confirmability must be explored 
(Nowell et al., 2017). These aspects are discussed in depth in Chapter 2.   
  
1.12 ETHICAL CONSIDERATIONS  
Every ethical matter was regarded as being important throughout the study, as doing so is a moral 
baseline for credible and just research. Participation in the study remained anonymous, and 
participants gave written and informed consent. Each participant was treated with respect and 
fairness. Audio recording was done to guarantee accurate documentation of the information and 
then deleted after the data was transcribed to ensure participants remained anonymous. During the 
interviews, the identities of patients that were seen by neurotherapists were not revealed to 
maintain confidentiality.   
  
1.13 POSSIBLE OUTCOMES  
One possible outcome of this qualitative study is that it will provide insight into the use and 
perceived significance of neurofeedback by neurotherapists in the treatment of patients with 
ADHD. This study will provide the foundation for future research in the field.   
  
1.14 CHAPTER SUMMARY   
This first chapter provided a background to the research problem and an outline of the study’s aim 
and purpose, as well as the possible outcomes. In the second chapter, the researcher will provide 
more detail regarding the study’s research methodology.  
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CHAPTER 2: METHODOLOGY  
  
2.1 INTRODUCTION   
In this chapter, an in-depth overview of the research design and procedure is provided.   
  
2.2 AIM AND OBJECTIVES   
2.2.1 Research design   
This study’s purpose was to explore neurotherapists’ experiences of using neurofeedback as a form 
of treatment for ADHD in their respective practices. As such, this study can be seen as both 
exploratory and descriptive. This study features a qualitative, phenomenological research design.  
  
2.2.1.1 Qualitative research design   
As explained by Yin (2016), qualitative research involves capturing the perspectives of a group of 
people in real-life situations, in circumstances or contexts that are of importance or lack prior 
research. It in no way involves preconceptions or the opinions of the researcher. Such a study is 
driven by a researcher who submerges into the participants’ natural environment for the purpose 
of exploring and collecting data that describes the research phenomenon (Creswell, 2013). This 
data comes from a variety of materials, such as interviews, transcripts, audio recordings and field 
notes from a diversified pool of participants. It involves capturing a multi-faceted array of 
perceptions, owing to the individuality of the participants (Yin, 2016).   
  
As such, qualitative research involves gathering information in a non-quantitative documentation 
of human experiences across various disciplines, such as psychology, sociology, communication, 
health sciences and business (Saldana, 2011). This type of research is predominantly found in areas 
where there is a lack of research, or the phenomenon is yet to be explored (Creswell, 2007).    
  
2.2.1.2 Phenomenological design   
Phenomenology, as explained by Creswell (2007), is a form of qualitative research that intends to 
observe the essence of human, real-life events as they are experienced in certain situations. This 
study uses transcendental phenomenology by prioritising the perceptions and experiences of the 
individuals in the research. Face-to-face interviews are often used in phenomenological studies as 
the most desired method of gathering data (Creswell, 2007).   
  
A phenomenological strategy was chosen in order to explore neurotherapists’ personal experiences 
and perceptions of treating ADHD patients using neurofeedback.   
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2.3 RESEARCH METHODOLOGY   
2.3.1 Purposive sample   
The study population consisted of neurotherapists registered with the BFSA. Each neurotherapist 
was recruited by means of purposive sampling, as their contact information was (and still is) 
accessible by the public on the BFSA website (BFSA Board, 2016).   
  
2.3.2 Inclusion criteria   
• All participants had to be registered members of the BFSA.  
• All participants had to have dealt with more than ten ADHD patients in their practice prior to the 
interview.   
• Each participant had to be actively using neurofeedback as their sole form of treatment or 
management of their ADHD patients.  
• All participants were practicing in the Gauteng province.   
  
2.4 RESEARCH PROCEDURE  
An email providing information (Appendix B) about the study was sent by the researcher to all 
potential participants. The neurotherapists who were interested in participating were asked to 
contact the researcher, whose contact details were provided in the information letter. Further 
participants were then sought to establish a larger sample size. After contact, appointments were 
scheduled at the convenience of the participants. Those who wished to participate were requested 
to sign both the consent form (Appendix C) and a form requesting permission to audiotape the 
session (Appendix D). Recruitment of participants occurred until data saturation was reached. To 
ensure a private setting, the interview was done in each of the participants’ consulting rooms and 
took approximately thirty minutes to complete. A face-to-face interview with one central question 
– “Tell me about your experiences of neurofeedback with ADHD patients in your practice?” – 
took place and was audiotaped. An additional set of sub-questions were occasionally asked to 
facilitate the interview process. Bracketing was performed by the researcher to establish more 
objective, unbiased results (Creswell, 2007). As each interview was in process, field notes were 
made by the researcher, which were used at a later stage to check the data. After each interview, a 
transcription was done from each audio recording and the latter was then erased. Prior to the formal 
study, a pilot study was done on a volunteer to refine the research technique; data extracted from 
that volunteer was not used in the final analysis.   
  
2.4.1 Data collection  
Data collection was done after every interview and was analysed using the qualitative data 
software, ATLAS.ti 8. Common patterns were found during the analysis of the data. The data was 
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managed by assigning codes to the statements, categorising the various types, then developing 
themes. After the common patterns and trends were identified, the data was assembled and 
compressed, then displayed using visual, tabulated and textual means (Taylor-Powell & Renner, 
2003).  
  
2.5 DATA ANALYSIS  
Prior to data analysis, each audio recording was compared to the corresponding transcription to 
ensure that no mistakes were made. Each transcription, which was typed using Microsoft Word, 
was numbered in chronological order to ensure confidentiality of the participants and maintain 
order; these transcriptions were saved on the researcher’s private computer. An example of a 
transcript is provided in Appendix I. Each transcript was studied repeatedly so that certain patterns 
and themes became familiar to the researcher. The researcher chose to use ATLAS.ti 8, a 
computer-assisted qualitative data analysis software, to ensure a far more reliable means of data 
analysis in which human error is eliminated as much as possible. This software was simply a 
platform the researcher used to arrange data. It also provided tools that made reflection of the data 
more efficient (Saldana, 2013). After the researcher obtained an ATLAS.ti 8 manual called 
“Qualitative Data Analysis with ATLAS.ti” by Susanne Friese, and watched a few online free 
training tutorials, the researcher felt confident to begin the analysis.   
  
After the software was used to organise and categorise the data, the researcher transferred the data 
into a simplified table in Microsoft Word (Appendix J). During the first cycle of the data analysis 
process, common patterns were identified. The researcher assigned codes to the statements, 
categorised the various types and developed themes. After the common patterns and trends were 
identified, the assembled and compressed data was best displayed in colour-coded blocks (Taylor-
Powell & Renner, 2003).   
  
The researcher adopted the open-ended, sentence-by-sentence method, thus each transcript was 
studied line by line. The data was separated into categories of similar themes, and every statement 
was considered and allocated a specific code number. Each response that was repeated or similar 
to a code was assigned the same code. The researcher used recoding so that any insignificant codes 
were erased, codes that were similar were combined and all indefinable codes were renamed 
(Saldana, 2013).    
  
Each category that was too large or vague was divided into sub-categories. Each code was given a 
colour according to the respective categories to further arrange the data. Throughout the coding 
process, the researcher made notes, which assisted in the identification of code names. The 
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documentation of memorandum notes is important in qualitative research, as it gives the researcher 
the opportunity for self-reflection on the research qualitative process and therefore allows for the 
conclusion to be made (Saldana, 2013).   
  
Once the second round of coding was done, a qualitative data analyst was asked to review the data 
analysis. A confidentiality form was signed by the qualitative analyst (Appendix E).   
  
2.6 RELIABILITY AND VALIDITY  
Trustworthiness is crucial in laying down a foundation for reliability and validity in this research 
study. For qualitative studies, credibility, transferability, dependability and confirmability must be 
explored (Shenton, 2004). These four main points are crucial in establishing trustworthiness in this 
study.   
  
2.6.1 Credibility  
Credibility speaks to the integrity of the captured data presented as well as whether the study 
presents valid information from the participants (Saldana, 2011; Korstjens & Moser, 2018). 
Credibility of this study was ensured by the researcher by means of gathering information until 
there was data saturation, which took six weeks. Each interview was audio recorded to further 
enhance accuracy. To enforce reliability, the main question and a structured set of sub-questions 
were asked in all interviews. Each interview was conducted with a purposively chosen participant 
who was registered with the legal national governing body, the BFSA, and who met the study’s 
inclusion criteria. Methodological triangulation was executed by means of in-depth, face-to-face 
interviews and by referring to field notes (Korstjens & Moser, 2018). The data analysis was 
verified by a qualitative analyst, which further ensures credibility. An external editor was asked to 
edit and proofread this study’s contents to ensure any grammatical mistakes were corrected, and 
they signed a confidentiality agreement (Appendix M).   
  
2.6.2 Transferability  
Transferability indicates the extent to which a specific study can be generalised or applied to other 
contexts and situations (Korstjens & Moser, 2018; Anney, 2014). Due to this study featuring a 
small sample size and only representing participants in Gauteng, it would be impossible to 
guarantee the applicability of the findings to other populations. Transferability in this study is 
therefore limited based on these boundaries, but may be relevant to those neurotherapists who can 
relate to the study and its subject matter.   
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2.6.3 Confirmability  
Confirmability in qualitative research describes the extent to which the information gathered for 
the study can be confirmed by other external researchers and is not a result of the researcher’s 
preconceptions or manipulation (Korstjens & Moser, 2018). Confirmability will always be difficult 
in every study as humans are naturally biased, even unintentionally (Shenton, 2004). The 
researcher factored in bias as a possible limitation and consequently used bracketing in the 
interviewing procedure to mitigate this effect. Field notes were used to enhance accuracy of data. 
The researcher complied with the methodology and used audio recordings in the data collection 
process. In order to achieve accurate transcription, the written transcripts were verified by an 
independent person. An audit trail – which is a detailed process of data handling and analysis – is 
seen in the transcriptions, the list of codes and the data analysis (Korstjens & Moser, 2018). 
Reflexivity is crucial in confirmability, as it involves self-reflection as a researcher (Korstjens & 
Moser, 2018).   
  
2.6.4 Dependability   
This term denotes the transparency of the study by describing the procedure from start to finish in 
order to allow for repeatability of the research process (Korstjens & Moser, 2018).   
Dependability was accomplished through the detailed and descriptive methodology discussed in 
Chapter 2, which enables others to follow the same procedure done by the researcher in order to 
duplicate this study. In order to achieve precision, the written transcription was redone at a later 
stage. Another way dependability was maintained was through conducting two rigorous cycles of 
coding in the data analysis process, in which the data was coded a second time to ensure accuracy 
and reliability. An audit trail – a detailed process of data handling and analysis – is seen in the 
literature review, the methodology, the transcriptions, the list of codes and the data analysis 
(Korstjens & Moser, 2018).   
  
2.7 ETHICAL CONSIDERATIONS  
In ethics, there is an essential rule to which every researcher who works with human volunteers 
has to abide: “But first, do no harm” The researcher has to first develop a heightened adaptation 
throughout the process of the study, in order to avoid any inconvenience or harm to the participant 
(Saldana, 2011). Throughout each step of the research process, the researcher made an effort to be 
as transparent as possible and uphold the ethical principles discussed below.   
 
2.7.1 Autonomy and respect for participants   
Autonomy refers to one’s ability to make one’s own decision without the influence of someone 
else (Cambridge Dictionary, 2019a). This principle implies that the participants gave full consent 
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to participate and understood that the study was voluntary. The researcher asked each participant 
to choose a convenient time and date for the interview. Then, throughout the process, the researcher 
made sure the participants were well aware of their rights to withdraw from the study, their 
participation rights, as well as the right to anonymity and confidentiality throughout. The latter 
was ensured by deleting any identifying information, giving each participant a number as a 
reference and never referring to his/her identity in the transcripts or write up of the study.   
  
To maintain confidentiality of each participant, the audio evidence was erased once the data was 
transcribed. Transcriptions and all study data will be stored in the researcher’s personal computer 
for a maximum of five years before being destroyed. The computer that contains the research data 
and transcriptions is password-protected and, as such, only the researcher has access to the contents 
of the computer. Any hardcopies made of the data will be stored at the Doornfontein campus of 
the University of Johannesburg, at the Department of Complementary Medicine for a period of 
five years, before that too is destroyed. Every participant will be given full access to the findings 
on request.   
  
2.7.2 Non-maleficence and beneficence   
Non-maleficence refers to the obligation and duty of not inflicting intentional harm on others to 
reach a beneficial conclusion, while beneficence describes the quality of doing good (Sundean & 
McGrath, 2013; Merriam-Webster, 2019c). This principle refers to minimising risk of injury or 
harm, psychologically and physically, to participants, while making clear the benefits of 
participation for society and the individual. In this study, there were no anticipated risks and no 
direct benefits to the participant; however they would be contributing to the body of knowledge 
on the topic, which may be of value to the profession.  
  
2.7.3 Justice   
Justice in research refers to the fair, just and impartial treatment of participants by the researcher 
(Cambridge Dictionary, 2019b). Every participant who was chosen in this study was selected 
purposefully for his/her ability to provide data that is relevant to the research. Participants will be 
given full access to the findings on request. Each interview was scheduled to take place at the most 
convenient time and place for every participant. The researcher gave the participant several 
opportunities to ask any questions or express concerns, and all questions and concerns were 
approached with respect.   
  
Permission to conduct this study was obtained from the Faculty of Health Sciences’ Research 
Ethics Committee (Appendix G) and Higher Degrees Committee (Appendix H).  
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2.8 CHAPTER SUMMARY    
Chapter 2 provided details of the research method utilised in this study. Chapter 3 will present the 
study results.   
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CHAPTER 3: LITERATURE CONTROL, RESULTS AND DISCUSSION  
  
3.1 INTRODUCTION  
In this chapter, the data that was collected by the researcher is interpreted. The data reflects the 
neurotherapists’ experiences using neurofeedback with ADHD patients and the value of 
neurofeedback in the biomedical field. This phenomenological, qualitative research study was 
made possible by face-to-face interviews with registered neurotherapists working in Gauteng, who 
utilised neurofeedback as an alternative therapy in treating their ADHD patients in private practice.    
  
3.2 DATA COLLECTION   
Recruitment of neurotherapists who met the inclusion criteria was achieved by means of email and 
telephone. Recruitment was purposive. Appointments were scheduled telephonically once 
interested participants who were informed of the purpose of the study via an email attachment 
(Appendix B) responded to the researcher. The participants of this study are all presently registered 
with the Biofeedback Association of South Africa (BFSA) and are making use of neurofeedback 
in their treatment of patients with ADHD.   
  
Originally, only neurotherapists who were practicing in Gauteng were approached but, owing to 
low response rates, the researcher reached out to three neurotherapists residing in the Western 
Cape. Presently, in the eleventh month of 2019, there is a total of fourteen neurotherapists 
practicing in South Africa: seven in Gauteng and seven in the Western Cape (BFSA, 2019). 
However, during the recruitment phase in April this year, there were eleven neurotherapists in 
Gauteng and a total of twenty in South Africa. This difference in numbers is due to practitioners 
deregistering with the BFSA. The researcher sent out recruitment emails to the eleven Gauteng-
based neurotherapists. Six volunteered to take part, two declined due to lack of time, one showed 
interest but did not feel experienced enough to contribute and two did not respond. The two 
neurotherapists who never responded were not approached a second time.  
  
Six interviews were conducted during April and May 2019 until data saturation was achieved. The 
researcher felt that no further recruitment of neurotherapists from the Western Cape was necessary, 
as the volume of information received from the Gauteng participants had given her sufficient 
appreciation and understanding of the cumulative experiences of the neurotherapists.   
The participants in this study contributed by describing their experiences from their own unique 
perspectives.   
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3.3 DEMOGRAPHICS   
After each interview was completed, the researcher asked questions that addressed the individual’s 
background. In terms of gender, the sample comprised of one male and five females – displaying 
the correct representation of the South African neurotherapist community, where 86% are female 
and 14% male (BFSA, 2019). Although every neurotherapist is of the same ethnicity and the 
majority are female, the individuals’ experiences varied. This offered diversity within the study 
even though the demographics were somewhat uniform.  
  
Participants were asked the following questions:   
• How many years have you been in private practice?   
• How many years have you been using neurofeedback on your ADHD patients?   
• How many ADHD patients do you treat per month?  
  
The information obtained is presented in Table 3.1 below. The number of years in practice ranged 
from three to twenty-two years. Table 3.1 below shows the relationship between the number of 
years in private practice and the numbers of years the neurotherapists have been using 
neurofeedback.   
  
It is important to note that every participant began using neurofeedback within the first three years 
of practice.   
  
  Number of Years in  
Private Practice  
Number of Years using 
neurofeedback  
Other Qualifications  
Participant 1  17  15  Homeopath  
Participant 2  22  19  Educational  Psychologist,  
Psychometrist   
Participant 3  7  6  Counsellor  
Participant 4  7  7  Psychologist  
Participant 5  3  3  Psychometrist  
Participant 6  17  16  Counsellor  
  
Table 3.1: The relationship between the number of years in private practice and the number 
of years using neurofeedback, as well as the qualification each participant holds.  
  
The researcher tried to establish if there was any correlation between the number of years using 
neurofeedback with the number of patients with ADHD seen per month, however, no correlation 
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was found. It is interesting to note that three participants are qualified psychologists and two are 
counsellors, which may indicate at a specific niche which neurofeedback appeals to. Neurotherapy 
features an integration between neurofeedback and psychology which supports the findings of 
Table 3.1. Psychologists are more inclined to seek alternative treatments and feature a large 
clientele of ADHD patients (Solomon, 2020).  
  
3.4 DATA ANALYSIS  
As this study was the first phenomenological research done on the experiences of neurotherapists 
using neurofeedback as an alternative treatment for ADHD, it provides a foundation for future 
exploration.   
  
As discussed in Chapter 2, the data was acquired through face-to-face interviews with six 
neurotherapists. The data was then transferred from audio recordings to written transcripts. An 
example of a written transcript is provided in Appendix I. Each transcription was reviewed to 
ensure accuracy and reliability. As the researcher was personally involved in the data collection, 
this made it easier to organise and arrange the data into respective themes and categories. Two 
cycles of coding were done to enhance accuracy.   
  
The researcher adopted line-by-line coding, which enabled her to personally sort through the data. 
This method of coding eliminates any risk of important information being disregarded or lost. 
Everything that was mentioned by the participants was coded and considered. Every line of 
information was organised and similar ideas were grouped and given a unique code number. Each 
group consisted of several quotes. These quotes were each given a number: the first digit indicated 
the group, while the second digit indicated from which interview the quote was extracted. Every 
group was then arranged into themes, categories and sub-categories, which became clear when the 
researcher studied the transcriptions. Appendix K provides a table of research codes.   
    
3.5 DISCUSSION OF RESULTS   
The themes and their relevant codes are presented in rigorous detail below. Appendix J provides a 
colour-coded key that demonstrates each theme and the relevant quotes that fall within each 
category, while Table 3.2 below is a simplified representation.    
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Table 3.2: Themes, categories and sub-categories   
Themes   Categories and Sub-categories   
3.5.1  Theme  one:  
Neurotherapists’ 
experiences   
3.5.1.1 Perceptions of neurofeedback as a therapy   
3.5.1.2 Personal experiences gained from using neurofeedback  
Knowledge acquired   
  Cases encountered   
3.5.1.3 Limitations of neurofeedback   
  Obstacles to cure  
Parents   
Teachers   
Other practitioners   
Dysfunctional situations  
3.5.1.4 Negative aspects of neurofeedback    
A high-cost treatment   
  Time commitment   
3.5.1.5 Challenges that neurotherapists encounter    
The patient’s age  
  Poor patient compliance   
3.5.1.5 First sign of improvement   
3.5.2 Theme two: Value 
of neurofeedback in  
practice  
3.5.2.1 Developing therapist-patient rapport   
3.5.2.2 Cases in which neurofeedback has value   
3.5.2.3 Cases in which neurofeedback has no value   
3.5.2.4 Integration with other therapies   
3.5.2.5 Neurofeedback as the last line of treatment   
 Patient no longer wants to take medication  
3.5.2.6 Its success   
3.5.2.7 qEEG: A supporting modality to neurofeedback   
3.5.2.8 Experience governs treatment   
3.5.2.9 Neurofeedback as holistic treatment  
3.5.3 Theme three: 
Neurofeedback and the 
public   
3.5.3.1 Neurofeedback’s uneven reputation   
3.5.3.2 The lack of public knowledge  
3.5.3.3 Incorrect practices of neurofeedback   
3.5.3.4 Research   
3.5.3.5 The misdiagnosis of ADHD  
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3.5.1 Theme One: Neurotherapists’ Experiences  
This theme consists of five categories. For this research, exploring the experiences of 
neurotherapists with neurofeedback is the primary focus. This theme is thus the largest and most 
concentrated. Conducting this research gave a newly found opportunity to neurotherapists to 
describe their past encounters with neurofeedback and express their attitude toward the use of this 
modality in practice. Even though each participant was unique, with different experiences, the data 
gathered was similar enough to ensure that data saturation was reached.  
  
3.5.1.1 Perceptions of neurofeedback as a therapy   
This theme was developed from the main question, “Tell me about your experiences using 
neurofeedback as a treatment for patients with ADHD in your practice?” A few participants 
remarked how neurofeedback is the most preferred treatment for all of their ADHD patients.  
  
“I use neurofeedback for the majority of my patients.” (code 47.1)  
  
“I use it for all of my ADHD patients.” (code 47.4)  
  
Other individuals spoke about its role in schools and how it should be made available to a wider 
population of school children and be easily accessible. It was acknowledged by participants that 
neurofeedback is an appropriate therapy for ADHD and can also be used to reveal cases of 
misdiagnosis, whether it is by practitioners, parents or teachers themselves.    
  
“I think it should be available in every school.” (code 36.3)  
  
“…so many children … are overmedicated… misdiagnosed… This is such an easy problem to 
solve if neurofeedback was accessible in every school.” (code 47.1)  
  
Another participant mentioned how neurofeedback helps her patients in a holistic way.   
  
“Neurofeedback can help to address the different parts of that complex set of difficulties.” (code  
39.6)  
  
One neurotherapist explained why he would use neurofeedback on his ADHD patients.  
  
“It’s a great tool to teach them how to concentrate.” (code 20.1)  
 
“I think neurofeedback should be the first option for treatment (for ADHD).” (code 47.1)  
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3.5.1.2 Personal experiences gained from using neurofeedback   
A. Knowledge acquired   
Neurofeedback offers the practitioner the flexibility to incorporate other modalities such as 
homoeopathy, occupational therapy and counselling to thoroughly understand each case in 
different perspectives and with a far wider horizon of information sources. For the participant 
below, discerning the patient’s reading and comprehension age not only shows the severity of the 
problem, but can also be used as a reference point to measure his/her progress.  
   
“Once again you have to have a look at where the concerns are on the qEEG and the continuous 
performance test – so what I do is I also do language and reading comprehension test to see the 
reading age or comprehension age.” (code 46.1)  
  
One participant in particular showed her awareness of the limitations of neurofeedback. Based on 
her experience, she accepts that there are patients she is unable to help as it is out of her scope of 
practice. Further on in the interview, she mentioned that she tends to refer people she cannot help 
to other specialists. 
  
“… I tend to keep my patient population very homogenous. I don’t really go out of my field of 
practice, like depression and bipolar, as I am not a clinical psychologist and I am not trained in 
treating those groups.” (code 33.2)  
  
Two participants expressed that they tend to discontinue the treatment and refer when a patient is 
not invested in the therapy.   
  
“If I find that the patient is not motivated to be here and that they have no faith in the therapy, I  
terminate the sessions.” (code 54.2)  
  
“In that case it frustrates the patient, it frustrates the parent, and I feel it’s unfair to waste their 
money and time if I know from the beginning it’s not going to work.” (code 38.2)  
  
One participant spoke about how she reflected on the challenges she faced in the sessions and 
developed strategies that helped her patients to receive the most benefit from each session.   
  
“But one does develop techniques on how to calm them down, getting them engaged and 
interested in the sessions.” (code 40.4)  
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The ability to develop a deeper understanding of one’s own profession comes with having dealt 
with different cases and discovering the strengths and weaknesses of neurofeedback as a therapy.   
  
“Neurofeedback does not focus on one diagnosis: we focus on which brain wave irregularities 
are causing what types of symptoms and how we can resolve those problems.” (code 39.6)  
  
“Neurofeedback can help to address individual irregularities that are present and that are 
causing symptoms and that is why it is effective, because we are not working with one blanket  
diagnosis, we are working with how this specific dysregulation affects that specific person.” 
(code 39.6)  
  
“The brain does take quite a while to process the information it has learnt in the therapy and 
integrate it in their lives, so usually patients will still see an improvement even after the 
neurofeedback sessions have ceased.” (code 47.2) 
  
Every practitioner noted that, when they started their private practice, they were nervous and lacked 
confidence. This is evident with the increased amount of time taken before results were seen.   
  
“… initially in my journey I saw the response time was slower in the beginning stages of my 
neurofeedback journey.” (code 50.2)  
  
A vital part of being a practitioner is having a thorough comprehension of every condition faced 
in practice.   
 
“We do find a lot of underlying co-morbidities with ADHD, such as depression and anxiety.” 
(code 33.4) 
  
One neurotherapist spoke about how even a small improvement should be noted. If one were to 
add up all the small improvements, the patient’s confidence may grow.   
  
“So, it’s not always only the concentration that improves within those ten sessions, but the other 
small issues they face.” (code 20.6) 
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B. Cases encountered   
Part of exploring neurotherapists’ experiences of using neurofeedback as a modality to treat ADHD 
is reflecting on the cases that were most prominent to them in their years of practice. One 
neurotherapist commented on why she uses neurofeedback in her practice:  
  
“So, I see a lot of ADHD kids and adults, with very good results.” (code 47.3)  
  
Participants noted improvements in general well-being, cognitive function and anxiety in their 
ADHD patients undergoing neurofeedback:   
  
“… parents first notice better sleep, improvements in handwriting and then the other symptoms 
such as getting better generally.” (code 19.1) 
  
“We have had more calm, focused, less fidgeting patients in class and get great feedback from 
home and the schools.” (code 19.3)  
  
“But most of time there is a significant improvement in concentration, anxiety, processing ability 
and in terms of sleep.” (code 26.6)  
  
Patient progression is also very important when noting the value neurofeedback offers in treating 
patients with ADHD.   
  
“As a therapy modality it’s something that’s great, because you do see the results fairly 
quickly.” (code 47.1)  
  
“…but once they start to see progress – sort of in the second month – then they are quite 
amazed.” (code 50.3)  
  
It is also the practitioner’s duty to explore all aspects of each patient’s case.   
  
“There was a girl that I did neurofeedback with yesterday – she has all the symptoms of ADHD, 
but she has three hours of sleep a night. So, her anxiety is off the charts, she’s very depressed 
and on a whole lot of medication but nobody has taken the time to look at how can we optimize 
this person’s sleep.” (code 39.6)  
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3.5.1.3 Limitations of neurofeedback  
A. Obstacles to cure   
Obstacles to cure refers to the factors in a patient’s life that aggravates the problem and prevents 
complete cure. When asked about the challenges neurotherapists face when treating ADHD, 
participants all spoke of the same four factors that influence the patient’s progress, namely:  
patients, teachers, other practitioners and dysfunctional situations.    
  
-  Parents   
All participants expressed their frustration when discussing situations where there is a lack of 
feedback from family members such as parents. The purpose of establishing feedback from third 
parties is to illustrate a total picture of the patient’s progress, some of which might not be evident 
during sessions.   
  
“Another thing is feedback from the parents during the treatment: sometimes you get parents 
who just drop off their kids and you never see them for some face to face feedback. Also, because 
the parent lives with the child, they aren’t open to changes or don’t really observe as closely as I  
do in a session.” (code 9.5)  
  
“… so often the parents complain it’s not working but when you ask the au pair who spends most 
of their day with the child, they can see a clear difference.” (code 9.3) 
  
“We do get parents we never see … so we struggle in terms of feedback from parents because 
the children play up when they do see the parents for that short amount of time because they 
crave their attention.” (code 9.3)  
  
Feedback may also be biased, which may result in the neurotherapist questioning if the therapy is 
helping.  
  
“You often get parents telling you, ‘Oh it’s because there’s a new teacher, or, ‘Yes, it’s because 
we changed the diet’, so they always want to attribute the change to something else and not 
willing to admit that it’s the neurofeedback that’s made the difference.” (code 54.3)  
  
-  Teachers   
Teachers are highly influential in a person’s foundational learning, especially considering the 
inadequate learning abilities of an ADHD child. One must be aware of this factor influencing both 
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the neurotherapists’ experience and may pose as a challenge itself. Teachers are also important to 
give the neurotherapist feedback regarding the patient’s progress.   
  
“So, another challenge is teachers are so medication-orientated, so they want the quick fix, they 
want this busy child that’s disrupting forty other kids in the class they want them out of the  
equation, so they want them sedated in a sense. That stigma sometimes is a problem … because 
they don’t want to wait a little bit, so they might discourage the parents of letting them undergo  
any treatment other than medication.” (code 8.1)  
  
“There are so many children that are over-medicated, almost disregarded by the teachers 
because they’re difficult to teach.” (code 8.3)  
  
- Other practitioners   
The below quote implies that conventional practitioners do not treat holistically but are more 
concerned with prescribing medication for concentration only.   
  
“Often in private practice, it is only the concentration problems that are treated, which is rather 
unfortunate.” (code 14.6)  
  
- Dysfunctional situations  
No matter how involved the patient is in their treatment, if there are external factors that are 
impeding their improvement, treatment may not be successful.   
  
“I’m not a psychologist or a counsellor so if there are external factors … those sorts of things 
can almost put a person back in terms of progression. So, the patient may have some type of 
improvement, but their parents are going through a divorce … neurofeedback cannot help in  
that aspect.” (code 10.1)  
  
“If that person’s family system is in dysfunction [sic], that patient is totally dysfunctional. No 
amount of therapy or medication is going to sort that out.”  (code 10.6)  
  
“If your patient is not getting the love and attention at home, he is going to look for attention in 
some other form and often that plays out as ADHD or an impulsive disorder.” (code 10.6)  
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3.5.1.4 Negative aspects of neurofeedback   
With every medical treatment, there are positive and negative aspects. In order for one to properly 
evaluate the role of neurofeedback in the treatment of ADHD, we have to investigate the negative 
features that neurotherapists have encountered over the years. The two aspects they all mentioned 
were high costs and the fact that it is a time-consuming therapy.   
A. A high-cost treatment   
Participants acknowledged that neurotherapy is an expensive investment. Seeing the total cost of 
neurofeedback sessions may overwhelm a person and cause them to look for cheaper alternatives.   
  
“I think part of it is the cost involved.” (code 38.1)  
  
“Also, it can be quite expensive.” (code 37.3)  
  
As explained by one participant, if one was to calculate the total amount of monthly repeats of 
medication along with bi-yearly visits to a practitioner to renew their prescription, the expenses 
would also be very high. The only difference between this situation and using neurofeedback is 
that the medication is palliative whereas neurofeedback could possibly correct the condition.  
Neurofeedback sessions only last a few months while medication needs to be taken for years.  
  
“Also, money is an issue for a lot of people, but I tend to explain to them that the overall cost of 
monthly repeats of Concerta and visiting GPs is a lot more than a few months of neurofeedback 
therapy.” (code 38.4) 
  
B. Time commitment   
Neurofeedback is not a quick-fix, and some people do not want to wait for an improvement.   
  
“A lot of people do not have the time to go through the therapy process; they want a quick fix 
and a miracle, so the amount [sic] of sessions is a bit of a drawback for some people.”  
 (code 37.4) 
  
3.5.1.5 Challenges that neurotherapists encounter   
A. The patient’s age  
The majority of ADHD patients seen in private practice are young. This neurological condition 
tends to manifest in symptoms that are often first noticed in younger patients. The presenting 
symptoms of hyperactivity, restlessness and disruptive behaviour are in themselves usually the 
challenges that neurotherapists face when conducting neurofeedback. In order to ensure the patient 
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receives the full benefit of each session, the neurotherapist have to adapt their approach to each 
individual.   
  
“So one of the challenges in terms of neurofeedback would be initially the severity or the age of 
the patient, because if they are too young they would have trouble sitting still, they don’t want to  
do the therapy, so they have to be calm enough to sit down a little bit to do the neurofeedback 
session.” (code 28.1)  
  
“I’ve seen a lot of restlessness in the sessions, they want to run around and touch and play and 
feel everything in the room, which creates movement artefacts in our readings so we can’t 
always get ‘clean EEG’ in our sessions so we need to closely watch and track the patients’ 
movements in relation to the EEG readings.” (code 17.3)  
  
B. Poor patient compliance   
As expressed by every participant, patient compliance is the most substantial challenge they face. 
It often causes unnecessary obstacles during the treatment process because, without compliance, 
the benefits of the therapy are limited.   
  
Inadequate patient compliance may stem from the fact that neurofeedback requires the patient to 
undergo frequent sessions over a prolonged period of time. This causes strain in terms of time 
management as either the patient has to take time off work, or the parent has to drop their child off 
and collect him/her later, which may be inconvenient.    
  
“… and if we feel like we still have work to do after those sessions, they are reluctant to sign in 
those extra sessions. So, progress is always made if the patient is compliant in the process.” 
(code 37.3)  
  
“… [what] plays a role in patient compliance [is] whether they want to terminate the sessions 
before we [are] even finished, which is one of the drawbacks of this therapy.” (code 49.3)  
  
As neurofeedback is an alternative, integrative and holistic therapy – the patient, too, has to be 
made aware of the process and the challenges involved.  
  
“…they will be non-compliant in the neurofeedback therapy because their anxiety will not be 
dealt with unless they become aware of it.” (code 49.2)  
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Often enough, there are parents who take their children to neurofeedback upon the request of their 
teachers or family, even when the child is disinclined to attend the sessions. This causes discomfort 
in the sessions. Non-compliance means that the rate of improvement will be impeded.   
  
“Even if you have everything in place, it’s the compliance of the patients so I feel that the 
motivation still needs to be there.” (code 49.2)  
  
“If the parent is also not compliant, then I know my prognosis won’t be good.” (code 39.2)  
  
“So, it’s a struggle to convince certain parents that the therapy is working.” (code 54.3)  
  
Neurofeedback as a modality requires the patient to be as involved with the treatment as the 
neurotherapist. If what is contributing to the issues involves lifestyle changes that can be adjusted, 
then no amount of treatment, whether conventional or alternative, will solve the problem 
completely.   
  
“… if the person is not willing to change their unhealthy living habits, their high-sugar high-fat 
diet, not willing to exercise and take supplements that they are deficient in.” (code 40.3)  
  
“It’s a waste of time if you come in for two sessions a week and pay all this money but go home 
and continue with your bad living habits that is contributing to the stoppage of your 
progression.” (code 40.3) 
  
“And you will get patients who will give you a myriad of excuses as to why they can’t be dairy 
free or gluten free.” (code 49.3)  
  
One neurotherapist gave some insight on challenges they face while treating adults with ADHD.    
 
“With ADHD adults they are a lot easier to treat but usually they are the ones with time 
management issues – they tend to be under a lot of pressure at work due to them not focusing on  
the tasks at hand, them often forgetting about the appointment or they always come late. So, the 
biggest challenge with the adults is getting them to come to regular sessions.” (code 30.4)  
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3.5.1.6 First signs of improvement  
Neurotherapists expressed, on average, how long it takes for the treatment to result in 
improvement. Every participant mentioned that they see their patients twice a week. Bearing this 
in mind, it appears the average improvement time is within the first five sessions or third week of 
the treatment.   
 
“You’ll see it probably within a month.” (code 50.1)  
  
“On average, from session three or four most people start seeing an improvement.” (code 50.4)  
  
3.5.2 Theme Two: Value of neurofeedback in practice  
One of the objectives of this research study was to explore the value that neurofeedback has in the 
treatment of ADHD and its role in the neurotherapists’ practice.   
  
3.5.2.1 Developing therapist-patient rapport   
A practitioner has a certain level of responsibility towards the patient being treated. As such, it is 
vital to the patient’s progress that a trusting, but professional relationship is developed. If the 
practitioner sees the patient as an individual and treats their concerns with respect, it allows for 
trust to develop between patient and practitioner. A patient is more likely to share his/her concerns 
with a practitioner who listens and is sincere, and this may play a valuable role in the treatment.   
  
One neurotherapist spoke about how neurofeedback is very patient-orientated, not symptom-
orientated. He also mentioned the relationship that neurotherapist develops with his patients. He 
also indicated that taking the time to listen to the patient is quite important.   
  
“From a homoeopathic or a holistic practitioner point of view, you see these patients weekly - 
you establish a relationship and bond with them.” (code 41.1)  
  
“So even in terms of prescription, you give them advice - you take the time to hear their 
symptoms and encourage supplementation.” (code 41.1)  
 
“…and as a neurotherapist you use that bond you have with them to help them overcome it step by 
step.” (code 41.2)  
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The same participant expressed how motivation and encouragement can be included in the 
procedure. Once an individual is involved in his/her own healing and is shown just how far they 
have come, this leads to understanding and awareness of their own capability.   
  
“The way you encourage them, the way you motivate them, and look at the progress of the 
patient … you’re a lot more involved in their wellbeing and progression…” (code 41.1)  
  
“If you have a client, and you show them that window into their brain and you show them the 
neurofeedback software and how their brainwaves are going within that favoured threshold and 
they see that change and they start to see how powerful their brain really is … that is tremendously 
powerful in their progress of healing.” (code 43.2)  
  
A bond between patient and therapist allows the patient to open up to the neurotherapist and explain 
how they are struggling, the issues they face and if there are any obstacles in the treatment.   
  
“As a neurotherapist, you know what’s happening in that patient’s life, you know how their 
condition is affecting them…” (code 39.1)  
  
“… [you know] whether they’re having bad days or how their social or family life is doing, so I 
quite enjoy working so closely with them during those months.” (code 41.1)  
  
This involvement allows the neurotherapist to adjust the treatment protocol as needed and perhaps 
give the patient lifestyle advice and coping skills.  
  
“We do have to offer some guidance to the parents on how to manage situations better and even 
how to continue implementing the healthy dietary changes for their ADHD child.” (code 39.4)  
  
3.5.2.2 Cases in which neurofeedback has value   
Identifying the conditions in which neurofeedback is most useful, is vital in acknowledging the 
role that it has in private practice. Other than ADHD, participants mentioned benefits for Tourette’s 
syndrome, tics, insomnia, depression and anxiety to name a few.  
  
“The most value, I see, is the concentration and also with Tourette’s – the tics.” (code 32.3)  
  
“It helps the most with sleep disorders, depression, anxiety disorders, tics, Tourette’s and then 
ADHD.” (code 13.6)   
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“Most value is anxiety and depression, insomnia, ADD, ADHD, epilepsy and stroke recovery.” 
(code 33.4)  
  
Neurofeedback appears to have a positive effect on emotional irregularities, enabling the patient 
to cope with difficult life circumstances.  
  
“In terms of emotional regulation, neurofeedback works well – they tend to be more calm, easier 
[sic] manageable.” (code 25.5)  
  
“The most value I have found is in improving attention, also regulating their emotions like 
anxiety, tempers, frustration, and how they cope to [sic] certain situations is much better than 
when they initially came in.” (code 25.5)  
  
3.5.2.3 Cases in which neurofeedback has no value   
It is also important to identify situations in which neurofeedback may not be of value. If the 
neurotherapist is aware of the lack of efficacy the therapy has in treating certain conditions, then 
referring the patients saves time, money and effort.  
  
As mentioned below by a participant, neurofeedback cannot cure or alleviate ADHD if there are 
biological issues that are contributing to the condition.   
  
“… if there is a physiological issue that is causing the ADHD, neurofeedback is limited in that it  
cannot cure that issue.” (code 48.1)  
  
“I feel the least value it holds is helping with bipolar disorder and drug addictions because of 
patient compliance.” (code 49.4)  
  
It is mentioned below that neurofeedback has its limitations, particularly with learning difficulties 
and autism.   
  
“Not to say that neurofeedback doesn’t work, but neurofeedback doesn’t cure autism and 
doesn’t most often cure a hundred percent improvement in ADHD.” (code 48.6)  
 
“…take longer to progress are the learning difficulties, like the dyslexia, the reading and math 
problems.” (code 48.3)  
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3.5.2.4 Integration with other therapies   
The referral of a patient to another practitioner requires acknowledgement that not every case is 
suitable for neurofeedback therapy and that prioritizing the patient’s needs is essential. Moreover, 
the ability to work closely with other professionals promotes interdisciplinary learning and is 
beneficial to the patient. It is thus common for a practitioner to refer a patient to other practitioners 
in addition to continuing neurofeedback.   
  
“I work very closely with a group of varied practitioners [who] all understand the basics of 
neurofeedback, so that makes it ideal for them to treat the patient according to, let’s say their  
phenotypes and what supplements or homoeopathic remedy will work for them.” (code 36.2)  
  
Neurotherapists find that some cases require supplementation, as nutritional deficiencies are 
common among ADHD individuals and a balanced diet contributes to lifelong health. As 
neurofeedback is integrative, it tends to complement other modalities of treatment and vice versa.   
  
“…but it’s something that works together with other interventions like supplementation, 
functional medicine and homoeopathy.” (code 36.1)  
  
Other interventions may include functional practitioners, movement therapy monitored by a 
biokineticist, and alternative remedies administered by a homoeopath.   
  
“So, I refer my patients to some of these practitioners so that they treat the patient according to 
what the qEEG has shown, such as prescribing supplements of components, which are lacking in  
their diet or treating the physiological or metabolic problem that is impacting their life.”  (code  
36.2)  
  
“So, neurofeedback is definitely a therapy that involves lifestyle changes to be more of a holistic 
approach.” (code 39.3)  
 
If a neurotherapist feels that the neurofeedback will be ineffective in some areas, then referring the 
patient to and working closely with another practitioner will be the correct course of action.   
  
“If epilepsy is involved, then they definitely need to see a neurologist.” (code 34.6)  
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3.5.2.5 Neurofeedback as the last line of treatment   
Neurofeedback is often one of the last treatment options considered – as is the case with most 
alternative therapies. One of the main reasons why patients seek out neurofeedback is due to a 
desire to discontinue conventional pharmacological treatment.   
  
A. Patient no longer wishes to take medication   
Conventional ADHD medication are associated with side effects which affect quality of life. There 
is a level of dependence when using medication as well as insufficient patient compliance.   
  
As stated by a few participants, many patients would prefer to discontinue their ADHD medication 
– whether it is due to the poor perceived efficacy, side effects, dependency or just the 
inconvenience of having to take medication daily.   
  
“… it could be that they come to me because they don’t want to be on medication, so they don’t  
want to go that route.” (code 3.1)  
  
“… or it could be that they want to take them off of medication for whatever reason like side 
effects.” (code 4.1)  
  
There is also the reason that, although the patient has been given this medication, the patient is 
dissatisfied with the outcome.   
  
“…their medication is not working well enough.” (code 4.1)  
  
“So, if there is an excess of slow theta activity in the frontal area which is almost always present 
in ADHD, Ritalin or Concerta helps to decrease that but what about the excess fast activity in 
the back areas that causes that body restlessness? Medication doesn’t do anything to help that.”  
(code 5.6)  
 
One neurotherapist described the process of eliminating the use of medication while using 
neurofeedback. The patient is required to go back and forth between neurotherapist and general 
practitioner to safely stop the medication without experiencing unwanted withdrawals.  
  
“Another challenge is more about the time it takes to treat a patient on medication - because you adjust 
their brainwaves with neurofeedback, then the doctor adjusts and reduces their medication, then you need 
to readjust their brainwaves again because of that change and so on.” (code 4.4)   
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“So, it is a much faster process if they are not on any medication.” (code 3.4)  
 
3.5.2.6 Its success   
When asked to describe, from their experience, the role of neurofeedback in treating ADHD, each 
participant spoke about the successes they had with it – not only with their ADHD patients, but in 
treating other conditions as well.   
  
“…to hear their experiences and their success stories is just so inspiring.” (code 47.2)  
  
“I’ve had so many successes.” (code 47.4)  
  
Although neurofeedback is not a cure-all therapy, it is capable of alleviating severe neurological 
complications. For example, if the cause of a patient’s ADHD is purely genetic, then 
neurofeedback may improve his/her quality of life in terms of lessening symptom severity and 
offering the patient better coping mechanisms.   
  
“It enables our patients to regulate themselves so that they will always have that long-term 
coping mechanism they can bring home.” (code 39.4)  
  
“In terms of success with ADHD, it depends on the severity of the condition.” (code 47.6)  
  
 Success in each case may also be partly dependent on the neurotherapist. If one is unlicensed and 
not aware of the strengths, weaknesses and limitations of the neurotherapy, then advancement is 
not guaranteed.   
 
“But in my field of practice I don’t see any component that neurofeedback has no value to 
because it depends on how you work with the patient.” (code 39.2)  
  
“I use neurofeedback on all of my ADHD patients, and I have never found a person which it 
doesn’t work well on.” (code 47.5)  
  
Two participants expressed their satisfaction with the success rate of neurotherapy.   
  
“Overall there has always been some kind of improvements and that’s the thing with 
neurofeedback, you always get a positive result.” (code 47.5)  
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“I mean it works, that’s the bottom line.” (code 47.6)  
  
3.5.2.7 qEEG: A supporting modality to neurofeedback   
The success rate of neurofeedback is significantly amplified by the supporting role of the qEEG. 
When asked about how they structure their sessions, participants revealed that a qEEG is 
conducted before and after the treatment.   
  
“Since I’ve brought in the qEEG and used neurofeedback as a more holistic therapy, the success  
rate has been higher.”  (code 39.2)  
  
“…but once I brought in the qEEG and I actually saw which were the problem areas and 
incorporated that into the therapy, the response rate increased dramatically.” (code 47.2)  
  
The purpose of using a qEEG before the start of the treatment is to illustrate what is happening in 
the brain in terms of wavelength imbalance, shown through over- and underactivity. The qEEG 
offers a map of the brain and highlights the problem areas, enabling the neurotherapist to develop 
a course of action by using it as a reference point. One neurotherapist voiced her belief in the 
tremendous power qEEg has on the treatment.   
  
“I don’t do any neurofeedback without a qEEG being done.” (code 46.2)  
  
A qEEG may be done again at a later stage to understand what progress has been made and what 
still needs to be improved. This technique makes the therapy precise and individualised. A qEEG 
is done a few weeks after the cessation of treatment to confirm that the issue has been corrected.   
 
“You need a full standard qEEG to make a diagnosis or assumption in terms of progress on a 
long-term basis.” (code 45.6) 
  
3.5.2.8 Experience governs treatment   
Part of this study’s inclusion criteria was that each of the participants had to have treated at least 
ten ADHD patients prior to the interview. This criterion was put in place to ensure that all 
information extracted was from experienced and knowledgeable neurotherapists. A neurotherapist 
who has taken note of the challenges commonly seen in sessions and acknowledges the results it 
has on the readings is one who observes the patient and understands what he/she is doing.   
  
   43  
“I take notice of those repetitive movements or habits and notice a change or reduction as we go 
deeper into the sessions, so that is usually the first sign of progression.” (code 43.3)  
  
As discussed in the literature review, neurofeedback addresses several factors that affect each type 
of neurological impediment. One participant spoke about the significant responsibility a 
neurotherapist has, to understand the distinction.   
  
“Different types of neurofeedback are effective in different cases.” (code 39.6)  
  
“So, you need to know your patient. If you don’t take the time to know where each of these types 
of neurofeedback are going to cause problems for that person, you’re going to get a negative 
response.” (code 55.6)  
  
3.5.2.9 Neurofeedback as holistic treatment  
It is clear that neurofeedback and homoeopathy share many traits, as seen in the relevant 
philosophies and holistic approaches. Neurotherapists are trained to look at the patient as a whole, 
as an individual comprising complicated layers, which are all interlinked.   
  
“We as neurotherapists need to look deeper at the individual because concentration alone tells 
us nothing about cognitive functioning.”  (code 39.6)  
  
“We need to look not just at a list of symptoms that tick the boxes, but what else is going on in 
the person’s life – what is his sleep like, is he being bullied at school, what is his family life  
like.” (code 39.6)  
 
One neurotherapist had spoken about another aspect of holism that neurofeedback embraces.   
   
“And not every small discrepancy from the norm is something that needs to be treated, so we  
need to look at it in terms of that person’s holistic functioning.” (code 39.6)  
  
“You can’t treat one person in isolation.” (code 39.6)  
  
3.5.3 Theme Three: Neurofeedback and the public  
Understanding this theme is relevant to the study’s objective as the image of neurofeedback 
contributes to the participants’ challenges. In order to analyse the neurotherapists’ experiences, we 
thus need to look at the global factors that may influence their practices and the types of clients 
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they receive. In this section, the impact of unqualified and incorrectly trained practitioners in the 
profession is also explored.   
  
3.5.3.1 Neurofeedback’s uneven reputation   
Out of the six participants, four expressed their frustrations and concerns over the infamous 
reputation that neurofeedback currently has, owing to unqualified individuals using neurofeedback 
and their tendency to advertise.  
  
“So they might compare or just go to another company which would give neurofeedback a bad 
name.” (code 53.1)  
  
“Those people aren’t even registered with the health professions council and it’s unfortunate, 
because there are equipment that are sold online.” (code 53.6)  
  
“I think one of the reasons to remain on the board of our association is to help guide the field in 
the right direction, in a professional, collegial, united network of the professionals who are 
providing a good service, and kind of leaving out those who are destroying the field.”  
(code 36.6)  
  
Unfortunately, a misinformed group of individuals or a bad experience may permanently tarnish 
the reputation of many neurotherapists, which can negatively affect patient intake and prevent 
practitioners from including neurofeedback in their practice.   
  
“There’s a lot of bad press out there regarding neurofeedback.” (code 53.3)  
 
The majority of participants found that part of the job was convincing their patients and their family 
that the improvement they were observing was due to neurofeedback. This necessity can cause 
unnecessary strain in the treatment of the patient.   
   
“Even if people are coming here or bringing their children here and they are paying for it, they 
almost believe it’s not going to work, so you almost have to convince them the change they’re 
seeing is because of the neurofeedback.” (code 54.3)  
  
“I feel one of the biggest challenges is convincing doctors and parents that neurofeedback 
works.” (code 54.4)  
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The statement below may hint at certain people approaching them with an already negative stance 
of neurofeedback.  
  
“It’s usually the people who are using neurofeedback as their first intervention, then they tend to 
be sceptical.” (code 54.3)  
  
Neurotherapists expressed the unfavourable sentiment that neurofeedback’s infamous reputation 
was partly due to its founders who painted the impression that neurofeedback was a universal 
“wonder” treatment.   
  
“It is a very big challenge for us neurotherapists now because at the start there was a big group 
of practitioners who kind of sold neurofeedback as this cure-all therapy for every condition 
which is a load of rubbish.” (code 51.6)  
  
“So the general impression is that neurofeedback oversells itself.” (code 51.6)  
  
Neurotherapists have had to work diligently to rebuild their field’s image, form meaningful 
relationships with other practitioners and develop a culture of research to create a positive 
impression of the therapy.   
  
“But we have put in an enormous amount of work and effort into publishing some good research 
and forming really good relationships with neurologists, psychiatrists and some GPs.”  
(code 36.6)  
  
According to the BFSA, no neurotherapist may advertise or formally market his/her profession, 
therefore practitioners are motivated to ensure that every patient benefits from the therapy.  One 
neurotherapist noted the significance of patient results regarding neurofeedback’s image.   
  
“A lot of my practice is word of mouth so hopefully that is changing the public perception of 
neurofeedback.” (code 51.6)  
  
3.5.3.2 The lack of public knowledge   
Owing to the restrictions in advertising neurofeedback, not everyone knows of its existence. 
Neurofeedback is also a very complicated mode of therapy, leaving room for ignorance and 
misconceptions.  
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“I think the other problem might be the public not understanding EEG neurofeedback.” 
(code 52.1) 
  
Although neurofeedback has been in existence since the early 1960’s, it has only been offered in  
South Africa for less than 20 years, which may explain the public’s unfamiliarity with this therapy.   
  
“…because neurofeedback is a relatively new field especially in South Africa, […] they don’t 
really know what can actually be achieved with the therapy.” (code 52.5)  
  
Recently, alternative therapies are increasingly being sought out, as many people are drawn to a 
more natural, holistic approach to health. However, while some parents believe in holistic therapies 
like neurofeedback, this may not be embraced in the school environment. As such, parents may 
choose not to tell the teachers that their child is receiving such treatment.   
 
“Often parents choose not to tell the teachers their child is doing neurofeedback or the patient 
themselves does not tell the family or their boss, because they don’t want those people to be 
biased and expect a change.” (code 51.3) 
  
Two participants voiced their frustration at people remaining sceptical over the treatment.   
  
“Sometimes the schools are a bit sceptical because they don’t know or understand 
neurofeedback.” (code 52.3)  
  
“Not everyone is open to it.” (code 51.4)  
  
3.5.3.3 Incorrect practices of neurofeedback   
One participant expressed her frustration over unlicensed individuals using neurofeedback on 
patients.   
 
“So, there are other companies or other modalities that is not necessarily neurofeedback that is 
being done, such as the therapists using the band around the arm or infrared or blood flow in the 
frontal cortex, it’s not efficient.” (code 55.1)  
  
The statement below shows how an incorrect form of neurofeedback mimics the unindividualised 
way some conventional doctors’ practice.   
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“Some people are trained in clinical neurofeedback which is an incorrect form of the therapy, 
where they hook the child up in a chair with electrodes on their head and they walk out and let 
the system do its own thing.” (code 55.2)  
  
A few participants spoke about how unqualified individuals are allowed to formally advertise and 
franchise their practices due to their disconnect from a governing body.  
  
“There are also a lot of unregistered people performing neurofeedback on patients and can 
establish a franchise and can advertise, whereas us registered neurotherapists aren’t allowed to 
do that according to the body we are registered under.” (code 53.2)  
  
Incorrectly administered neurofeedback also presents risk of seizures, depression and anxiety, 
particularly when administered by someone who is poorly trained.   
  
“As much as it is a wonderful tool to create improvement, if you change brain function … 
without knowing what you are doing, or what you are changing, it will create problems where 
there weren’t.” (code 55.6)  
  
“These unregistered people can actually cause more damage to the patient, they can even cause  
a seizure if they don’t know what they are doing.” (code 55.2)  
  
“You can create an anxiety disorder, you can make someone very depressed by enhancing alpha 
waves in a brain that already has too much alpha.” (code 55.6)  
  
3.5.3.4 Research   
Although there is little research done on the efficacy of neurofeedback, those that have been done 
show that it can be used as an alternative treatment.   
  
“I mean the research on EEG neurofeedback is different and has been proven to work.”  
(code 47.1)  
  
One participant mentioned that part of building a good reputation is being involved in research and 
cultivating opportunity for more studies on a profession that lacks research.   
  
“But we have put in an enormous amount of work and effort into publishing some good 
research.” (code 43.6)  
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3.5.3.5 The misdiagnosis of ADHD   
The misdiagnosis of ADHD falls under the third theme because, like neurofeedback, ADHD is 
largely misunderstood by the public. Since ADHD is known for its symptoms of hyperactivity and 
inability to concentrate, there is a trend of labelling disruptive individuals as ADHD.   
 
One participant stated that, in some cases, teachers label the children in their class based on their 
behaviour.   
  
“…and some have even been incorrectly diagnosed as ADHD.” (code 45.4)  
  
“Because they are not reading, they won’t concentrate in school and may be labelled the class 
clown, they’ll be misdiagnosed as having ADHD.” (code 45.1)  
  
While a large part of diagnosing ADHD is based on an assessment of the symptoms, the most 
significant part of the diagnosis is performing special investigations to rule out conditions that 
mimic this neurological condition.   
  
“…[the patient may] even [be] misdiagnosed as ADHD when they actually have something else 
that presents like ADHD.” (code 45.3)  
 
“You know, we need to look through all these things first, before just assuming it’s ADHD.” 
(code 45.6)  
  
While other practitioners in different fields may be quick to diagnose a condition and administer 
medication without doing a thorough investigation, this form of practice is wrongful.   
  
“Some of the psychiatrists (and not the ones I work with) spend no more than fifteen minutes 
with the child and make a diagnosis, ‘there’s your schedule six drug’ – it’s criminal to not do a 
proper investigation.” (code 44.6)  
  
One participant revealed that, in certain cases, neurofeedback is not needed and a referral is 
necessary.   
  
“So, if concentration is not a concern and only reading and writing [is a problem], maybe that 
patient doesn’t need neurofeedback but needs remedial lessons.” (code 40.1)  
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3.6 LITERATURE CONROL  
 3.6.1 Theme One: Neurotherapists’ experiences     
There is a paucity of studies done on the experiences of neurotherapists in treating ADHD. 
Although a 2010 study was conducted using American neurotherapists, no study has looked at the 
experiences of those residing in South Africa, specifically in the province of Gauteng (Larson et 
al., 2010). Yet, because every country presents a unique set of challenges based on cultural and 
climate-specific traits, which has a surprising influence on the population’s state of health – both 
mental and physical – it is vital to acknowledge that mental health can be affected by one’s genetics 
and cultural background (Omu & Reynolds, 2012; Legg & Penn, 2013; Chersich et al., 2018; 
Merikangas, K.R., 2019; Merikangas, A.K., 2019; Lewis, 2019). This consideration is important 
when exploring the experiences of South African neurotherapists who treat a globally known 
neurological condition such as ADHD, because it can provide a basis for comparison should this 
study be replicated in other countries. The value of using neurofeedback to treat this complicated 
condition is examined under the third objective of this study.  
  
As neurofeedback has only been in South Africa for less than twenty years as opposed to forty 
years in America, this alternative therapy is still in its infancy stage in South Africa.   
  
3.6.1.1 Perceptions of neurofeedback as a therapy   
Participants spoke about the positive role of neurotherapy in the treatment of ADHD and how it 
should be made available to a wider population of school children and be easily accessible in terms 
of location. A British study done in 2013 showed that as many as three children in each classroom 
have a learning disability (Butterworth & Kovas, 2013). ADHD is one of the most frequently 
diagnosed childhood psychiatric disorders, with a universal prevalence of up to 5% – indeed, there 
is a larger prevalence of learning disabilities than there was two decades ago (Mitchison & 
Njardvik, 2015; Houtrow, 2013).   
  
Neurofeedback can have a positive influence on a developing child, as well as other individuals 
with learning disabilities if it is within reach, as it is acknowledged by participants that 
neurofeedback is an appropriate therapy to support a child’s learning. Neurofeedback is an 
alternative modality that not only aids in the improvement of the neurological condition but also 
treats other issues the patient may have as a result of that condition (Costello & Stone, 2012).   
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3.6.1.2 Personal experiences gained from using neurofeedback   
A. Knowledge acquired   
Participants expressed how it takes experience over many cases to understand the importance a 
qEEG has on the success of the neurotherapy. One neurotherapist explained that a qEEG done 
before the start of the therapy highlights the problem areas and provides the neurotherapist with 
an individualised map of the patient from which the treatment protocol is constructed. The success 
rate of neurofeedback is thus significantly amplified by the supporting role that a qEEG has, and 
neurotherapists have noticed that qEEG changes demonstrate symptom improvement (Arns et al., 
2012; Aguilar-Prinsloo & Lyle, 2010). Success in treatment relies on the patient and their family 
being invested in the therapy. Experience is vital in being able to understand the strengths and 
weaknesses of this therapy and apply it in a holistic and individualised manner.  
  
3.6.1.3 Limitations of neurofeedback  
A. Obstacles to cure   
The phrase obstacles to cure refers to the contributing factors in the patient’s life that causes or 
exacerbates the problem and prevents effective treatment. Unfortunately, if a practitioner does not 
help the patient deal with those issues and instead views the case superficially, limited 
improvement will occur. When asked about the challenges neurotherapists face when treating 
ADHD, all participants spoke of the same four factors that impede the patient’s improvement: 
parents, teachers, dysfunctional situations and other practitioners.   
A factor that was not mentioned by the participants was social interactions, specifically with peers. 
In Canada and the United States of America, a combined study was done on ADHD children and 
their classmates to investigate socialisation in a classroom environment. The data revealed that 
those with ADHD and oppositional defiant disorder were more likely to be rejected by their peers 
and be bullied. The distress caused by social rejection, bullying and victimisation eventually can 
contribute to anxiety disorders and feelings of low self-worth (Mrug et al., 2012; Mrug et al., 
2009).  
 
- Parents   
Although the patient is required to be involved in his/her treatment, the patient’s family is also 
meant to participate (Useche & Alonso, 2017). Gaining feedback from others gives the 
neurotherapist another perspective on the patient’s issues. Establishing a well-rounded picture of 
the case contributes to the prognosis. If feedback from a third party is lacking or prejudiced, then 
both the neurotherapist and the patient are placed at a disadvantage.   
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- Teachers   
 Participants in this study voiced their concern over the methods teachers use to interact with 
ADHD children in their classroom. Many neurotherapists mentioned that teachers often label the 
child with ADHD without referring the child for a proper investigation. This hasty diagnosis often 
leads to the persuasion of parents to take their child to a practitioner who may administer 
psychiatric medication to those children, without conducting a proper diagnosis.   
  
Tegtmejer (2019) conducted a study in Denmark that explored teacher’s strategies in their 
classroom when interacting with children diagnosed with ADHD. This study shows that the 
majority of teachers attempted to establish structure within the classroom when the child lost 
concentration, while others ignored the child. A systematic review done on teachers’ interactions 
with students with ADHD demonstrated that these children fear rejection from teachers, which 
consequently raises their levels of stress and exacerbated behavioural issues (Ewe, 2019).   
   
- Dysfunctional situations  
A longitudinal study sampling 258 three-year-old preschoolers showed that family dysfunction can 
contribute to the worsening of ADHD symptoms in children (Breaux & Harvey, 2019). The results 
of this study supported the correlation between negative family situations and severe ADHD 
symptoms in children (Hawes et al., 2013; Keown, 2012). This study also found a high prevalence 
of maternal and paternal depression owing to difficult family interactions with their ADHD child 
(Breaux & Harvey, 2019). One participant in this study explained that, in a dysfunctional situation, 
it is harder to treat the patient owing to this problem. She explained that one cannot fix brainwaves, 
then put the patient back into a chaotic system and still expect them to make progress.  
  
3.6.1.4 Negative aspects of neurofeedback  
A. A high-cost treatment  
Participants have admitted that neurotherapy can be very expensive at times, especially owing to 
the number of sessions required in a relatively short space of time. The high cost might also be due 
to the extremely valuable machinery used to conduct the therapy and the labour required by the 
neurotherapist, who monitors the feedback in real-time. However, if one were to calculate the sum 
total of monthly medication as well as visits to the prescribing practitioner twice a year to renew 
the prescription, one would be surprised at how these therapies may be even more expensive. 
Neurofeedback is thus an expensive short-term therapy that usually ceases in three to four months 
and produces long-term effects making it cost-effective in the long run (Larson et al., 2012; Harris, 
2017).   
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3.6.1.5 Challenges that neurotherapists encounter  
A. Poor patient compliance   
Each participant was asked to describe the challenges they have faced since using neurofeedback 
in practice. All neurotherapists mentioned that inadequate patient adherence could possibly be the 
most frustrating and substantial challenge they face. It causes unnecessary restrictions in their 
treatment protocol and hinders the patient’s improvement. Lack of compliance may be due to the 
fact that the therapy requires a lot of time and effort from the patient, which are resources that the 
patient may not have. For the neurotherapy to work quickly and efficiently, the patient is required 
to attend two sessions per week for three to four months. This may cause problems regarding time 
management and transportation for either the parent or the patient themselves, which can be 
inconvenient. An American study showed that neurotherapists also experienced non-compliance 
with attendance to sessions and engagement in lifestyle interventions (Harris, 2017; Larson et al., 
2012).   
  
Adults suffering from the effects of ADHD face higher levels of stress because of work impairment 
and pressure owing to poor time management (Combs et al., 2015). Although ADHD adults may 
cope with their impairment by choosing careers appropriate to the limitations created by their 
condition (Combs et al., 2015), one neurotherapist also mentioned that these patients often struggle 
to be on time when attending neurofeedback sessions.  
  
3.6.2 Theme Two: Value of neurofeedback in practice  
This theme deals with the perceived value that neurotherapists experience from the use of 
neurofeedback for ADHD patients.   
  
3.6.2.1 Developing therapist-patient rapport   
One neurotherapist commented on how utilising the patient-practitioner bond that develops 
benefits the patient. Neurofeedback adopts individualisation in its philosophy, therefore the 
neurotherapist tailors the treatments to every patient. The researcher noticed that all six 
neurotherapists viewed and spoke about their patients with sincerity and respect. A patient is more 
likely to share his/her embarrassing concerns to a practitioner who listens and is sincere, which in 
turn may play a valuable role in the treatment outcome. It is essential for the neurotherapist to 
create a safe and confidential environment, which allows for trust to develop between the 
practitioner and patient (Aguilar-Prinsloo & Lyle, 2010).  
  
The neurotherapist has a certain level of responsibility to practice positive psychology with the 
patient. When neurotherapists show their patients their qEEG results, this allows the patient to 
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become aware of their improved capability over time. This confidence that the patient develops 
may be healing in itself. Costello and Stone (2012) suggested that motivation and encouragement 
should be a requisite in every therapy. The authors declared that giving patients back their 
confidence by working on their strengths helps them become self-efficacious. One patient, when 
asked about his experience with neurotherapy, said that the greatest benefit from the therapy was 
derived from the fact that the neurotherapist helped him understand that he is not the first and only 
person suffering from the condition and that it can be improved (Aguilar-Prinsloo, 2010).   
  
3.6.2.2 Cases in which neurofeedback has value   
ADHD is a frustrating and demanding condition that deprives sufferers of their confidence and 
effects their social interaction. Because the condition presents early on in their school years, these 
children often develop a weak learning foundation and experience slow learning. They will often 
struggle for years before being diagnosed with ADHD, if ever. This learning disability often results 
in tense interactions between with their classmates and it may be harder for the child to form 
friendships, possibly resulting in a poor self-image (Mrug et al., 2009; Golden et al., 2018).    
 
Neurofeedback is a complementary, drug-free alternative in the treatment of ADHD. Young and 
Myers (2011) described neurofeedback as a non-invasive, holistic therapy that needs to be included 
in counselling treatments, as it addresses the physiological symptoms of mental disorders. 
Neurotherapists have noted that one of the first signs of improvement in neurofeedback is the 
amelioration of anxiety. Psychological distresses such as depression and anxiety often benefit from 
neurofeedback as a stand-alone intervention (Harris, 2017; Larson et al., 2010). Indeed, there is a 
great possibility that ADHD individuals suffer from co-morbidity conditions like anxiety, 
depression and behavioural problems (Harris, 2017). Several longitudinal studies done in the 
United States have shown that young ADHD individuals are at a higher risk of developing 
depressive disorders than those without ADHD (Meinzer & Chronis-Tuscano, 2017). In a study 
done on 197 children with ADHD, 41.96% had symptoms of anxiety (Mitchison & Njardvik, 
2015). In addition to behavioural issues and delayed learning, individuals with ADHD experience 
difficulties in social and emotional interactions. ADHD sufferers also have a high incidence of 
insomnia (Gaultney, 2014; Buchanan, 2011). Indeed, the participants in this study mentioned that 
they encounter many ADHD cases in which the patients experience anxiety, insomnia and 
depression. Neurotherapists expressed confidence in the efficacy of this therapy and its ability to 
treat a wide range of patients presenting with ADHD and other co-morbid conditions.   
 
A similar qualitative study similar was done in Chicago, where perceptions of practitioners were 
explored regarding neurofeedback in the treatment of mental disorders (Appendix L). Larson and 
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colleagues (2012) recruited participants with similar experiences to those included in this study, 
even though the American study focused on a broad range of mental disorders and this study 
focuses on ADHD. The American practitioners also found that neurofeedback was a favoured 
therapy when medication no longer worked or where the patient was unable to take any medication. 
Unlike participants in the current research, those in the Chicago study stated that neurofeedback 
also offers neurological regulation that conventional medication does not (Larson et al., 2012).   
  
When asked to describe the role neurofeedback has when treating ADHD, each participant spoke 
about the successes in not only their ADHD patients, but in other conditions such as depression, 
insomnia, Tourette’s syndrome and tics. This finding offers us another perspective of how 
neurofeedback may play an essential role in treating neurological conditions. Although 
neurofeedback has its limitations, it can help alleviate distressing neurological symptoms. 
Neurofeedback may improve the patient’s quality of life in terms of lessening symptom severity 
and offering the patient better coping mechanisms (Luctkar-Flude et al., 2019). The patient is then 
able to handle day-to-day stressful situations and adapt to their condition, helping them gain some 
quality of life (Reddy et al., 2014). This holistic approach is therapeutic itself. Success of the case 
may also be partly dependent on the neurotherapist. If a practitioner is untrained and not aware of 
the strengths, weaknesses and limitations of the neurotherapy, then patient improvement is not 
guaranteed. While neurofeedback may not always be useful, therapeutic success is more likely if 
the neurotherapist is experienced and well-trained.   
  
In order to acknowledge the role neurofeedback has in private practice, it is important to recognize 
the conditions neurofeedback corrects or improves. The types of neurological disorders that were 
mentioned by the participants are ADHD, strokes, tics and Tourette’s syndrome, where anxiety is 
almost always the first symptom to disappear. Aguilar-Prinsloo and Lyle (2010) interviewed 
patients on their experience of neurofeedback and asked whether the therapy had helped with 
regards to their anxiety levels. One patient responded, “I experienced an exponential improvement 
in my anxiety levels. Overall, I feel that the results of my therapy far exceeded my original 
expectations.” However, some patients may still experience a lingering of anxiety after the 
treatment has ceased. Nevertheless, the anxiety was described by patients as easier to manage, 
even without medication. In this situation, although complete cure has not been achieved, the 
therapy was beneficial as it enhanced the patient’s quality of life (Larson et al., 2010). Neuronal 
defects such as strokes and epilepsy have also been treated in the past with success due to 
consisting of mild cases (Wang et al., 2018b; Tan et al., 2009).  
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Participants of this study could not confidently say that neurofeedback has lasting effects, because 
the clients seldom return after the cessation of treatments. A study done by Harris (2017) showed 
that effects lasted at least a year after treatment, but no other studies have explored a longer time 
frame.   
  
3.6.2.3 Cases in which neurofeedback holds no value   
It is important when evaluating the role neurofeedback has in treating ADHD, is to recognise the 
therapy’s limitations. If the neurotherapist is aware of the conditions that cannot be treated by this 
therapy, it saves time, money and effort if that patient is referred. One participant noted that 
neurofeedback cannot cure or alleviate ADHD if there are psychological issues that are 
contributing to the condition. In such cases, working alongside a medical practitioner is vital. One 
participant explained that, “[It’s] not to say that neurofeedback doesn’t work, but neurofeedback 
doesn’t cure autism and doesn’t most often cure a hundred percent improvement in ADHD.” Even 
with conditions that neurofeedback is known to help, not every case is cured. Success may depend 
on the patient as well as factors such as genetics, family situation, diet, trauma, compliance, 
relationships and other concomitant medical conditions, as stated by participants.   
  
One participant noted that autism is a neurological challenge in which neurofeedback cannot help. 
However, participants in other studies remarked that neurological impairments like Asperger’s, 
temporary brain injury (TBI) and autism did improve in symptomology when using neurofeedback 
(Larson et al., 2010; Aguilar-Prinsloo & Lyle, 2010; Datko et al., 2018; Coben et al., 2010). This 
difference in findings may show that the limitations of neurofeedback may be case- or 
neurotherapist-dependent and not necessarily based on the condition.   
  
3.6.2.4 Integration with other therapies   
The referral of one’s patient to another practitioner requires acknowledging that not every case is 
suitable for neurotherapy and that putting the patients’ needs first is essential in giving them the 
best form of care possible. Moreover, being part of an integrative profession has its merits. The act 
of working closely with other practitioners initiates learning from one other, therefore contributing 
to the growth of each practitioner (Scaria, 2016). It was found in this study that practitioners often 
refer their patients to other practitioners to augment the treatment outcome. For instance, 
participants declared that neurofeedback cannot cure or alleviate ADHD if there are metabolic 
issues that are contributing to the condition. In such cases, working alongside a medical 
practitioner is vital, where special investigations can be conducted in order to isolate those 
biochemical obstacles and heal the patient from within (Gray & Orrok, 2014).   
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3.6.2.5 Neurofeedback as the last line of treatment   
Neurofeedback is often considered a last-resort treatment option usually when patients seek a 
holistic alternative and have a desire to avoid or discontinue medication use.   
  
A. The patient no longer wishes to take medication  
Conventional medication is often the first sought after form of treating medical disorders, 
especially a frustrating condition like ADHD. Utilising medication for the treatment of ADHD is 
effective in most cases, yet side effects may influence patient compliance, particularly in the long 
term. Stimulant medications like Ritalin can lead to suppressed appetite, nervousness and 
headaches (Harris, 2017). Cunill et al (2015) coordinated a meta-analysis on studies that assessed 
pharmacological efficacy in ADHD treatments. The researchers discovered that the medications 
were only effective in lessening the symptoms of ADHD and did not cure the condition. They also 
found that those who took the medication were often not consistent in taking it daily and eventually 
discontinued the treatment, either due to inconvenience or side effects (Cunill et al., 2015). 
Unfortunately, randomised trials of the long-term usage of ADHD medication (both stimulant and 
non-stimulant) have not been done (Craig et al., 2015). Although it is not necessarily a limitation, 
having to wean the patient off the medication during neurofeedback therapy prolongs the treatment 
time, which may affect patient compliance.  
  
3.6.2.9 Neurofeedback as holistic treatment  
It is clear that neurofeedback and homoeopathy share fundamental traits and focus on a holistic 
approach towards a case and their patients. Each neurofeedback session is different, as each patient 
progresses and heals in different ways. No two brains are alike, and functionality and imbalances 
differ from person to person (Chang-Hee et al., 2016). This practice is similar to the prescribing 
of homeopathic remedies to patients, which is not based the diagnosis but how the individual 
presents with that disease (Ciocanel, 2016). The significance that neurotherapists place on 
individualisation is a tremendous contributing factor to the beneficial effects noted with this 
therapy (Chang-Hee et al., 2016).   
  
Neurofeedback is described as a form of counselling that “teaches” the brain to self-regulate and 
offers coping skills (Harris, 2017).   
  
One participant stated that neurofeedback thus helps address the various dimensions of the 
problems that the patient experiences. People may tend to view a learning disorder as being one-
dimensional, not a network of entangled parts that influence each other. Too often, a practitioner 
focuses on one problem and remains unaware of the other issues (Othmer & Othmer, 2015). A 
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study done by Aguilar-Prinsloo and Lyle (2010) demonstrates the integrative approach 
neurofeedback has and how improving a symptom like anxiety may indirectly influence 
interpersonal relationships. One participant in this current study explained that she adapts to the 
challenges she often faces with certain types of patients and develops strategies that helps her 
patients improve.   
  
Neurotherapists are thus aware of the many complexities that need to be addressed when treating 
patients with ADHD and know that in order to help the patient as much as possible, each issue 
needs to be dealt with consecutively. For example, a patient with a physiological disorder should 
have this imbalance treated before neurofeedback is considered. However, although neurofeedback 
is often one of the last forms of treatment patients attempt, this does not discredit the practice. 
Indeed, this final treatment may be more appreciated by the patients, as they see the level of care 
neurotherapists offer.   
  
One neurotherapist mentioned another aspect of holism that neurofeedback embraces. Unlike 
conventional therapeutics, neurofeedback does not adopt the “one size fits all” approach. It is 
individualistic and views every patient as being unique as their problems are (Stoler, 2012; 
ChangHee et al., 2016). There is never an assumption of what is causing the issue and how to treat 
it, as every treatment is as distinct as the patient. Another reason why neurofeedback is holistic is 
the amount of involvement the neurotherapist has in the session, where every bit of feedback is 
analysed live and in person, and each session is altered in line with the patient’s progress 
(ChangHee et al., 2016; Hammond, 2010b).  
  
3.6.3 Theme Three: Neurofeedback and the public    
  
3.6.3.1 Neurofeedback’s uneven reputation   
Reputation can be both infamous as well as credible. Often, a patient’s first impression of a therapy 
can elicit either a positive or negative reaction from a patient, especially when the treatment is not 
understood properly. This subjective opinion can in turn dictate the patient’s actions, where he/she 
will either continue with the neurofeedback or cease treatment. Other people’s experiences may 
also influence the opinion of a potential patient. The influence of others is powerful and not a 
factor that neurotherapists can control. Negative opinions may also be the result of deceptive 
marketing, where unlicensed individuals market the therapy as a “cure all” (Larson et al., 2010).   
  
In Texas, a qualitative study was done on neurofeedback clients’ perception of the therapy in the 
treatment of their anxiety. Notably, one client was asked what would have been beneficial to know 
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before the start of his treatment protocol. He said that he did no research before the therapy began 
because the internet can give one preconceived opinions and persuade one into thinking it may not 
work (Aguilar-Prinsloo & Lyle, 2010).   
  
3.6.3.2 The lack of public knowledge  
The misconception that the public has of neurofeedback has been shown to cause a lot of frustration 
among participants (Larson et al., 2010). This frustration eventually results in neurotherapists 
becoming discouraged, as building a credible profession is both time and energy consuming, 
especially when the only way of advertising is through word-of-mouth. External factors, such as a 
poor reputation caused by incorrect practices, bad experiences or ignorance, may have a negative 
impact on their credibility, amplifying the challenges they face as alternative therapists. However, 
it is important that, when working in a profession that has an uneven reputation, one acknowledges 
that such matters are out of their control and that channelling their energy into helping their patients 
is the best way of handling the situation.    
  
Much of the ignorance and scepticism stems from the fact that there is insufficient research on 
neurofeedback, which can be addressed by increasing the number of published studies. Research 
not only benefits those in the profession but ordinary people as well, as helping them to become 
knowledgeable in alternative therapies may widen their options for treatment – especially since 
conventional treatments may be seen as being generalised and thus unfavourable. It is also very 
difficult to discuss neurofeedback therapy with the public, other practitioners and to patients due 
to its complexities (Larson et al., 2010).   
  
Recent studies have discovered that neurofeedback can enhance and improve cognitive functions 
in not just neurological conditions, but also healthy people, which has caused neurofeedback to 
receive a lot more attention (Chang-Hee et al., 2016). Nevertheless, the lack of recognition in the 
medical field means that the patient is not reimbursed by his/her  medical aid, which may influence 
whether the patient will continue with the sessions. Other disciplines, too, are not aware of this 
alternative therapy, which may reduce the number of referrals a neurotherapist will receive (Larson 
et al., 2010).    
  
3.6.3.3 Incorrect practices of neurofeedback   
As discussed in the literature review, neurofeedback comprises several protocols which are used 
for different types of neurological impediment. Only a neurotherapist who has practiced 
neurofeedback for many years would fully know the strengths and weaknesses of each variant. 
Just as patients are individualistic, the variants of neurofeedback are as well. Poor knowledge of 
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this feature can become a form of malpractice as harm to the patient is possible, which in turn may 
contribute to the uneven image of the profession.   
  
Out of the six participants, four expressed their frustration and concerns over the poor reputation 
that neurofeedback has. Participants attributed this unfavourable reputation to the unqualified 
individuals using neurofeedback. Such individuals advertise to promote their trade, which gives 
them an unfair advantage over affiliated neurotherapists (Larson et al., 2010). Moreover, 
neurofeedback hardware and software are easily accessible online, making it simple for any 
unlicensed individual to purchase equipment and claim to be “trained” in neurotherapy. In order 
to earn an income, some people may resort to studying under unaffiliated colleges and, while 
unregistered with the BFSA, practice as a neurotherapist. This places qualified neurotherapists at 
a disadvantage, because they are bound to the rules and regulations of the BFSA, which state that 
no formal advertising may be done to promote their business, thus forcing them to rely solely on 
word-of-mouth. In contrast, untrained and unregistered individuals do not need to abide by such 
rules. They can also franchise their practices and offer their services at a lower cost. There is then 
a large potential for mistakes to be made, thus creating a bad impression of neurofeedback in 
general (Larson et al., 2010). There is also space for the “snake oil syndrome”, which is deceptive 
marketing of a medical trade. According to an American study, the treatment is overrun by client 
referrals, which shows there is no shortage of clientele – but encouraging them to go to qualified 
and registered practitioners is difficult (Larson et al., 2010).  
  
While the BFSA can regulate the affiliated courses offered in South Africa, there is a limit as to 
what it can monitor when it comes to online courses that are governed by foreign countries. These 
online courses may be very superficial and not explain the limitations of neurotherapy, creating 
confident individuals who are incorrectly trained. Patients who then are treated by these people 
have placed their faith in neurofeedback, but either do not have any improvement and think of 
neurofeedback as a scam, or they may find their symptoms worsening.  
 
3.6.3.5 The misdiagnosis of ADHD  
The misdiagnosis of ADHD falls under the third theme because, like neurofeedback, ADHD is 
largely misunderstood by the public. There is a high rate of ADHD misdiagnosis in South Africa 
(ADHASA, 2014). It has also been shown that children in particular are subject to misdiagnosis, 
whether it is by practitioners, parents or teachers themselves (Schwandt & Wuppermann, 2016). 
Teachers who incorrectly label a child with ADHD do so based on visible psychological signs such 
as high levels of anxiety and stress (Harrison et al., 2013). However, research suggests that many 
neuropsychological conditions have overlapping symptoms that may be perceived as ADHD 
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(Abramovitch, 2016). These symptoms can be anxiety, stress, weak learning skills, difficulty in 
concentrating, poor social skills and impulsivity.  
  
3.7 RESEARCHER’S BRACKETING, REFLEXIVITY AND OBSERVATIONS  
  
“Bracketing” refers to the careful efforts a qualitative researcher adopts in order to ensure that the 
researcher’s perceptions, expectations and personal experiences do not influence the organisation 
and interpretation of the data (Creswell, 2013). Prior to the start of the interviews, the researcher 
felt the need to practice with a pilot interview, paying attention to tone, mistakes in guiding the 
interview and signs of affirmation. The researcher practiced bracketing with every interview by 
starting with an open-ended central question, followed by sub-questions to facilitate structure and 
ensure relevance to the aim of the study. After every sub-question was asked, there was an 
additional question of: “Is there anything else you would like to add?” With this question, the 
researcher strived to create the opportunity for genuine, honest answers that were no longer 
facilitated by the direction of a question. The researcher reflected on her own demeanour after 
every interview and, where there were mistakes of subjectivity, the researcher made a conscious 
effort never to repeat those mistakes in the next interviews. Throughout the two cycles of data 
coding during data analysis, bracketing was adopted once again. Having to recode the data later 
also eliminated the opportunity for subjectivity.   
  
Owing to the researcher’s personal experience with neurofeedback, she had to be extremely careful 
in her approach to every interview. The researcher tried her best to stay as objective and as 
disconnected from the topic as possible by not thinking about her own experiences. The researcher 
had to ensure that that her perception and expectations towards the research’s outcomes were 
eliminated and no data was contaminated. Another level of objectivity was achieved with the help 
of an external qualitative analyst, who evaluated and confirmed the validity of the data coding and 
analysis.   
  
The researcher acknowledges that every participant is diverse and individualised, and so were their 
experiences of neurofeedback. Nevertheless, every participant expressed ideas relating to the same 
topics but in their own words. Although the participants are at different stages in their career, their 
experiences were also similar, but often interpreted differently. Every participant showed an 
admirable level of passion and confidence towards their profession. Each participant engaged with 
the researcher. The participants were encouraged to speak openly, without any judgement from the 
interviewer.   
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3.8 CHAPTER DESCRIPTION   
In Chapter 3, the experiences of the participants were organised and categorised into themes, 
categories and sub-categories. Thereafter, the data was discussed in detail. To conclude this 
chapter, all the steps the researcher implemented to remain unbiased were mentioned. In Chapter 
4, the findings of this phenomenological, qualitative research study was summarised and 
recommendations are offered.    
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CHAPTER 4: CONCLUSIONS AND RECOMMENDATIONS   
  
4.1 INTRODUCTION   
In this final chapter, the findings of the study are summarised and discussed. Thereafter, the 
limitations of this research are outlined, and recommendations for both the neurotherapists and 
future researchers are provided.   
  
4.2 CONCLUSION   
There is a high prevalence of children with ADHD in South Africa who are struggling 
academically, socially and functionally. Parents often seek out alternative therapies due to 
unfavourable side effects of conventional medications experienced by their ADHD children. This 
brings in neurofeedback – a holistic and integrative mode of treating ADHD with potentially long 
term benefits. Unfortunately, there is a lack of research done on neurofeedback, and it remains 
largely unknown among the public.   
  
This study aimed to explore and describe the experiences of neurotherapists using neurofeedback 
in the treatment of ADHD. In addition, it intended to evaluate the role and value of neurofeedback 
within the psychiatric field, especially in treating neurological conditions like ADHD. A 
qualitative, phenomenological study was therefore undertaken. Data was collected by means of 
face-to-face interviews with six Gauteng-based neurotherapists who use neurofeedback as a 
therapy to treat patients with ADHD in their practice, who volunteered to take part in the study. 
Every interview was conducted using the same open-ended questions. The central question was: 
“Tell me about your experiences using neurofeedback as a treatment of patients with ADHD in 
your practice?” Other sub-questions where then used to elicit more information to answer the 
research question.   
  
After data was collected, it was transcribed, then organised and coded using a qualitative analysis 
software called ATLAS.ti 8. Three themes became apparent, therefore categories and 
subcategories were created to differentiate information into their respective groups.   
  
The objectives of this study were:  
1. To examine and discuss, using a qualitative and phenomenological framework, the experiences of 
neurotherapists who use neurofeedback to treat patients with ADHD in their practice.  
2. To identify the challenges faced by neurotherapists when treating patients with ADHD.      
3. To identify the perceived value and role neurofeedback plays in the treatment of ADHD.  
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4.2.1 Objective 1: To examine and discuss, using a qualitative and phenomenological 
framework, the experiences of neurotherapists who use neurofeedback to treat patients with 
ADHD in their practice.  
This objective was accomplished by conducting a phenomenological, qualitative study of which 
data was extracted from face-to-face interviews. By adopting a phenomenological approach, this 
allowed for the researcher to be exposed to various distinct perspectives and experiences from 
every neurotherapist that volunteered to take part in this study.    
  
•   Theme One: Neurotherapists’ experiences.   
This theme was sub-divided into six categories, each of which focused on different aspects of the 
neurotherapists’ experiences. This theme included how their perceptions of the therapy developed, 
the limitations of the treatment and any drawbacks they may have noticed over the years of using 
neurofeedback. This theme is especially important when describing the potential use of 
neurofeedback. It was shown that neurofeedback is instrumental in the improvement of ADHD. It 
was mentioned by a few participants that neurofeedback is their preferred treatment for ADHD, 
based on previous results. They noted that the patient starts noticing an improvement within the 
third week of treatment, on average. Participants also indicated that this therapy should be made 
widely available in schools to help children with their foundational learning and to identify any 
weaknesses that may have otherwise been missed by teachers and parents. This would allow or a 
more integrative and holistic approach to be explored at a foundational level.   
  
Neurofeedback has been described by many participants as a treatment that improves attention, 
concentration and anxiety. However, a few neurotherapists mentioned that, although 
neurofeedback is a promising modality, it cannot cure every condition and that referring patients 
with conditions such as bipolar disorder and autism to specialists is usually the best approach.   
  
Moreover, every neurotherapist interviewed approached the central question by not only 
describing the strengths of this treatment, but also its weaknesses. Neurofeedback may not be able 
to cure the condition, but does improve the symptoms and the patient’s ability to cope. Other 
factors, such as the patient themselves, the parents and even the teachers may also impede the 
process. It was mentioned by every participant that the therapy itself is also very expensive and 
tends to require a lot of time from the patient, which is not always feasible. It is quite evident that, 
because neurofeedback is an alternative, holistic form of treatment, it requires effort from the 
patient, who needs to be involved in his/her own healing. Insufficient patient compliance is an 
issue that all was expressed by all participants in this study.   
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The neurotherapists also often educate their patients on the contributing factors to their condition 
and the solutions appropriate to the treatment. It is within the patient’s best interest to eradicate 
those contributing factors, but many of the participants stated that the patients struggle with this. 
Indeed, one of the limitations of neurofeedback is that the patient’s improvement is dependent on 
how determined they are to change their lifestyle habits.   
  
4.2.2 Objective 2: To identify the challenges faced by neurotherapists when treating patients 
with ADHD.     
This objective is highlighted in both theme one and theme three. An individual cannot truly 
experience a situation without having experienced a negative aspect from it, just like how 
neurotherapists cannot fully describe their experiences of using neurofeedback without mentioning 
the negative aspects.   
  
•    Theme One: Neurotherapists’ experiences  
The challenges and limitations mentioned in theme one were discussed in detail under the first 
objective. These limitations included patient compliance, their participation in the treatment 
process and external factors such as parents and teachers. Other challenges were the cost of the 
therapy and the amount of time it demands from the patient.    
  
•    Theme Three: Neurofeedback and the public  
This theme focuses on the challenges neurotherapists have encountered over the years in practice. 
The public, through ignorance or bad experiences, may have a negative perception of 
neurofeedback. There are also individuals who are not trained in the practice but who treat people 
with neurofeedback equipment because it is readily available online. Usually in such situations, 
the patient either does not have any improvement or may find that their symptoms are aggravated.   
  
Moreover, in South Africa, alternative therapies are not as well recognised as conventional 
treatments. A contributing factor to neurofeedback’s bad reputation is that a large part of the 
population does not know of it and hearing the opinions of others changes theirs as well. The lack 
of research done on neurofeedback is also disadvantageous to the profession as it limits its 
credibility.   
  
The misdiagnosis of patients is also a frustration for many participants. Participants noted how 
often they come across teachers labelling children as having ADHD in their class and persuading 
the parents to have their child medicated to avoid future disturbances in class. Moreover, other 
practitioners also may misdiagnose their patients.   
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4.2.3 Objective 3: To identify the perceived value and role neurofeedback plays in the 
treatment of ADHD.  
It is important to understand the value this therapy has. Theme two focuses on this objective and 
is sub-divided into nine categories.    
  
•   Theme Two: Neurofeedback’s value in private practice  
The neurotherapist focuses not only on the treatment of the prescribing condition, but the patient’s 
life as well. As such, a professional and trusting relationship develops, where the patient is able to 
speak about any contributing factors that are impeding his/her improvement. Neurotherapists also 
focus on lifestyle interventions to aid in improvement.   
  
Participants noted that neurofeedback is most effective in treating ADHD, tics, Tourette’s 
syndrome and conditions in which attention and concentration is lacking and anxiety is 
debilitating. In contrast, participants felt that neurofeedback is not helpful in treating neurological 
deficits such as bipolar disorder and autism.   
  
Neurofeedback therapists also tend to have close connections with other practitioners. For instance, 
the neurotherapist may refer the patient to a general practitioner, counsellor, psychologist or a 
homoeopath. It is within the patients best interest for the neurotherapist to closely work with other 
practitioners involved in the patients care.   
  
The therapy’s success is predominantly due to the neurotherapist who conducts the treatment, thus 
often relies on the experiences and training of the neurotherapist. The success rate also relies on 
utilizing qEEG before the start of treatment, as this acts as a reference point in which the 
neurotherapist plans the treatment. This qEEG may also motivate the patients in their healing 
journey, as seeing an improvement on a diagram provides them with concrete evidence that they 
are on the right path. On careful examination of the information collected, it is evident that 
neurofeedback has a high position in the biomedical field and holds great value in giving ADHD 
individual’s back their quality of life. It not only has shown to have a positive influence on the 
patient’s life, but the practitioner’s way of treating neurological conditions as well as the success 
of their own practice.  
  
There are many similarities between neurofeedback and homoeopathy, which can be seen in their 
philosophies, how they approach a case and their holistic approaches. Neurotherapists are trained 
to look at the patient as a whole. Unlike conventional therapeutics, neurofeedback does not adopt 
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the “one size fits all” rule. It is individualistic and there is never an assumption of what is causing 
the issue and how to treat it, as every treatment is as unique as the patient.  
  
4.3 LIMITATIONS  
The intention of the study was to investigate and discuss the experiences of neurotherapists based 
in Gauteng who use neurofeedback in their treatment of ADHD. Face-to-face interviews with 
information-rich participants were used to gather data. The transcriptions, which were written 
collections of the interview data, were then analysed to establish the role and value of 
neurofeedback in the treatment of ADHD. Throughout the process of this study, the researcher 
encountered a few limitations, which are described below.    
  
• The researcher had never performed interviews. The researcher first practiced her interviewing 
skills by making use of a pilot interview. This interview’s purpose was to reveal any mistakes or 
points upon which the researcher could improve. The researcher performed self-criticism after 
every interview, making a conscious effort to improve with every interview that was held. As such, 
appropriate information as well as data saturation was achieved. This proved to be a limitation, 
and not an interruption.   
• The researcher had no previous experience with conducting research, or the process of categorising 
qualitative data. Owing to time constraints, the researcher could not attend courses on the 
qualitative analysis software known as ATLAS.ti 8 but watched a few online training tutorials and 
bought an ATLAS.ti 8 manual as learning material. The researcher made use of Susanne Friese’s 
“Qualitative Data Analysis with ATLAS.ti” throughout the process of organising and coding the 
data. Although the researcher lacked confidence, she felt that the best way of learning was through 
experience and conducting the research. After the data was organised into a table consisting of 
themes, categories and sub-categories, the data became easier to interpret. As the outcomes of the 
study have been influenced by the researcher’s subjectivity, an external qualitative analyst was 
asked to review and verify that the entire data process, from data organising to coding and analysis, 
was correct. The researcher strived to remain as impartial throughout the entire data process as 
possible.   
• At times, participants would offer little information on certain questions, leading to the researcher 
having to prompt the participant in order to extract more information. Doing so may have appeared 
as coaxing the interviewee, so the researcher tried her best to only ask open-ended questions.   
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4.4 RECOMMENDATIONS   
In order to facilitate further research, recommendations are provided below. As the researcher 
emerged in the study and experienced the process herself, she has consequently been exposed to 
all the challenges within the study’s procedure.  
  
4.4.1 Recommendations for neurotherapists   
Owing to the limited research regarding neurofeedback, more neurotherapists should publish case 
studies and articles in accredited journals. Neurotherapists who are not experienced enough to 
handle an ADHD patient should rather work under the care of an experienced neurotherapist as 
their mentor, in order to gain experience and knowledge where there is lacking.   
  
4.4.2 Recommendations for the BFSA  
Although this governing body has already implemented rules and regulations to ensure that 
professional, safe and efficient therapies are carried out by every affiliated member, it is extremely 
difficult to supervise online websites that offer discounted neurofeedback courses. Perhaps laws 
can be drafted that prohibit sites from offering neurofeedback-related courses unless they are 
approved by the BFSA. This law, however, may take many years to be approved, if ever. The 
BFSA can also promote education regarding the field. The association may also consider offering 
courses that allow the neurotherapists to specialise in specific conditions or fields, which may 
provide the profession with greater credibility and help patients achieve the most benefit from 
specialised neurotherapists.   
  
4.4.3 Recommendations for future researchers   
It has been previously mentioned that there is lack of research with regards to treating patients with 
ADHD using neurofeedback, and few studies have focused on the experiences of neurotherapists 
using this treatment. It is thus imperative that more studies like this one are carried out in the future. 
This study provides future researchers with a guideline for future work, which may possibly help 
promote interest in such research.  
  
This study was restricted in its sample size. It is therefore recommended that, in future studies, 
neurotherapists from every province within South Africa should be included, so that there is a 
larger and more diverse sample group. Other types of studies such as clinical trials, observational 
studies and surveys should also be considered.   
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The below research fields can also be considered:   
• Neurotherapists’ experiences with using neurofeedback in the treatment of patients with ADHD 
who are not on psychiatric medication.   
• Neurotherapists’ experiences with using neurofeedback in the treatment of patients with ADHD 
who are on psychiatric medication.   
• Neurotherapists’ experiences with using neurofeedback in the treatment of patients with ADHD 
and autism.   
• Neurotherapists’ experiences with using neurofeedback in the treatment of anxiety in patients with 
ADHD.   
• Neurotherapists’ experiences using the different types of neurofeedback in the treatment of 
patients with ADHD.   
• ADHD patient experiences of neurofeedback therapy.   
  
4.5 CHAPTER DESCRIPTION   
In Chapter 4, the findings of the study are summarised. The limitations of this research were 
discussed and recommendations were offered for future study and practice.   
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APPENDIX A  
Source: American Psychiatric Association (2013). Diagnostic and statistical manual of mental 
disorders, fifth edition (DSM-5).   
  
The American Psychiatric Association’s DSM-5 classifies ADHD under the Neurodevelopmental 
Disorder category and arranges it into three types: hyperactive impulsive, predominantly 
inattentive and combined.   
  
A) A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with 
functioning or development, as characterized by (1) and/or (2):  
  
1. Inattention: Six (or more) of the following symptoms have persisted for at least 6 months to a 
degree that is inconsistent with developmental level and that negatively impacts directly on social 
and academic/occupational activities:  
Note: The symptoms are not solely a manifestation of oppositional behaviour, defiance, hostility, 
or failure to understand tasks or instructions. For older adolescents and adults (age 17 and older), 
at least five symptoms are required.  
a. Often fails to give close attention to details or makes careless mistakes in schoolwork, at work, 
or during other activities (e.g., overlooks or misses details, work is inaccurate).  
b. Often has difficulty sustaining attention in tasks or play activities (e.g., has difficulty remaining 
focused during lectures, conversations, or lengthy reading).  
c. Often does not seem to listen when spoken to directly (e.g., mind seems elsewhere, even in the 
absence of any obvious distraction).  
d. Often does not follow through on instructions and fails to finish schoolwork, chores, or duties 
in the workplace (e.g., starts tasks but quickly loses focus and is easily side-tracked).  
e. Often has difficulty organizing tasks and activities (e.g., difficulty managing sequential tasks; 
difficulty keeping materials and belongings in order; messy, disorganized work; has poor time 
management; fails to meet deadlines).  
f. Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort 
(e.g., schoolwork or homework; for older adolescents and adults, preparing reports, completing 
forms, reviewing lengthy papers).  
g. Often loses things necessary for tasks or activities (e.g., school materials, pencils, books, tools, 
wallets, keys, paperwork, eyeglasses, mobile telephones).  
h. Is often easily distracted by extraneous stimuli (for older adolescents and adults, may include 
unrelated thoughts).  
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i. Is often forgetful in daily activities (e.g., doing chores, running errands; for older adolescents 
and adults, returning calls, paying bills, keeping appointments).  
  
2. Hyperactivity and impulsivity: Six (or more) of the following symptoms have persisted for at 
least 6 months to a degree that is inconsistent with developmental level and that negatively impacts 
directly on social and academic/occupational activities:  
Note: The symptoms are not solely a manifestation of oppositional behaviour, defiance, hostility, 
or a failure to understand tasks or instructions. For older adolescents and adults (age 17 and older), 
at least five symptoms are required.  
a. Often fidgets with or taps hands or feet or squirms in seat.  
b. Often leaves seat in situations when remaining seated is expected (e.g., leaves his or her place 
in the classroom, in the office or other workplace, or in other situations that require remaining 
in place).  
c. Often runs about or climbs in situations where it is inappropriate. (Note: In adolescents or 
adults, may be limited to feeling restless.)  
d. Often unable to play or engage in leisure activities quietly.  
e. Is often “on the go,” acting as if “driven by a motor” (e.g., is unable to be or uncomfortable 
being still for extended time, as in restaurants, meetings; may be experienced by others as being 
restless or difficult to keep up with).  
f. Often talks excessively.  
g. Often blurts out an answer before a question has been completed (e.g., completes people’s 
sentences; cannot wait for turn in conversation).  
h. Often has difficulty waiting his or her turn (e.g., while waiting in line).  
i. Often interrupts or intrudes on others (e.g., butts into conversations, games, or activities; may 
start using other people’s things without asking or receiving permission; for adolescents and 
adults, may intrude into or take over what others are doing).  
  
B) Several inattentive or hyperactive-impulsive symptoms were present prior to age 12 years.  
C) Several inattentive or hyperactive-impulsive symptoms are present in two or more settings (e.g., 
at home, school, or work; with friends or relatives; in other activities).  
D) There is clear evidence that the symptoms interfere with, or reduce the quality of, social, 
academic, or occupational functioning.  
E) The symptoms do not occur exclusively during the course of schizophrenia or another psychotic 
disorder and are not better explained by another mental disorder (e.g., mood disorder, anxiety 
disorder, dissociative disorder, personality disorder, substance intoxication or withdrawal).  
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Specify whether:  
314.01 (F90.2) Combined presentation: If both Criterion A1 (inattention) and Criterion A2 
(hyperactivity-impulsivity) are met for the past 6 months.  
314.00 (F90.0) Predominantly inattentive presentation: If Criterion A1 (inattention) is met but 
Criterion A2 (hyperactivity-impulsivity) is not met for the past 6 months.  
314.01 (F90.1) Predominantly hyperactive/impulsive presentation: If Criterion A2  
(hyperactivity/impulsivity) is met but Criterion A1 (inattention) is not met over the past 6 months.  
  
Specify current severity:  
Mild: Few, if any, symptoms in excess of those required to make the diagnosis are present, and 
symptoms result in only minor functional impairments.  
Moderate: Symptoms or functional impairment between “mild” and “severe” are present.  
Severe: Many symptoms in excess of those required to make the diagnosis, or several symptoms 
that are particularly severe, are present, or the symptoms result in marked impairment in social or 
occupational functioning.  
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APPENDIX B  
  
                                                   
  
DEPARTMENT OF HOMOEOPATHY  
RESEARCH STUDY INFORMATION LETTER  
  
August 2018  
  
Good Day  
  
My name is Jessica Oliveira, I WOULD LIKE TO INVITE YOU TO PARTICIPATE in a 
research study on neurotherapists’ experiences of the use of neurofeedback in the treatment of 
Attention-deficit hyperactivity disorder.  
  
Before you decide on whether to participate, I would like to explain to you why the research is 
being done and what it will involve for you. I will go through the information letter with you 
and answer any questions you have. This should take about 10 to 20 minutes. The study is part 
of a research project being completed as a requirement for a Master’s Degree in Homoeopathy 
through the University of Johannesburg.  
  
THE PURPOSE OF THIS STUDY is to determine neurotherapists’ experience of the use of 
neurofeedback in the treatment of ADHD.   
  
Below, I have compiled a set of questions and answers that I believe will assist you in 
understanding the relevant details of participation in this research study. Please read through these. 
If you have any further questions I will be happy to answer them for you.  
  
DO I HAVE TO TAKE PART? No, you don’t have to. It is up to you to decide to participate in 
the study. I will describe the study and go through this information sheet. If you agree to take part, 
I will then ask you to sign a consent form.   
  
WHAT EXACTLY WILL I BE EXPECTED TO DO IF I AGREE TO PARTICIPATE?  As 
a volunteer in this study, you partake in an interview of approximately one hour, during which 
your experiences of neurofeedback in the treatment of ADHD patients will be discussed. The 
interview will be audio recorded for validity. Subsequent to the interview, audio recordings will 
be typed out and the audio-recording erased. The interview will take place in your private rooms, 
at your most convenient time. No personal information will be disclosed in this study. By signing 
the consent form for the interview and for the audio recordings, you agree to partake in this study.  
  
  
  
 
  Participant initials:____________  
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WHAT WILL HAPPEN IF I WANT TO WITHDRAW FROM THE STUDY? If you decide 
to participate, you are free to withdraw your consent at any time without giving a reason and 
without any consequences. If you wish to withdraw your consent, you should inform me as soon as 
possible.  
  
IF I CHOOSE TO PARTICIPATE, WILL THERE BE ANY EXPENSES FOR ME, OR 
PAYMENT DUE TO ME: You will not be paid to participate and there will be no expenses for 
you.  
  
RISKS INVOLVED IN PARTICIPATION: There are no foreseen risks.   
  
BENEFITS INVOLVED IN PARTICIPATION: There are no direct benefits however the  
information derived from this study may be of value to those working in the field  
  
WILL MY PARTICIPATION IN THIS STUDY BE KEPT CONFIDENTIAL? Yes. There 
will be no names as each participant will be assigned a number. All data and back-ups thereof will 
be kept in password protected folders and/or locked away as applicable. Any other person wishing 
to work with your anonymised information as part of the research process (e.g. an independent 
data coder) will be required to sign a confidentiality agreement before being allowed to do so.  
  
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? The results 
will be written into a research report that will be assessed. In some cases, results may also be 
published in a scientific journal. In either case, you will not be identifiable in any documents, 
reports or publications. You will be given access to the study results if you would like to see them, 
by contacting me.   
  
WHO IS ORGANISING AND FUNDING THE STUDY? The study is being organised by 
myself, under the guidance of my research supervisor at the Department of Homoeopathy in the 
University of Johannesburg. This study will be funded by the UJ Supervisory- linked Bursary.  
  
WHO HAS REVIEWED AND APPROVED THIS STUDY? Before this study was allowed to 
start, it was reviewed in order to protect your interests. This review was done first by the 
Department of Homoeopathy, and then secondly by the Faculty of Health Sciences Research Ethics 
Committee at the University of Johannesburg. In both cases, the study was approved.  
  
WHAT IF THERE IS A PROBLEM? If you have any concerns or complaints about this research 
study, its procedures or risks and benefits, you are free to contact me or my research supervisor at 
any time. You should contact me at any time if you feel you have any concerns about being a part 
of this study.   
  
My contact details are:   
Jessica Oliveira   
0766177916  
Jessicatoliveira@icloud.com Research 
supervisor:  
Dr. J. Pellow (M.Tech Hom)  
Jpellow@uj.ac.za  
  
  
  
            Participant initials:___________  
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If you feel that any questions or complaints regarding your participation in this study have not been 
dealt with adequately, you may contact the Chairperson of the Faculty of Health Sciences Research 
Ethics Committee at the University of Johannesburg:  
  
Prof. Christopher Stein  
Tel: 011 559-6564  
Email: cstein@uj.ac.za   
  
FURTHER INFORMATION AND CONTACT DETAILS: Should you wish to have more 
specific information about this research project information, have any questions, concerns or 
complaints about this research study, its procedures, risks and benefits, you should communicate 
with me using any of the contact details given above.  
  
  
Researcher:  
  
Jessica Oliveira   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   91  
APPENDIX C  
  
   
DEPARTMENT OF HOMOEOPATHY RESEARCH CONSENT FORM  
  
NEUROTHERAPISTS’ EXPERIENCES ON THE USE OF NEUROFEEDBACK IN THE 
TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER  
  
Please initial each box below:  
  
  
  I confirm that I have read and understand the information sheet dated August 2018 for 
the above study. I have had the opportunity to consider the information, ask questions and have 
had these answered satisfactorily.  
  
  
  I understand that my participation is voluntary and that I am free to withdraw from 
this study at any time without giving any reason and without any consequences to me.  
  
  
  I agree to take part in the above study.  
  
  
  
________________           ________________________              _______________  
  
 Name of Participant                Signature of Participant                     Date  
  
  
  
  
________________             _______________________             ________________  
  
 Name of Researcher        Signature of Researcher            Date  
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APPENDIX D  
  
   
DEPARTMENT OF HOMOEOPATHY RESEARCH CONSENT FORM 
FOR INTERVIEWS TO BE AUDIOTAPED  
  
NEUROTHERAPISTS’ EXPERIENCES ON THE USE OF NEUROFEEDBACK IN THE 
TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER  
  
Please initial each box below:  
  
  
                    I hereby give consent for my interview, conducted as part of the above study, to be 
audio-taped.  
  
  
                    I understand that my personal details and identifying data will be changed in order to 
protect my identity. The audio tapes used for recording my interview will be destroyed once data 
has been transcribed.  
  
  
  I have read this consent form and have been given the opportunity to ask questions.  
  
  
  
  
  
__________________    ______________________           ______________  
Name of Participant   
  
  
  
  
      Signature of Participant                        Date  
__________________     ______________________           ______________  
Name of Researcher        Signature of Researcher               Date  
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APPENDIX E  
  
                                                 
Confidentiality Agreement  
  
This agreement is between, Jessica Oliveira (201477038), currently registered at the University of  
Johannesburg Department of Homoeopathy, to complete a research project as a requirement for a  
Master’s Degree in Homoeopathy (the “Discloser”); and Charmaine Williamson (name),  
6101140022088 (ID number) (the “Recipient”), as an independent coder for the research undertaken 
by the discloser.   
The recipient agrees that all confidential information provided by the discloser for the purpose of 
independently coding qualitative data, whether disclosed in writing, orally or otherwise and specified 
by the discloser as confidential, will be kept confidential for an indefinite period of time.   
The recipient agrees to:   
• Keep the discloser confidential information strictly confidential. 
• Not disclose the discloser confidential information to any person without the discloser written 
consent,   
• Not to use the discloser confidential information in any way during the course of the recipient’s own 
work,   
• Use the same degree of care to protect the confidentiality of the discloser confidential information as 
the recipient uses to protect the recipient’s own confidential information,  
• Destroy all of the discloser confidential information and irrevocably delete any discloser confidential 
information from the recipient’s own computer system, as soon as the work completed as the 
independent coder for this study is delivered to the discloser,   
The parties have indicated their acceptance of this Agreement by executing it below.  
 SIGNED  BY  Jessica  Oliveira  (the  discloser),  on  
[………………….……]:……………………………..11/11/2019  
SIGNED BY […………Charmaine Williamson…………] (the recipient), on 11-11-2019  
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APPENDIX F 
  
Report on review of coding to theme-ing data for Jessica Oliveira Compiled by Dr 
Charmaine Williamson, Independent Qualitative Data Analysis advisor  
  
1. Introduction  
Ms Oliveira contacted Dr Charmaine Williamson, who specialises in qualitative data analysis, for 
Dr Williamson to review her approach to coding, categorising and theme-ing data from 6 
interviews around uses of Neurotherapy.  Ms Oliveira identified the assignment as informed by 
two conceptual lenses: quality assurance and learning. She highlighted that she had embarked on 
self-directed learning with regard to the process of coding and theme-ing the data.  
As an independent advisor, Dr Williamson follows the ethical principles of advising researchers 
with regard to their coding: whether the code assigned captures the meaning of the raw data and is 
aligned to the assemblage of quotations to which the code has been assigned. Thereafter, she 
reviews whether the categories and themes are also coherent to the code-quotations linkages. Dr 
Williamson does not do any analysis or interpretation on the basis that these form part of a 
candidate’s original contribution for their study. Furthermore, she does not have the disciplinary 
knowledge inherent to the study.   
Dr Williamson received the following documents for the assignment:  
1. Six interview transcripts;  
2. Research codes which groups the quotations in relation to the codes (raw data text);  
3. Themes Table which is the categorising table of themes, categories and sub-categories 
along with the quotes that corresponds to each;  
4. Confidentiality agreement  
2. Outcome of Review  
Dr Williamson confirms that the following:  
With regard to numbers 1 and 2 above:  
The grouping of the quotations in relation to the research codes is well aligned. The grouping is 
transparently linked to the code with the codes being mainly descriptive.  The quotations coalesce 
well with the code-having an internal consistency that shows the logic of each quotation to code. 
With 55 codes, there are sufficient and they accurately cover a range of issues raised by the 
participants.  
The codes range between two conceptual domains:  1) bio-medical which involve the language of 
diagnosis, treatment, technical practices, patient, etc. to 2) more ecological concepts of healing and 
integration of functions within individual and society: this domain includes the language of holism, 
lifestyle, bonding between therapist and patient, change patterns, supplementary concerns, etc.  
Considering the codes within this continuum might provide a useful means to write up the codes 
within the methodology section and as a springboard into theme-ing the data.  
With regard to 3 above:  
There is again a sound and coherent logic created for the aggregation of quotations against the 
sub/categories and then for the sub/categories in relation to the themes. The researcher has done 
well to group the descriptive codes into higher levels of analysis such as the categories and themes 
that she has conceptualised. There is a clear line of sight from quotation-to-code-to sub/categories 
to themes.  
Dr Williamson has made extensive comments in the document with regard to the themes and some 
of the categories  
From a qualitative data analysis point of view, the main area arising from quality assurance and 
learning is that the themes are too descriptive. In the absence of a conceptual framework 
(conceptual lens), the researcher is viewing the themes too literally. Themes are usually comprised 
of categories which are a clustering of the data together with concepts from the 
literature/conceptual framework. In other words, when viewing a theme, the reader should see 
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which theoretical or conceptual position has been taken. The theme should also suggest the 
assumptions that are composite with the theory/concept. Dr Williamson has suggested a number 
of potential concepts and theories that might inform the more theoretical theme-ing of the existing 
descriptive themes.   The theories and/or concepts include, but are not limited to: • biomedical or   
• behaviourism (alpha/theta; operant conditioning)   
• ecology of care/ethics of care or ecology of healing  
• learning theories   
• social cognitive theories   
• self -efficacy or efficacy of outcomes, etc  
  
The researcher might consider concepts from these theories or the theory itself or a combination 
of theories in a conceptual framework (articles attached as part of the learning). Looking at the 
theme through the lens of a theory makes for a stronger interpretive study than if the themes remain 
at the descriptive level. I have also tried to highlight if the language is scientific, diagnostic etc., 
the assumptions then shows that there is more of a biomedical model being adopted; if language 
is more relational and human-centric, then the assumptions are towards a more ecological model 
of care.  
  
3. Conclusion  
The current documents provided to Dr Williamson show that the researcher has interrogated the 
data in relation to her research questions and her disciplinary focal area of neurotherapy.  She has 
done sound foundational work and does not have to do further cycles of coding.   
Her reading of the data is accurate and satisfies the trustworthiness criteria for qualitative data 
analysis.   
The main improvement that is needed is for the researcher to re-think/conceptualise her themes to 
be more theoretically/conceptually informed.  This might well entail some re-
arrangement/restructuring of quotations as assigned to the themes.    
I thank the researcher for inviting me to review her cognitive journey around coding, categorising 
and theme-ing her participant data.  
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APPENDIX G  
  
FACULTY OF HEALTH SCIENCES  
RESEARCH ETHICS COMMITTEE  
  
NHREC Registration: REC 241112-035  
  
ETHICAL CLEARANCE LETTER  
(REDX 2.0)  
  
  
Approval of the research proposal with details given above is granted, subject to any conditions under below, and is 
valid until 31 January 2019.  
  
1. Conditions:  
Click to enter conditions, if applicable. If no conditions, enter "None".  
  
2. Renewal:  
It is required that this ethical clearance is renewed annually, within two weeks of the date indicated above. Renewal 
must be done using the Ethical Clearance Renewal Form (REC 10.0), to be completed and submitted to the Faculty 
Administration office. See Section 12 of the REC Standard Operating Procedures.  
  
3. Amendments:  
Any envisaged amendments to the research proposal that has been granted ethical clearance must be submitted to the 
REC using the Research Proposal Amendment Application Form (REC 8.0) prior to the research being amended. 
Amendments to research may only be carried out once a new ethical clearance letter is issued. See Section 13 of the 
REC Standard Operating Procedures.  
  
4. Adverse Events, Deviations or Non-compliance:  
Adverse events, research proposal deviations or non-compliance must be reported within the stipulated time-frames 
using the Adverse Event Reporting Form (REC 9.0). See Section 14 of the REC Standard Operating Procedures.  
  
The REC wishes you all the best for your studies.  
Yours sincerely,  
  
Prof. Christopher Stein  
Chairperson: REC Tel: 
011 559 6564  
Email: cstein@uj.ac.za  
RECX 2.0 - Faculty of Health Sciences                                                                                                        Secretariat: Ms Raihaanah Pieterse   
Research Ethics Committee                                                                                                          Tel: 011 559 6073 email: rpieterse@uj.ac.za  
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FACULTY OF HEALTH SCIENCES   
RESEARCH ETHICS COMMITTEE  
  
NHREC Registration: REC 241112-035  
  
ETHICAL CLEARANCE RENEWAL LETTER  
(RECX 3.0)  
  
Approval of the research with details given above is renewed and is valid until 29 July 2020  
  
1. Conditions:  None.  
  
2. Renewal:  
It is required that this ethical clearance is renewed annually, within two weeks of the date indicated above. Renewal 
must be done using the Ethical Clearance Renewal Form (REC 10.0), to be completed and submitted to the Faculty 
Administration office. See Section 12 of the REC Standard Operating Procedures.  
  
3. Amendments:  
Any envisaged amendments to the research proposal that has been granted ethical clearance must be submitted to the 
REC using the Research Proposal Amendment Application Form (REC 8.0) prior to the research being amended. 
Amendments to research may only be carried out once a new ethical clearance letter is issued. See Section 13 of the 
REC Standard Operating Procedures.  
  
4. Adverse Events, Deviations or Non-compliance:  
Adverse events, research proposal deviations or non-compliance must be reported within the stipulated time-frames 
using the Adverse Event Reporting Form (REC 9.0). See Section 14 of the REC Standard Operating Procedures.  
  
The REC wishes you all the best for your studies.  
  
Yours sincerely.  
  
Prof. Christopher Stein  
Chairperson: REC  
Tel: 011 559 6564  
Email: cstein@uj.ac.za  
 RECX 3.0 - Faculty of Health Sciences                                                                             Secretariat: Ms Raihaanah Pieterse  
Research Ethics Committee                                                                                           Tel: 01 1 559 6073 email: rpieterse@uj.ac.za  
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APPENDIX H 
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APPENDIX I  
Example of Transcript   
  
R: Tell me about your experiences with Neurofeedback and ADHD patients in your practice?   
  
P: I did plain Neurofeedback for about four years in the beginning and then started the QEEG 
afterwards. Since I’ve brought in the QEEG and used Neurofeedback as a more holistic therapy, 
the success rate has been higher. I think Neurofeedback should be the first option for the treatment 
of ADHD.   
  
R: What are the challenges you face when dealing with ADHD patients in particular?  
  
P: There are some patients who are so detached from their anxiety so they have no idea as to how 
anxious they really are, they will be non-compliant in the Neurofeedback therapy because their 
anxiety will not be dealt with unless they become aware of it, and as a Neurotherapist you use that 
bond you have with them to help them overcome it step by step. Even if you have everything in 
place, it’s the compliance of the patients so I feel that the motivation still needs to be there. If I 
find that the patient is not motivated to be here and that they have no faith in the therapy, I terminate 
the sessions. In that case it frustrates the patient, it frustrates the parent, and I feel it’s unfair to 
waste their money and time if I know from the beginning it’s not going to work. If the parent is 
also not compliant then I know my prognosis won’t be good.  
  
R: What challenges do you experience with Neurofeedback? Drawbacks, breakthroughs etc.   
  
P: Some people are trained in clinical Neurofeedback which is an incorrect form of the therapy, 
where they hook the child up in a chair with electrodes on their head and they walk out and let the 
system do its own thing. If I am not in there as a therapist giving motivational input and live 
feedback to the patient, then I think that way of doing Neurofeedback will be less successful and 
will give other Neurotherapists doing the correct form of Neurofeedback a bad reputation. There 
are also a lot of unregistered people performing Neurofeedback on patients and can establish a 
franchise and can advertise, whereas us registered neurotherapists aren’t allowed to do that 
according to the body we are registered under. These unregistered can actually cause more damage 
to the patient, they can even cause a seizure if they don’t know what they are doing. Another 
challenge I faced, was initially in my journey I saw the response time was slower in the beginning 
stages of my neurofeedback journey, but once I brought in the QEEG and I actually saw which 
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were the problem areas and incorporated that into the therapy, the response rate increased 
dramatically. There are   
  
R: In your experience, what is the role of neurofeedback in the treatment of ADHD?   
  
P: Anxiety is the most valued component and the quickest symptom which changes. In terms of 
the least value – I don’t see that much because I tend to keep my patient population very 
homogenous. I don’t really go out of my field of practice, like depression and bipolar as I am not 
a clinical psychologist and I am not trained in treating those groups. So there might be fields that 
Neurofeedback has no effect with but I wouldn’t know as I keep within my scope of practice. But 
in my field of practice I don’t see any component that Neurofeedback has no value to because it 
depends on how you work with the patient. If you have a client, and you show them that window 
into their brain and you show them the Neurofeedback software and how their brainwaves are 
going within that favoured threshold and they see that change and they start to see how powerful 
their brain really is and that negativity they always held about themselves isn’t actually necessary 
and true, that is tremendously powerful in their progress of healing.    
  
R: How long on average before an effect is noticed with neurofeedback on your ADHD patients?  
  
P: I usually give it about 3 sessions, but remember that my neurofeedback therapy is only done 
after homoeopathic and nutritional intervention has been done so it’s a lot faster in terms of 
response than what research says and what other neurotherapists have done. Sometimes the change 
is only seen initially within the EEG, and then soon after it is seen physically.  
  
R: Do you find Neurofeedback to be a valuable tool for your ADHD patients in your practice?  
Please elaborate on your answer?   
  
P: Yes, absolutely. I’ve been doing it for such a long time and I just came back from an 
internationally neurofeedback conference and to hear their experiences and their success stories is 
just so inspiring.   
  
R: Is there anything else you would like to add?  
  
P: No comment.  
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APPENDIX J   
Themes Table  
 
Theme  Category Sub-
category  
Sub-
category  
Quote 
1. Neuro-
therapists’ 
experiences  
Perceptions of 
neuro- 
feedback as a 
therapy 
  It’s a great tool to teach them how to 
concentrate (code 20.1) 
I use neurofeedback for majority of my 
patients (code 47.1) 
I think that neurofeedback is a great tool 
(code 47.1) 
I think neurofeedback should be the first 
option for the treatment of ADHD (code 
47.1) 
… so many children that are 
overmedicated … misdiagnosed …This is 
such an easy problem to solve if 
Neurofeedback was accessible in every 
school (code 5.3) 
I use it for all of my ADHD patients (code 
47.4) 
Neurofeedback can help to address the 
different parts of that complex set of 
difficulties (code 39.6) 
But what neurofeedback does is alleviating 
that condition and improve quality of life. 
(code 39.6) 
I think it should be available in every 
school (code 36.3) 
Personal 
experiences 
gained from 
using neuro-
feedback   
Knowledge 
acquired   
 Once again you have to have a look at 
where the concerns are on the QEEG and 
the continuous performance test – so what 
I do is I also do language and reading 
comprehension test to see the reading age 
or comprehension age (code 46.1) 
… I tend to keep my patient population 
very homogenous. I don’t really go out of 
my field of practice, like depression and 
bipolar as I am not a clinical psychologist 
and I am not trained in treating those 
groups (code 33.2) 
If I find that the patient is not motivated to 
be here and that they have no faith in the 
therapy, I terminate the sessions (code 
54.2) 
In that case it frustrates the patient, it 
frustrates the parent, and I feel it’s unfair 
to waste their money and time if I know 
from the beginning it’s not going to work 
(code 38.2) 
The brain does take quite a while to 
process that information it has learnt in the 
therapy and integrate it in their lives, so 
usually patients will still see an 
improvement even after the 
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Neurofeedback sessions have ceased. 
(code 47.2) 
We do find a lot of underlying co-
morbidities with ADHD – such as 
depression and anxiety (code 33.4) 
But one does develop techniques on how 
to calm them down, getting them engaged 
and interested in the sessions (code 40.4) 
Neurofeedback does not focus on one 
diagnosis, we focus on which brain wave 
irregularities are causing what types of 
symptoms and how we can resolve those 
problems (code 39.6) 
Neurofeedback can help to address 
individual irregularities that are present 
and that are causing symptoms and that is 
why it is effective, because we are not 
working with one blanket diagnosis – we 
are working with how does this specific 
dysregulation affect that specific person 
(code 39.6) 
So it’s not always only the concentration 
that improves within those ten sessions, 
but the other small issues they face. (code 
20.6) 
… initially in my journey I saw the 
response time was slower in the beginning 
stages of my Neurofeedback journey (code 
50.2) 
 Cases 
encountered  
 There’s few reasons the patients will come 
to you (code 26.1) 
As a therapy modality it’s something that’s 
great, because you do see the results fairly 
quick (code 47.1) 
… parents first notice better sleep, 
improvements in hand writing and then the 
other symptoms such as getting better 
generally (code 19.1) 
but people would often comment and say, 
“why you’ve been doing great recently”, 
so yes the feedback is promising (code 
47.3) 
We have had more calm, focused, less 
fidgeting patients in class and get great 
feedback from home and the schools (code 
19.3) 
…but once they start to see progress – sort 
of in the second month – then they are 
quite amazed (code 50.3) 
So I see a lot of ADHD kids and adults, 
with very good results (code 47.3) 
But overall I’ve had many good 
improvements with patients that cannot 
focus and keep still in class, to actually 
concentrating and doing the work that is 
assigned. I wouldn’t say I’ve had many 
drawbacks to be honest. (code 47.5) 
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There was a girl that I did neurofeedback 
with yesterday – she has all the symptoms 
of ADHD but she has three hours of sleep 
a night. So her anxiety is off the charts, 
she’s very depressed and on a whole lot of 
medication but nobody has taken the time 
to look at how can we optimize this 
person’s sleep. (code 39.6) 
But most of time there is a significant 
improvement in concentration, anxiety, 
processing ability and in terms of sleep 
(code 26.6) 
Limitations of 
neurofeedback 
Obstacles to 
cure  
Parents  You often get parents telling you, “Oh it’s 
because there’s a new teacher,” or, “Yes, 
it’s because we changed the diet”, so they 
always want to attribute the change to 
something else and not willing to admit 
that it’s the Neurofeedback that’s made the 
difference (code 54.3) 
We do get parents we never see … so we 
struggle in terms of feedback from parents 
because the children play up when they do 
see the parents for that short amount of 
time because they crave their attention 
(code 9.3) 
… so often the parents complain it’s not 
working but when you ask the aupere who 
spends most of their day with the child 
they can see a clear difference  (code 9.3) 
Another thing is feedback from the parents 
during the treatment, sometimes you get 
parents who just drop off their kids and 
you never see them for some face to face 
feedback. Also because the parent lives 
with the child, they aren’t open to changes 
or don’t really observe as closely as I do in 
a session (code 9.5) 
Effective feedback from the parents and 
from the client – especially with ADHD 
kids who have the hyperactivity because 
five of the seven days may have been good 
but the last two days were so bad that it 
completely overshadows those five good 
days (code 9.6) 
Teachers  So another challenge is some teachers are 
so medication-orientated – so they want 
the quick fix, they want this busy child 
that’s disrupting 40 other kids in the class 
they want them out of the equation so they 
want them sedated in a sense, and that 
stigma sometimes is a problem or the label 
they have of the child because they don’t 
want to wait a little bit, so they might 
discourage the parents of letting them 
undergo any treatment either than 
medication (code 8.1) 
Well yeah, I think that, well challenges 
would obviously be that they come to you 
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having trouble with concentrating at 
school ultimately, teachers complaining 
about behaviour and them not 
concentrating (code 8.1) 
There’s so many children that are over 
medicated, almost disregarded by the 
teachers because they’re difficult to teach 
(code 8.3) 
Other 
practitioners  
Often in private practice, it is only the 
concentration problems that are treated – 
which is rather unfortunate. (code 14.6) 
Dysfunction
al situations  
One of the least efficacy it has is on 
behavioural issues caused by external 
factors (code 10.1) 
I’m not a psychologist or a counsellor so if 
there are external factors - those sort of 
things can almost put a person back a bit 
in terms of progression, so the patient may 
have some type of improvement but their 
parents are going through a divorce or they 
have a traumatic accident – 
Neurofeedback cannot help in that aspect 
(code 10.1) 
There are some patients who are so 
detached from their anxiety so they have 
no idea as to how anxious they really are 
(code 16.2) 
If that person’s family system is in 
dysfunction, that patient is totally 
dysfunctional, and no amount of therapy 
or medication is going to sort that out. 
(code 10.6) 
It depends on the compliance of the patient 
and the amount of chaos within the family 
system. (code 10.6) 
…where there are external factors like a 
dysfunctional family. You can’t fix 
brainwaves and put the patient back into a 
chaotic system and expect them to be 
make some miraculous progress. (code 
10.6) 
If your patient is not getting the love and 
attention at home, he is going to look for 
attention in some other form and often that 
plays out as ADHD or an impulsive 
disorder (code 10.6) 
Negative 
aspects of 
neurofeedback  
A high cost 
treatment   
 I think part of it is the cost involved (code 
38.1) 
The costing might be slightly different. 
(code 38.1) 
Also it can be quite expensive and also 
time consuming to get here and sit through 
the sessions (code 37.3) 
Also money is an issue for a lot of people 
but I tend to explain to them that the 
overall cost of monthly repeats of 
Concerta and visiting GP’s is a lot more 
   105  
than a few months of Neurofeedback 
therapy (code 38.4) 
Time 
commitment   
 …because it is a long term therapy (code 
37.1) 
A lot of people do not have the time to go 
through the therapy process, they want a 
quick fix and a miracle so the amount of 
sessions is a bit of a drawback for some 
people (code 37.4) 
Challenges 
encountered 
The 
patient’s age  
 So one of the challenges in terms of 
neurofeedback would be initially the 
severity or the age of the patient, because 
if they are too young they would have 
trouble sitting still, they don’t want to do 
the therapy – so they have to be calm 
enough to sit down a little bit to do the 
neurofeedback session. (code 28.1) 
I’ve seen a lot of restlessness in the 
sessions, they want to run around and 
touch and play and feel everything in the 
room – which creates movement artefacts 
in our readings so we can’t always get 
“clean EEG” in our sessions so we need to 
closely watch and track the patients 
movements in relation to the EEG readings 
(code 17.3) 
First of all to get them to sit still, I mean 
some of my patients look like they’re 
vibrating in the chair with energy (code 
17.4) 
Poor patient 
compliance  
 …they will be non-compliant in the 
Neurofeedback therapy because their 
anxiety will not be dealt with unless they 
become aware of it (code 49.2) 
Even if you have everything in place, it’s 
the compliance of the patients so I feel that 
the motivation still needs to be there (code 
49.2) 
… and if we feel like we still have work to 
do after those sessions, they are reluctant 
to sign in those extra sessions. So progress 
is always made if the patient is compliant 
in the process (code 37.3) 
If the parent is also not compliant then I 
know my prognosis won’t be good (code 
39.2) 
… plays a role in patient compliance 
whether they want to terminate the 
sessions before we even finished, which is 
one of the drawbacks of this therapy (code 
49.3) 
so it’s a struggle to convince certain 
parents that the therapy is working (code 
54.3) 
… if the person is not willing to change 
their unhealthy living habits, their high-
sugar high-fat diet, not willing to exercise 
   106  
and take supplements that they are 
deficient in (code 40.3) 
It’s a waste of time if you come in for two 
sessions a week and pay all this money but 
go home and continue with your bad living 
habits that is contributing to the stoppage 
of your progression (code 40.3) 
And you will get patients who will give 
you a myriad of excuses as to why they 
can’t be dairy free or gluten free (code 
49.3) 
Neurofeedback can go so far if the patient 
is non-compliant in those lifestyle changes 
(code 48.3) 
… not complying with dietary changes 
especially when the parents don’t adhere 
to it too (code 49.4) 
With ADHD adults they are a lot easier to 
treat but usually they are the ones with 
time management issues – they tend to be 
under a lot of pressure at work due to them 
not focusing on the tasks at hand, them 
often forgetting about the appointment or 
they always come late. So the biggest 
challenge with the adults is getting them to 
come to regular sessions (code 30.4) 
Typically it’s the sitting in the chair for 
half an hour staring at the screen that is 
difficult for the patient. But it depends on 
severity. But once they get used to the 
practicality of the session its more 
manageable. (code 17.5) 
An excessive movements in the session 
affects the quality of the session (code 
18.6) 
Excessive movement, non-compliance. 
(code 18.6) 
sometimes people set an idea in their mind 
that it’s going to be 40 sessions and that’s 
it (code 51.3) 
First sign of 
improvement   
  You’ll see it probably within a month 
(code 50.1) 
I usually give it about 3 sessions… (code 
50.2)  
Normally around session 10, so if the 
patient is coming twice a week it’ll be 
within the second month of the therapy 
(code 50.3) 
Usually within the third or fourth session 
they tend to calm down so then it’s no 
longer an issue (code 19.4) 
On average, from session three or four 
most people start seeing an improvement 
(code 50.4) 
Within the first 5 sessions (code 50.5) 
Some people from the second session 
notice a change, but within ten session 
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there must be some improvement (code 
50.6) 
2. Value of 
neuro-
feedback 
in  
practice  
Developing 
therapist- 
patient  
rapport  
  From a homoeopathic or a holistic 
practitioner point of view, you see these 
patients weekly - you establish a 
relationship and bond with them (code 
41.1)  
So even in terms of prescription, you give 
them advice, you take the time to hear their 
symptoms and encouraging 
supplementation (code 41.1)  
The way you encourage them, the way you 
motivate them, and look at the progress of 
the patient – you’re a lot more involved in 
their wellbeing and progression… (code 
41.1) 
… whereas a patient comes to a GP, they 
give them a prescription of Ritalin or 
Concerta and then in two months they see 
them again for their repeat prescription – 
it’s not therapeutic (code 44.1)  
As a Neurotherapist you know what’s 
happening in that patient’s life, you know 
how their condition is affecting 
them…(code 39.1)  
…and whether they’re having bad days or 
how their social or family life is doing, so 
I quite enjoy working so closely with them 
during those months (code 41.1) 
…and as a Neurotherapist you use that 
bond you have with them to help them 
overcome it step by step (code 41.2) 
If you have a client, and you show them 
that window into their brain and you show 
them the Neurofeedback software and how 
their brainwaves are going within that 
favoured threshold and they see that 
change and they start to see how powerful 
their brain really is … that is tremendously 
powerful in their progress of healing (code 
43.2) 
We do have to offer some guidance to the 
parents on how to better manage situations 
better and even how to continue 
implementing the healthy dietary changes 
for their ADHD child (code 39.4) 
Cases in which 
neuro-
feedback has 
value  
  The most value, I see, is the concentration 
and also with Torret’s – the tics (code 
32.3) 
Most value is anxiety and depression, 
insomnia, ADD, ADHD, epilepsy and 
stroke recovery (code 33.4) 
In terms of emotional regulation, 
Neurofeedback works well – they tend to 
be more calm, easier manageable (code 
25.5) 
The most value I have found is in 
improving attention, also regulating their 
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emotions like anxiety, tempers, 
frustration, and how they cope to certain 
situations is much better than when they 
initially came in. (code 25.5) 
It helps the most with sleep disorders, 
depression, anxiety disorders, tics, torrets 
and then ADHD (code 13.6) 
It works very well with ADHD (code 1.6) 
It has a lot of value in improvement of 
attention (code 22.1) 
Anxiety is the most valued component and 
the quickest symptom which changes 
(code 22.2) 
Cases in which 
neuro-
feedback has 
no value  
  … take longer to progress are the learning 
difficulties, like the dyslexia, the reading 
and maths problems (code 48.3) 
I feel the least value it holds is helping with 
bipolar disorder and drug addictions 
because of patient compliance (code 49.4) 
Not to say that neurofeedback doesn’t 
work, but neurofeedback doesn’t cure 
autism and doesn’t most often cure a 
hundred percent improvement in ADHD 
(code 48.6) 
… if there is a physiological issue that is 
causing the ADHD, Neurofeedback is 
limited in that it cannot cure that issue 
(code 48.1) 
Integration 
with other 
therapies  
  …but it’s something that works together 
with other interventions like 
supplementation, functional medicine and 
homoeopathy (code 36.1) 
… but rather a medical intervention may 
be needed alongside the Neurofeedback 
therapy (code 36.1) 
…my neurofeedback therapy is only done 
after homoeopathic and nutritional 
intervention has been done so it’s a lot 
faster in terms of response (code 36.2) 
I work very closely with a group of varied 
practitioners which all understand the 
basics of neurofeedback, so that makes it 
ideal for them to treat the patient according 
to, let’s say their phenotypes and what 
supplements or homoeopathic remedy will 
work for them. (code 36.2) 
So I refer my patients to some of these 
practitioners so that they treat the patient 
according to what the QEEG has shown, 
such as prescribing supplements of 
components, which are lacking in their 
diet or treating the physiological or 
metabolic problem that is impacting their 
life. (code 36.2) 
I don’t see any reason on doing 
Neurofeedback on a patient who has a 
metabolic problem without fixing that 
issue first. (code 39.2) 
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it’s important to get the doctors and 
psychiatrists on board because they will be 
adjusting the medication along the journey 
(code 36.4) 
If epilepsy is involved then they definitely 
need to see a neurologist. (code 34.6) 
So Neurofeedback is definitely a therapy 
that involves lifestyle changes to be more 
of a holistic approach (code 39.3) 
Neuro-
feedback as the 
last line  
of  
treatment  
Patient no 
longer wants 
to take 
medication  
 …their medication is not working well 
enough (code 4.1)  
… it could be that they come to me 
because they don’t want to be on 
medication so they don’t want to go that 
route (code 3.1) 
… or it could be that they want to take 
them off of medication for whatever 
reason like side effects (code 4.1)  
Another challenge is more about the time 
it takes to treat a patient on medication - 
because you adjust their brainwaves with 
Neurofeedback, then the doctor adjusts 
and reduces their medication, then you 
need to readjust their brainwaves again 
because of that change and so on (code 
4.4) 
So if there is an excess of slow theta 
activity in the frontal area which is almost 
always present in ADHD, Ritalin or 
Concerta helps to decrease that but what 
about the excess fast activity in the back 
areas that causes that body restlessness? 
Medication doesn’t do anything to help 
that (code 5.6) 
So it is a much faster process if they are not 
on any medication (code 3.4) 
Its success    …to hear their experiences and their 
success stories is just so inspiring (code 
47.2) 
We’ve had great success (code 47.3) 
I’ve had so many successes (code 47.4) 
It enables our patients to regulate 
themselves so that they will always have 
that long term coping mechanism they can 
bring home. (code 39.4) 
Overall there has always been some kind 
of improvements and that’s the thing with 
Neurofeedback – you always get a positive 
result (code 47.5) 
I use Neurofeedback on all of my ADHD 
patients and I have never found a person 
which it doesn’t work well on. (code 47.5) 
I mean it works, that’s the bottom line 
(code 47.6) 
But in my field of practice I don’t see any 
component that Neurofeedback has no 
value to because it depends on how you 
work with the patient (code 39.2) 
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In terms of success with ADHD, it depends 
on the severity of the condition, (code 
47.6) 
qEEG: A 
supporting 
modality to 
neuro-
feedback  
  Since I’ve brought in the qEEG and used 
Neurofeedback as a more holistic therapy, 
the success rate has been higher (code 
39.2) 
Also, I don’t do any Neurofeedback 
without a QEEG being done. (code 46.2) 
…but once I brought in the qEEG and I 
actually saw which were the problem areas 
and incorporated that into the therapy, the 
response rate increased dramatically (code 
47.2) 
You need a full standard EEG to make a 
diagnosis or assumption in terms of 
progress on a long term basis. (code 45.6) 
Experience 
governs 
treatment 
  I take notice of those repetitive movements 
or habits and notice a change or reduction 
as we go deeper into the sessions, so that 
is usually the first sign of progression 
(code 43.3) 
So you need to know your patient. If you 
don’t take the time to know where each of 
these types of neurofeedback are going to 
cause problems for that person – you’re 
going to get a negative response. (code 
55.6) 
Different types of neurofeedback are 
effective in different cases. (code 39.6) 
Neuro-
feedback as 
holistic 
treatment  
  And not every small discrepancy from the 
norm is something that needs to be treated 
– so we need to look at it in terms of that 
persons holistic functioning. (code 39.6) 
You can’t treat one person in isolation. 
(code 39.6) 
ADHD can be a stand-alone diagnosis - 
absolutely. But often it is part of a more, 
complex set of difficulties. (code 39.6) 
We as neurotherapists need to look deeper 
at the individual because concentration 
alone tells us nothing about cognitive 
functioning.  (39.6) 
Whether it is a patient wanting us to 
specifically target their attention, even 
then they’ll start seeing improvements in 
manageability and then later on it moves 
onto better focus and better concentration 
– so with the brain everything is 
connected, which makes Neurofeedback 
so successful because you deal with one 
part of the brain and the other parts start 
improving as well. (code 26.5) 
We need to look not just at a list of 
symptoms that tick the boxes, but what 
else is going on in the person’s life – what 
is his sleep like, is he being bullied at 
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school, what is his family life like. (code 
39.6) 
3. Neuro-
feedback 
and the 
public  
Neuro-
feedback’s 
uneven 
reputation  
  …will give other Neurotherapists doing 
the correct form of Neurofeedback a bad 
reputation (code 53.2) 
Even if people are coming here or bringing 
their children here and they are paying for 
it, they almost believe it’s not going to 
work – so you almost have to convince 
them the change they’re seeing is because 
of the Neurofeedback (code 54.3) 
So they might compare or just go to 
another company which would give 
neurofeedback a bad name (code 53.1) 
There’s a lot of bad press out there 
regarding Neurofeedback (code 53.3) 
I feel  one of the biggest challenge is 
convincing doctors and parents that 
Neurofeedback works (code 54.4) 
so they don’t really give Neurofeedback 
credit (code 54.5) 
So the general impression is that 
neurofeedback oversells itself. (code 51.6) 
I think one of the reasons to remain on the 
board of our association, is to help guide 
the field in the right direction – in a 
professional, collegial, united network of 
the professionals who are providing a good 
service, and kind of leaving out those who 
are destroying the field. (code 36.6) 
Those people aren’t even registered with 
the health professions council and it’s 
unfortunate, because there are equipment 
that are sold online (code 53.6) 
It is a very big challenge for us 
neurotherapists now because at the start 
there was a big group of practitioners who 
kind of sold neurofeedback as this cure-all 
therapy for every condition which is a load 
of rubbish (code 51.6) 
But we have put in an enormous amount of 
work and effort into publishing some good 
research and forming really good 
relationships with neurologists, 
psychiatrists and some GP’s (code 36.6) 
A lot of my practice is word of mouth so 
hopefully that is changing the public 
perception of neurofeedback (code 51.6) 
It’s usually the people who are using 
Neurofeedback as their first intervention, 
then they tend to be sceptical (code 54.3) 
The lack of 
public 
knowledge  
  I think the other problem might be the 
public not understanding EEG 
neurofeedback (code 52.1) 
Sometimes the schools are a bit sceptical 
because they don’t know or understand 
Neurofeedback (code 52.3) 
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Often parents choose not to tell the 
teachers their child is doing 
Neurofeedback or the patient themselves 
does not tell the family or their boss, 
because they don’t want those people to be 
biased and expect a change (code 51.3) 
Not everyone is open to it (code 51.4) 
…because Neurofeedback is a relatively 
new field especially in South Africa so 
they don’t really know what can actually 
be achieved with the therapy. (code 52.5) 
We really do struggle with fighting for 
credibility of Neurofeedback, with both 
the public and with doctors and 
psychiatrists. (code 54.6) 
Incorrect 
practices of 
neuro-
feedback   
  Some people are trained in clinical 
Neurofeedback which is an incorrect form 
of the therapy, where they hook the child 
up in a chair with electrodes on their head 
and they walk out and let the system do its 
own thing (code 55.2) 
There are also a lot of unregistered people 
performing Neurofeedback on patients 
and can establish a franchise and can 
advertise, whereas us registered 
neurotherapists aren’t allowed to do that 
according to the body we are registered 
under (code 53.2) 
These unregistered people can actually 
cause more damage to the patient, they can 
even cause a seizure if they don’t know 
what they are doing (code 55.2) 
As much as it is a wonderful tool to create 
improvement, if you change brain function 
… without knowing what you are doing, 
or what you are changing, it will create 
problems where there weren’t. (code 55.6)  
You can create an anxiety disorder, you 
can make someone very depressed by 
enhancing alpha waves in a brain that 
already has too much alpha. (code 55.6) 
So there are other companies or other 
modalities that is not necessarily 
Neurofeedback that is being done, such as 
the therapists using the band around the 
arm or infrared or blood flow in the frontal 
cortex, it’s not efficient (code 55.1) 
Research     I mean the research on EEG 
Neurofeedback is different and has been 
proven to work (code 47.1) 
But we have put in an enormous amount of 
work and effort into publishing some good 
research (code 43.6) 
The 
misdiagnosis 
of ADHD 
  So if concentration is not a concern and 
only reading and writing, maybe that 
patient doesn’t need neurofeedback but 
needs remedial lessons (code 40.1)  
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Because they are not reading, they won’t 
concentrate in school and may be labelled 
the class clown, they’ll be misdiagnosed as 
having ADHD (code 45.1) 
or even misdiagnosed as ADHD when 
they actually have something else that 
presents like ADHD (code 45.3) 
and some have even been incorrectly 
diagnosed as ADHD (code 45.4) 
… You know, we need to look through all 
these things first, before just assuming it’s 
ADHD. (code 45.6) 
Some of the psychiatrists (and not the ones 
I work with) spend no more than fifteen 
minutes with the child and make a 
diagnosis, “there’s your schedule six 
drug” – its criminal to not do a proper 
investigation.(code 44.6) 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
   114  
APPENDIX K   
Table of Research Codes  
A table showing the unique code numbers according to the grouped relevant quotes. Quotes are 
given verbatim.   
 
1. ADHD “…ADHD” (code 1.1,2,3,4,5,6) 
2. The challenges of 
having ADHD  
“…you know how their condition is affecting them” (Code 2.1) 
“…often forgetting about the appointment” (code 2.4) 
“…they tend to be under a lot of pressure at work due to them not 
focusing on the tasks at hand” (code 2.4) 
“…they always come late.” (code 2.4) 
“…cannot focus and keep still in class,” (code 2.5)  
“…due to not coping for a long time” (code 2.6) 
3. Patients 
disinclined to 
starting 
medication  
“So, it is a much faster process if they are not on any medication.” 
(code 3.4) 
“no amount of … medication is going to sort that out” (code 3.6) 
“because they don’t want to be on medication so they don’t want to go 
that route” (code 3.1) 
4. Patients wanting 
to be weaned off 
of medication 
“…there’s medication is not working well enough” (code 4.1) 
 “…they want to take them off of medication for whatever reason like 
side effects” (code 4.1) 
“and because they will be adjusting the medication along the journey” 
(code 4.4) 
“…then the doctor adjusts and reduces their medication” (code 4.4) 
“…not needing to medicate as much” (code 4.6) 
5. The overly 
medicated 
society 
“…some teachers are so medication-orientated” (code 5.1) 
“they might discourage the parents of letting them undergo any 
treatment either than medication.” (code 5.1) 
“There’s so many children that are over medicated” (code 5.3) 
“the time it takes to treat a patient on medication” (code 5.4) 
“…on a whole lot of medication” (code 5.6) 
“Sleeping pills are not the answer with regards to a long term cure” 
(code 5.6) 
“Medication doesn’t do anything to help that.” (code 5.6) 
“there’s your schedule six drug” (code 5.6)  
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6. Ritalin and 
Concerta 
“…GP … they give them a prescription of Ritalin or Concerta” (code 
6.1) 
“overall cost of monthly repeats of Concerta” (code 6.4) 
“Ritalin or Concerta helps to decrease that…” (code 6.6) 
7. Side effects of 
ADHD 
medication   
“for whatever reason like side effects.” (code 7.1) 
 
8. Teacher’s 
influence  
“…teachers complaining about behaviour.” (code 8.1) 
“…they want this busy child that’s disrupting 40 other kids in the class, 
out of the equation so they want them sedated in a sense” (code 8.1) 
“…they might discourage the parents (of stopping medication).” (code 
8.1) 
“…they want the quick fix” (code 8.1) 
“…almost disregarded by the teachers because they’re difficult to 
teach” (code 8.3) 
“they want a quick fix and a miracle” (code 8.4) 
9. Discouragement 
from parents 
“If the parent is also not compliant then I know my prognosis won’t be 
good.” (code 9.2) 
“We do get parents we never see, … so we struggle in terms of 
feedback from parents” (code 9.3) 
“…especially when the parents don’t adhere to it too” (code 9.4) 
“it would be to get the parents on board,” (code 9.5) 
“sometimes you get parents who just drop off their kids and you never 
see them for some face to face feedback” (code 9.5) 
“Another thing is feedback from the parents during the treatment” 
(code 9.5) 
“So the parents will come with feedback… saying that he was 
completely terrible” (code 9.6) 
“(no) Effective feedback from the parents” (code 9.6) 
10. Negative 
influences a 
dysfunctional 
environment has 
on patient 
“…caused by external factors.” (code 10.1) 
“…those sort of things can almost put a person back a bit in terms of 
progression, so the patient may have some type of improvement but 
their parents are going through a divorce or they have a traumatic 
accident” (code 10.1) 
“how their social or family life is doing…” (code 10.1) 
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“…amount of chaos within the family system” (code 10.6) 
“If that person’s family system is in dysfunction, that patient is totally 
dysfunctional” (code 10.6) 
“what is his family life like.” (code 10.6)  
“there are external factors like a dysfunctional family.” (code 10.6) 
“You can’t fix brainwaves and put the patient back into a chaotic 
system and expect them to be make some miraculous progress.” (code 
10.6)  
“If your patient is not getting the love and attention at home…plays 
out as ADHD or an impulsive disorder” (code 10.6) 
11. Low self-esteem 
of the patient 
“…low self-esteem” (code 11.6) 
 
12. Hyperactivity  “…who have the hyperactivity” (code 12.6) 
 
13. Insomnia  “Most value is … insomnia” (code 13.4) 
“Difficulties such as sleep disorders” (code 13.6) 
“she has three hours of sleep a night” (code 13.6) 
“Sleep is so important to regulate well” (code 13.6) 
“most value - … sleep disorders” (code 13.6) 
““what is his sleep like” (code 13.6) 
14. Concentration “…they come to you having trouble with concentrating at school 
ultimately” (code 14.1) 
“…and them not concentrating.” (code 14.1) 
“…they won’t concentrate in school” (code 14.1) 
“…concentration” (code 14.6) 
“it is only the concentration problems that are treated” (code 14.6) 
15. Impulsivity  “…impulse control difficulties” (code 15.6) 
“an impulsive disorder.” (code 15.6) 
16. Anxiety “…who are so detached from their anxiety, so they have no idea as to 
how anxious they really are” (code 16.2) 
“…their anxiety will not be dealt with unless they become aware of it,” 
(code 16.2) 
“such as … and anxiety” (code 16.4) 
 “Most value is anxiety…” (code 16.4) 
“…anxiety” (code 16.6) 
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“So her anxiety is off the charts” (code 16.6) 
“most of the time there is a significant improvement in … anxiety” 
(code 16.6) 
“You can create an anxiety disorder” (code 16.6)  
17. Inability to sit 
still/ restlessness  
“…they would have trouble sitting still” (code 17.1) 
“I’ve seen a lot of restlessness in the sessions,” (code 17.3) 
“to get them to sit still … my patients look like they’re vibrating in the 
chair with energy” (code 17.4) 
“it’s the sitting in the chair for half an hour staring at the screen that is 
difficult” (code 17.5) 
18. The patient’s 
disruptive 
behaviour  
“that’s disrupting 40 other kids in the class” (code 18.1) 
“Excessive movement” (code 18.6) 
 
19. Physical 
improvements 
“… parents first notice … other symptoms such as getting better 
generally” (code 19.1) 
“…We have had more calm, focused, less fidgeting patients in class” 
(code 19.3) 
“usually within the third or fourth session they tend to calm down” 
(code 19.4) 
“they tend to be calmer” (code 19.5) 
“…show that he is calm” (code 19.6) 
20. Concentration “It’s a great tool to teach them how to concentrate.” (code 20.1) 
“The most value, I see, is the concentration…” (code 20.3) 
“it’s not only concentration” (code 20.6) 
“not always only the concentration that improves” (code 20.6) 
“…because concentration alone” (code 20.6) 
21. Sleep  “The parents first notice better sleep…” (code 21.1) 
“most of the time there is a significant improvement… in terms of 
sleep” (code 21.6) 
“that sleep quality is better” (code 21.6)  
22. Attention “It has a lot of value in improvement of attention.” (code 22.1) 
“Anxiety is the most valued component and the quickest symptom 
which changes” (code 22.2) 
“because they crave their attention,” (code 22.3) 
“a patient wanting us to specifically target their attention” (code 22.5) 
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“…is in improving attention,” (code 22.5) 
23. Handwriting  “…improvements in handwriting.” (code 23.1) 
24. Behavioural 
improvements  
“Overall there has always been some kind of improvements” (code 
24.5) 
“…improve tempers” (code 24.5) 
“how they cope to certain situations is much better than when they 
initially came in” (code 24.5) 
“that for an adult, they weren’t drinking so many beers at night” (code 
24.6) 
“he’s not fighting so much with his siblings at home.” (code 24.6) 
25. Emotional 
regulation 
“In terms of emotional regulation” (code 25.5) 
“the most value I’ve seen is … also regulating their emotions like 
anxiety, … frustration” (code 25.5) 
26. Cognitive 
improvements  
“There’s few reasons the patients will come to you” (code 26.1) 
“…to actually concentrating and doing the work that is assigned.” 
(code 26.5) 
“it moves onto better focus and better concentration” (code 26.5) 
“with the brain everything is connected, you deal with one part of the 
brain and the other parts start improving as well.” (code 26.5) 
“most of the time there is a significant improvement in concentration 
… processing ability” (code 26.6) 
“the child had remembered to take his plate to the kitchen after eating” 
(code 26.6) 
27. Manageable 
symptoms  
“…easier manageable” (code 27.5) 
“they’ll start seeing improvements in manageability” (code 27.5) 
“more manageable” (code 27.5) 
28. Children in a 
neurofeedback 
session  
“…if they are too young, they would have trouble sitting still, they 
don’t want to do the therapy – so they have to be calm enough to sit 
down a little bit to do the neurofeedback session.” (code 28.1) 
“…another challenge in terms of neurofeedback would be initially the 
severity or the age.” (code 28.1) 
“they want to run around and touch and play and feel everything in the 
room” (code 28.3) 
“…getting them engaged and interested in the sessions” (code 28.4) 
“An excessive movements in the session” (code 28.6) 
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29. ADHD children 
as patients  
“So I see a lot of ADHD kids” (code 29.4) 
“A lot of my clients are actually pre-school to early primary school 
children” (code 29.5)  
“with ADHD kids” (code 29.6) 
30. ADHD adults as 
patients  
“So I see a lot of ADHD … adults” (code 30.4) 
“With ADHD adults they are a lot easier to treat” (code 30.4) 
“biggest challenge with the adults is getting them to come to regular 
sessions” (code 30.4) 
31. Symptoms  “Symptoms” (Code 31.1,2,3,4,5,6) 
32. Tourette’s and 
Tics  
 
“The most value, I see, is the … Tourette’s…” (code 32.3) 
“…tics, Tourette’s” (code 32.6) 
33. Psychiatric 
disorders  
“…like depression and bipolar” (code 33.2) 
“We do find a lot of co-morbidities with ADHD, such as depression 
…” (code 33.4) 
“Most value is … depression” (code 33.4) 
“I feel the least value it holds is helping with Bipolar Disorder” (code 
33.4) 
“she’s very depressed” (code 33.6) 
“…depression, anxiety disorders” (code 33.6) 
“…autism” (code 33.6) 
“you can make someone very depressed” (code 33.6) 
34. Brain 
abnormalities 
“…epilepsy and stroke recovery.” (code 34.4) 
“If epilepsy is involved” (code 34.6) 
35. Neurotherapist “Neurotherapist” (Code 35.1,2,3,4,5,6) 
36. Neurofeedback is 
complementary 
to other therapies 
“…As a therapy modality” (code 36.1) 
“…that works together with other interventions like … functional 
medicine and homoeopathy” (code 36.1) 
“…but rather a medical intervention may be needed alongside the 
Neurofeedback therapy. “ (code 36.1) 
“my neurofeedback therapy is only done after homoeopathic and 
nutritional intervention has been done” (code 36.2) 
“So I refer my patients to some of these practitioners so that they treat 
the patient” (code 36.2) 
“I work very closely with a group of varied practitioners” (code 36.2) 
   120  
“I think it should be available in every school” (code 36.3) 
“It’s important to get the doctors and psychiatrists on board” (code 
36.4) 
“forming really good relationships with neurologists…” (code 36.6)  
“united network of the professionals who are providing a good service” 
(code 36.6)  
37. Long term 
therapy 
“…it is a long term therapy” (code 37.1) 
“…time consuming to get here and sit through the sessions” (code 
37.3) 
“A lot of people do not have the time to go through the therapy 
process” (code 37.4) 
“so the amount of sessions is a bit of a drawback for some people.” 
(code 37.4) 
38. Expensive 
therapy 
“…part of it is the cost involved…” (code 38.1) 
“I feel it’s unfair to waste their money and time if I know from the 
beginning it’s not going to work” (code 38.2) 
“it can be quite expensive” (code 38.3) 
“and pay all this money…” (code 38.3) 
“Also, money is an issue for a lot of people” (code 38.4) 
39. The holistic 
approach of 
neurofeedback  
“From … holistic practitioner point of view” (code 39.1) 
“As a Neurotherapist you know what’s happening in that patient’s life” 
(code 39.1) 
“…used Neurofeedback as a more holistic therapy” (code 39.2) 
“I don’t see any reason on doing Neurofeedback on a patient who has 
a metabolic problem without fixing that issue first.”  (code 39.2) 
“But in my field of practice I don’t see any component that 
Neurofeedback has no value to because it depends on how you work 
with the patient” (code 39.2) 
“Neurofeedback is definitely a therapy that involves lifestyle changes 
to be more of a holistic approach” (code 39.3) 
 “It enables our patients to regulate themselves so that they will always 
have that long term coping mechanism they can bring home.” (code 
39.4) 
“We do have to offer some guidance to the parents on how to better 
manage situations better” (code 39.4) 
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“we focus on which brain wave irregularities are causing what types of 
symptoms and how we can we resolve those problems” (code 39.6) 
“so we need to look at it in terms of that persons holistic functioning” 
(code 39.6) 
“You can’t treat one person in isolation” (code 39.6) 
“We as neurotherapists need to look deeper at the individual” (code 
39.6) 
“then they definitely need to see a neurologist.” (code 39.6)  
“We need to look not just at a list of symptoms that tick the boxes, but 
what else is going on in the person’s life” (code 39.6)  
“neurofeedback does is alleviating that condition and improve quality 
of life.” (code 39.6)  
“Neurofeedback can help to address the different parts of that complex 
set of difficulties” (code 39.6) 
“But often it is part of a more, complex set of difficulties.” (39.6) 
“…we are working with how does this specific dysregulation affect 
that specific person” (code 39.6) 
“but nobody has taken the time to look at how can we optimize this 
person’s sleep” (code 39.6) 
“Different types of neurofeedback are effective in different cases.” 
(code 39.6) 
40. Lifestyle 
interventions  
“…but needs remedial lessons” (code 40.1) 
“…which are lacking in their diet or treating the physiological or 
metabolic problem that is impacting their life.” (code 40.2) 
“and continue with your bad living habits that is contributing to the 
stoppage of your progression” (code 40.3) 
“the person is not willing to change their unhealthy living habits, their 
high-sugar high-fat diet, not willing to exercise.” (code 40.3) 
“But one does develop techniques on how to calm them down” (code 
40.4) 
“…even how to continue implementing the healthy dietary changes for 
their ADHD child.” (code 40.4) 
41. Bond between 
neurotherapist 
and patient  
“…you establish a relationship and bond with them” (code 41.1) 
“take the time to listen to their symptoms and progress…” (code 41.1) 
   122  
“…you’re a lot more involved in their wellbeing and progression” 
(code 41.1) 
“…as a Neurotherapist you use that bond you have with them to help 
them overcome it step by step.” (code 41.2) 
42. Supplementation  “…like supplementation.” (code 42.1) 
“…and encouraging supplementation” (code 42.1) 
“…such as prescribing supplements of components” (code 42.2) 
“and take supplements that they are deficient in” (code 42.3) 
43. Encouraging 
neurotherapists  
“…you give them advice…” (code 43.1) 
“The way you encourage them, the way you motivate them” (code 
43.1) 
 “If I am not in there as a therapist giving motivational input and live 
feedback to the patient, then I think that way of doing Neurofeedback 
will be less successful” (code 43.2) 
“If you have a client, and you show them that window into their brain 
… that is tremendously powerful in their progress of healing.  “ (code 
43.2) 
“I take notice of those repetitive movements or habits and notice a 
change or reduction as we go deeper into the sessions, so that is usually 
the first sign of progression” (code 43.3) 
“But we have put in an enormous amount of work and effort into 
publishing some good research” (code 43.6) 
44. Other 
practitioners  
“they give them a prescription of Ritalin or Concerta and then in two 
months they  see them again for their repeat prescription – it’s not 
therapeutic” (code 44.1) 
“visiting GP’s is a lot more than a few months of Neurofeedback 
therapy.” (code 44.4) 
“A psychiatrist I know …” (code 44.6) 
“at the start there was a big group of practitioners” (code 44.6) 
“psychiatrists and some GP’s.” (code 44.6) 
45. Misdiagnosing 
ADHD 
“…they’ll be misdiagnosed as having ADHD.” (code 45.1) 
“…or even misdiagnosed as ADHD” (code 45.3) 
“some have even been incorrectly diagnosed as ADHD”  (code 45.4) 
“you can’t possibly make that kind of diagnosis” (code 45.6) 
“…before just assuming it’s ADHD.” (code 45.6) 
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“there’s your diagnosis … its criminal to not do a proper investigation” 
(code 45.6) 
“spend no more than fifteen minutes with the child and make a 
diagnosis” (code 45.6) 
“make a diagnosis or assumption” (code 45.6) 
46. qEEG “…have a look at where the concerns are on the QEEG” (code 46.1) 
“…then started the QEEG afterwards. Since I’ve brought in the 
QEEG…” (code 46.2) 
“…but once I brought in the QEEG…” (code 46.2) 
“…what the QEEG has shown” (code 46.2) 
“From the QEEG we have a better idea of what are the problematic 
Neurotransmitters we need to work with,” (code 46.2) 
“On the very first session, I do a QEEG to see where the patient stands 
and use that as a reference point on their progress” (code 46.3) 
“I’ll do another QEEG at the end of their therapy” (code 46.3) 
“from a two channel QEEG” (code 46.6)  
47. The successes of 
neurofeedback  
“…you do see the results fairly quick” (code 47.1) 
“…has been proven to work” (code 47.1) 
“I use Neurofeedback for majority of my patients” (code 47.1) 
“I think that neurofeedback is a great tool.” (code 47.1) 
“I think Neurofeedback should be the first option for the treatment of 
ADHD” (code 47.1) 
“…the success rate has been higher.” (code 47.2) 
“to hear their experiences and their success stories is just so inspiring” 
(code 47.2) 
“Yes, absolutely. “ (code 47.2) 
“So usually patients will still see an improvement even after the 
Neurofeedback sessions have ceased.” (code 47.2) 
“… the response rate increased dramatically “ (code 47.2) 
“We’ve had great success.” (code 47.3) 
“but people would often comment and say, “why you’ve been doing 
great recently”, so yes the feedback is promising” (code 47.3) 
“So, progress is always made if the patient is compliant in the process.” 
(code 47.3) 
“that is usually the first sign of progression.” (code 47.3) 
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“…with very good results.” (code 47.4) 
“I’ve had so many successes.” (code 47.4) 
“I use it for all of my ADHD patients.” (code 47.4) 
“But overall I’ve had many good improvements with patients” (code 
47.5) 
“…you always get a positive result.” (code 47.5) 
“which makes Neurofeedback so successful” (code 47.5) 
“I use Neurofeedback on all of my ADHD patients and I have never 
found a person which it doesn’t work well on.” (code 47.5) 
“In terms of success with ADHD,” (code 47.6) 
“I mean, it works” (code 47.6) 
48. The limitations 
of neurofeedback  
“…least efficacy it has is on behavioural issues caused by external 
factors.” (code 48.1) 
“Neurofeedback cannot help in that aspect” (code 48.1) 
“Neurofeedback is limited in that it cannot cure that issue” (code 48.1) 
“I wouldn’t exactly call it failures…” (code 48.3) 
“the parents complain it’s not working” (code 48.3) 
“Neurofeedback can go so far if the patient is non-compliant in those 
lifestyle changes.” (code 48.3) 
“Things I find that take longer to progress are the learning difficulties, 
like the dyslexia” (code 48.3) 
“neurofeedback doesn’t cure autism” (code 48.6) 
49. Non-compliance 
of patients  
“…they will be non-compliant in the Neurofeedback therapy” (code 
49.2) 
“…it’s the compliance of the patients” (code 49.2) 
“plays a role in patient compliance whether they want to terminate the 
sessions before we even finished,” (code 49.3) 
“…not willing to change…” (code 49.3) 
“…not complying with dietary changes” (code 49.4) 
“…because of patient compliance.” (code 49.4) 
“it depends on the compliance of the patient” (code 49.6) 
“…non-compliance” (code 49.6) 
50. Response time of 
patients to 
neurofeedback  
“I usually give it about 3 sessions” (code 50.2) 
“…initially in my journey I saw the response time was slower” (code 
50.2) 
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“sort of in the second month” (code 50.3) 
“Normally around session 10,” (code 50.3) 
“session three or four most people start seeing an improvement.” (code 
50.4) 
“Within the first 5 sessions” (code 50.5) 
“from the second session notice a change …within ten sessions there 
must be some improvement” (code 50.6) 
51. Misconceptions 
of neurofeedback  
“Not everyone is open to it,” (code 51.4) 
“sometimes people set an idea in their mind that it’s going to be 40 
sessions and that’s it, …they are reluctant to sign in those extra 
sessions” (code 51.3) 
“who kind of sold neurofeedback as this cure-all therapy for every 
condition” (code 51.6) 
“general impression is that neurofeedback oversells itself” (code 51.6)  
“that is changing the public perception of neurofeedback.” (code 51.6)  
“…choose not to tell the teachers their child is doing Neurofeedback 
or the patient themselves does not tell the family or their boss, because 
they don’t want those people to be biased and expect a change.” (code 
51.3) 
52. Lack of public 
knowledge 
“…the public not understanding EEG neurofeedback” (code 52.1) 
“because they don’t know or understand Neurofeedback” (code 52.3) 
“…the biggest thing is that people don’t understand what you are 
doing” (code 52.3) 
“so they don’t really know what can actually be achieved with the 
therapy.” (code 52.5) 
“Neurofeedback is a relatively new field especially in South Africa” 
(code 52.5) 
53. The infamous 
image of 
neurofeedback  
“…they might just go to another company which would give 
neurofeedback a bad name” (code 53.1) 
“…and will give other Neurotherapists doing the correct form of 
Neurofeedback a bad reputation” (code 53.2) 
“…There are also a lot of unregistered people performing 
Neurofeedback on patients and can establish a franchise” (code 53.2) 
“There’s a lot of bad press out there regarding Neurofeedback.” (code 
53.3) 
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“kind of leaving out those who are destroying the field.” (code 53.6)  
“Those people aren’t even registered with the health professions 
council” (code 53.6)  
54. Doubting 
neurofeedback  
“…is not motivated to be here…no faith in the therapy…” (code 54.2) 
“Sometimes the schools are a bit sceptical …” (code 54.3) 
“they almost believe it’s not going to work” (code 54.3) 
“so, they always want to attribute the change to something else and not 
willing to admit that it’s the Neurofeedback that’s made the difference” 
(code 54.3) 
“it’s a struggle to convince certain parents that the therapy is working” 
(code 54.3) 
“is convincing doctors and parents that Neurofeedback works” (code 
54.4) 
“so, they don’t really give Neurofeedback credit.” (code 54.5) 
“We really do struggle with fighting for credibility of Neurofeedback, 
with both the public and with doctors and psychiatrists.” (code 54.6) 
55. Incorrect 
methods of using 
neurofeedback  
“…there are other companies or other modalities that is not necessarily 
Neurofeedback that is being done,” (code 55.1) 
 “Some people are trained in clinical Neurofeedback which is an 
incorrect form of the therapy” (code 55.2) 
“These unregistered can actually cause more damage to the patient” 
(code 55.2) 
“If you don’t take the time to know where each of these types of 
neurofeedback are going to cause problems for that person – you’re 
going to get a negative response” (code 55.6) 
“you can make someone very depressed by enhancing alpha waves in 
a brain that already has too much alpha” (code 55.6) 
“without knowing what you are doing, or what you are changing, it 
will create problems where there weren’t” (code 55.6) 
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APPENDIX L  
Source: Larson et al., (2010) study done of practitioner’s perspectives of neurofeedback therapy 
for mental health and physiological disorders.   
  
Neurofeedback  
advantages         
  
  
Physical and  
Psychological  
Health  
Improvements  Effectiveness  
Alternative=  
Addition to  
Traditional 
Therapy  
Positive Client 
Feedback  
Promotes  
Holistic  
Awareness of  
Self and  
Environment  
Positive  
Feedback from 
NFT  
Increased calming 
effect for 
participating in 
the therapeutic 
process  
Accelerated pace of 
therapy  
Acts as a stand-
alone 
intervention  
NFT gives client’s 
the rewarding 
feeling to 
overcome 
problems  
Teaches mind and 
body awareness  
Treatment has 
empirical support  
Improved sleep  Increased 
improvements 
that verbal 
therapy cannot 
produce  
Complementary 
treatment for 
psychotherapy 
and biofeedback  
Assists clients 
without dwelling 
on the problems  
Identifies 
neurological 
benefits and  
helps client  
become aware 
of harmful 
contexts  
Treatment is 
overrun with 
client referrals  
Decreased 
hyperactivity  
Quick, efficacious, 
and direct 
symptom  
reduction  
Helpful when 
medications 
may be needed  
but are 
ineffective or 
have too 
many side 
effects  
Changes and 
transforms lives  
Provides 
selfawareness 
and self-
reflection  
Treatment allows 
interaction with 
clients  
Decreased 
depression  
Assist numerous 
people in a short 
period  
Provides more 
options for 
treatment  
High client 
satisfaction  
because of  
immense 
benefits  
Provides 
awareness of 
self within the 
environment  
The therapy is 
interesting for 
the practitioner  
Increased 
concentration  
85–90% client 
progress rates  
Good for clients 
who don’t want 
traditional talk 
therapy  
Engages the client  Clients better 
understand 
the underlying 
issues within 
their brain 
rather than the  
DSM  
criteria  
Therapists have 
seen improved 
revenues  
Improved 
attention  
Safe, effective, and 
enduring  May be better 
than 
medication for 
some clients  
Close clinical 
interaction 
between 
therapist and 
client  
Promotes a grasp of 
mind, brain, and 
body principles  
Treatment 
stimulates 
learning  
Decreased 
impulsivity  
Long-term 
resolution  
Provides an 
adjunct option 
to medication  
Provides a client-
centered 
treatment  
  Provides the 
feeling that one 
can finally make 
a  
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Neurofeedback    
advantages          
Physical and  
Psychological  
Health  
Improvements  Effectiveness  
Alternative=  
Addition to  
Traditional 
Therapy  
Positive Client 
Feedback  
Promotes  
Holistic  
Awareness of  
Self and  
Environment  
Positive  
Feedback from  
NFT  
          real difference 
in people’s lives  
Decreased anxiety  Addresses 
symptoms 
rather than 
diagnosis for 
long term 
solution  
Innovative treatment  
    Practitioners 
can learn a lot 
from NFT  
Improved speech  Works with all 
cultures, 
education, age 
levels  
Provides 
neurological 
regulation that 
medication and 
psychotherapy 
do not address  
    Treatment is client 
centered  
Concentrated 
problem solving  
Works for 
numerous 
domains, health, 
education, 
relationships, 
employment, 
and mental 
health  
May be better than 
hypnosis because 
there is less of a  
possibility of 
secondary trauma  
      
Improved calmness 
of mind and 
body  
Incorporates peak 
performance  Provides salient 
advantages over 
other mental 
health resources  
      
Increased general 
health  
Direct impact of 
brain functioning  
May be better 
than cognitive 
rehabilitation 
for brain injury  
symptoms  
      
Improved hearing  Best tool for 
regulation of 
affect and pain  
May be 
integrated with 
traditional 
psychotherapy  
      
Improved 
symptoms of 
Asperger’s, 
autism, TBI,  
Scientific  Provides a new way to 
regulate arousal  
       
PTSD, ADHD = ADD, 
addiction,  
epilepsy,  
OCD   
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Neurofeedback 
disadvantages        
  
Expenses  Time Consuming  Novelty of Discipline  Mixed Results  
Not  
Well-Recognized 
Outside Field  
Equipment costs  Can be considered a 
boring procedure  
Lack of independent 
research  
Can be slower than 
hypnosis in gaining 
response  
People may think NFT is 
weird  
Education costs  Major time requirement 
for learning the  
technical and brain 
knowledge  
Limited understanding 
of  
NFT by many 
physicians  
Does not work for 10– 
15% of clients  
Confusion with other 
types of biofeedback  
Huge initial financial 
setback for 
practitioners  
Major time 
commitment for 
clients  
Difficult to discuss 
medical reductions  Can be technical 
problems with 
software and 
hardware  
Lack of recognition and 
therefore 
reimbursement  
Ongoing expenses  Additional time to 
maintain equipment  
People think it will cure 
everything and forge 
to look at other life 
factors: family, diet, 
sleep patterns, drugs, 
alcohol use  
Outcome is best 
using integrative  
practice, but there 
are no signs of this 
happening on a large 
scale  
Practitioners are 
frustrated with 
NFT being ignored  
Fear that insurance 
companies will shut  
down  
Additional time to 
write reports to pass 
audits  
Psychiatrists do not 
know how  
medications affect 
brain wave 
functioning  
Not used on average 
problems— typically 
used for hard cases 
that  
do not respond to 
earlier interventions  
Lack of public 
knowledge of NFT  
Most insurance 
companies will not 
pay for NFT  
Additional time for 
billing and insurance 
coding  Warring factions 
regarding theories 
and  
practice in the 
field  
  Treatment is ignored by 
the medical field  
Lack of insurance 
coverage  
  Wild claims by 
unlicensed providers  
  Difficult to explain the 
NFT process to 
clients, the public, 
funders, 
practitioners, and 
researchers not in 
the field  
Out-of-pocket expenses  
  Too many unlicensed 
individuals providing 
NFT and making 
wild claims  
  May cause a snake oil 
syndrome for the 
public, medical, and 
other practitioners  
Billing  
      
Lack of the public 
domain knowledge  
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Neurofeedback 
disadvantages         
  
Expenses  Time Consuming  Novelty of Discipline  Mixed Results  
Not  
Well-Recognized 
Outside Field  
Lack of recognition in 
terms of 
reimbursement  
Many clients have to 
self-pay  
Entrepreneurial 
element  
Expenses to keep up 
with the latest 
equipment  
Long-term expense 
ramp-up costs  
Too expensive for most 
families  
Limited billing codes  
      Not well-known in 
other disciplines: 
psychology, social 
work, counseling, 
medicine, and 
psychiatry  
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APPENDIX M  
Confidentiality Agreement - Editor   
  
CONFIDENTIALITY AGREEMENT  
  
I, Kelly Gilbertson, hereby declare that I understand and agree to the following conditions with 
regards to the editing of this research study.   
I understand that the content of this study was received for the purpose of editing and proofreading.   
I understand that the identity of the participants and any individual or company discussed as well as 
the content of the interview transcriptions are confidential and may not be revealed.   
I accept to treat all information as confidential content to which only I have access. I will keep all 
digital and hard copies securely.   
I will return all information back to the researcher on completion of their editing and will delete 
any digital evidence in my possession thereafter.   
  
  
  
Name (Editor):          Kelly Gilbertson  
  
  
Signature:                  
  
  
  
Date:                          09/12/2019                    
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